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“Healing is a matter of time, but sometimes also a matter of opportunity” 
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CHAPTER I 
 
INTRODUCTION 
 
Since the days of the first humans, man has been developing remedies to 
heal wounds.  Artifacts describing treatment for an assortment of wound types 
date back to ancient Mesopotamia with the world’s oldest medical text being a 
description of poultices inscribed on a Sumerian tablet dating to about 2158-
2008B.C. (Majno, 1975).  Throughout the ages a variety of methods were 
employed to stimulate healing from washing wounds in vinegar, as prescribed 
by Galen (court physician to Marcus Aurelius), to “allowing the wound to rot a 
bit,” common in the Middle Ages, where wounds were left untreated until 
infection and pus developed, to the use of maggots to debride the wound of 
necrotic tissue (Broughton et al., 2006), a technique actually still used to treat 
some chronic wounds today.  Even with all the medical advances afforded to 
physicians and patients of the 21st century, treatment of wounds, particularly 
chronic wounds, pose a serious health concern conferring a cost just in the 
United States of approximately $10 billion annually (Murphy, 2011), with chronic 
wounds affecting approximately 1-2% of the population (Hess and Kirsner, 2003; 
Murphy, 2011).  A better understanding of the biological mechanisms involved 
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in wound healing will lead the development of novel therapeutic approaches, 
leading to an improvement in wound care. 
 
Fundamentals of Wound Healing 
 Wound healing involves the precise orchestration of numerous cell types 
and signaling events in order to efficiently and effectively restore a continuous 
tissue.  There are three basic, overlapping, phases of wound healing: 
inflammation, re-epithelialization, and scar formation (Singer and Clark, 1999).  
Impairments during any of these three phases can have deleterious consequences 
including sustained infection, prolonged inflammation, persistent open wounds 
or ulcerated wounds, and / or excessive fibrosis leading to formation of keloids 
or hypertrophic scars (Singer and Clark, 1999). 
Inflammation. 
 Tissue injury is typically accompanied by a rapid inflammatory response, 
which is characterized by an influx of platelets and leukocytes that primarily 
function to facilitate hemostasis, neutralize external pathogens, and phagocytose 
damaged or dying cells (Singer and Clark, 1999).    Within minutes of wounding 
the clotting cascade is activated, leading to the recruitment, aggregation, and 
degranulation of platelets forming the thrombus (Furie and Furie, 1992).  The 
alpha granules released from activated platelets at wound sites function to 
provide the requisite membrane surface that facilitates the coordination of 
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clotting factors leading to the production of fibrin, and  formation the fibrin clot, 
thus sealing the wound (Furie and Furie, 1992).  Additionally, platelets stimulate 
the inflammatory response by releasing growth factors, such as platelet-derived 
growth factor (PDGF), transforming growth factor-beta (TGF-β), as well as pro-
inflammatory cytokines such as interleukin-1 (IL-1) (modeled in Fig1.1), which 
promotes infiltration of immune responsive cells (Barrientos et al., 2008).    
Wounding induces a rapid release of hydrogen peroxide, which has been 
shown in zebarafish to initiate the inflammatory response, stimulating the rapid 
recruitment of leukocytes (Niethammer et al., 2009).  Neutrophils, or 
polymorphonuclear leukocytes, are effector cells of the innate immune system 
that are rapidly recruited to areas of tissue damage.  As quickly as one day post-
wounding, neutrophils comprise roughly 50% of the leukocytes found at the 
wound site (Engelhardt et al., 1998), attracted by chemoattractant gradients of IL-
1, tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ) released 
from platelets, or possibly attracted by the clot itself (Brandt et al., 2000; Eming et 
al., 2007; Gillitzer and Goebeler, 2001). Once at the wound site, neutrophils 
degranulate, releasing numerous cytotoxic factors including reactive oxygen 
species (ROS) in order to neutralize invading pathogens, which will be 
subsequently phagocytosed along with damaged epidermal cells.  Release of 
ROS also functions in the  recruitment of macrophages and the propagation of 
the inflammatory response (Weiss, 1989).  Studies have also shown that 
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neutrophils transcriptionally up-regulate a number of other cytokines, proteases, 
and growth factors known to the involved in promoting extracellular matrix 
(ECM) remodeling, angiogenesis, as well as migration and proliferation of 
keratinocytes and fibroblasts, indicating that neutrophils may play an important 
role in facilitating tissue repair (Theilgaard-Monch et al., 2004).  In addition to 
neutralizing any external pathogens found in the wound site, the degranulation 
of neutrophils often results in collateral damage to the surrounding tissue, as the 
cytotoxic molecules released by neutrophils are also toxic to the host cells.   
Interestingly, studies suggest that neutrophils may actually act to delay wound 
closure, as wounds in mice devoid of neutrophils have been shown to close faster 
relative to controls (Dovi et al., 2003).    
Shortly following the influx of neutrophils into the wound site, monocytes 
infiltrate the wound site, where they are converted into macrophages, in 
response to cues  found  in the wound milieu (Barrientos et al., 2008).   Longer 
lived than neutrophils, macrophages can be found at the wound site throughout 
the wound healing process, including the final tissue remodeling phases 
(Brancato and Albina, 2011).  Isolation of macrophages from various time points 
throughout wound healing have suggested that there are multiple 
subpopulations of macrophages, whose phenotypic expression profiles differ 
temporally and spatially (Brancato and Albina, 2011; Daley et al., 2010).  
Macrophages isolated early post-wounding express high levels of pro-
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inflammatory cytokines, such as TNF-α, while macrophages isolated later 
express higher levels for pro-repair growth factors, such as TGF-β.  Granulocytes, 
such as neutrophils, basophils, and mast cells, found in the wound also 
contribute to the activation of resident macrophages by secreting IL-4, which 
leads to the production of collagen and polyamines through IL-4 induced 
arginase activity in the macrophage (Kreider et al., 2007; Mosser and Zhang, 
2008).   Similar to neutrophils, macrophages are also “professional” phagocytes 
that function to engulf pathogens and cell debris.  As the wound ages, 
neutrophils undergo apoptosis and are cleared by wound macrophages 
(Meszaros et al., 2000).  Growth factors, such as fibroblast growth factor (FGF), 
epidermal growth factor (EGF), PDGF, and TGF-β, are also released by 
macrophages at the wound site to stimulate cell migration, initiating the 
proliferative phase of wound healing (Barrientos et al., 2008).  Despite all the 
evidence that macrophages play an integral role in wound healing, mice devoid 
of macrophages are able to close wounds at rates similar to controls.  In fact these 
mice are reported to also have a reduced inflammatory response and less 
scarring (Martin et al., 2003), suggesting that while initially inflammation may 
play a role in minimizing infection and promoting repair, minimizing the 
inflammatory response may actually improve the outcome of tissue repair. 
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granulation tissue, establishing a provisional matrix to support cell migration.  In 
mammals, unwounded epidermis is a stratified tissue composed of multiple cell 
layers with older or dead cells, resting above younger cells, which sit on a layer 
of extracellular molecules, which compose  the basement membrane (Silverthorn, 
2004).  Prior to epidermal cell migration into the wound bed, a matrix must be 
established, providing a scaffold to support migrating cells (Singer and Clark, 
1999).  Along with neutrophils and macrophages, fibrocytes, bone-marrow 
derived cells that have features of both monocytes and fibroblasts (Bucala et al., 
1994), are recruited to the wound site where they function to promote 
angiogenesis, through secretion of vascular endothelial growth factor (VEGF) 
and PDGF, among other growth factors (Chesney et al., 1998; Hartlapp et al., 
2001).  In cell culture, fibrocytes have also been shown to promote ECM 
component production, aiding in granulation tissue formation (Abe et al., 2001; 
Bucala et al., 1994), although evidence of an in vivo function for fibrocytes 
remains unclear.  Fibroblasts found in the wound bed respond to both growth 
factors secreted by macrophages (Fig. 1.1) and potentially signals released from 
the damaged ECM by producing collagen and other ECM components  to 
establish a provisional matrix (Grinnell, 1994).   
 As cells move into the wound bed, they release matrix metalloproteinases 
(MMPs) to modify the provisional fibrin matrix and establish a collagen-based 
matrix to facilitate migration (Pilcher et al., 1997).  Keratinocytes at the wound 
edge remodel their actin cytoskeleton to facilitate migration, as well as modify 
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cell-ECM adhesions, largely through modifications of integrins, heterodimeric 
transmembrane cell surface receptors that mediate cell-ECM adhesion (Cavani et 
al., 1993; Hynes, 2002; Juhasz et al., 1993).  Integrins play a role in promoting cell 
proliferation as well, as seen in integrin α9 null mice, which have proliferation 
defects resulting in a thinner migrating epithelium following cutaneous 
wounding (Singh et al., 2009).  Regulation of cell-cell and cell-ECM adhesion is 
critical for epithelial cell movement, as movement requires the generation of 
forces through actin polymerization coupled with cell adhesions (Lauffenburger 
and Horwitz, 1996; Mitchison and Cramer, 1996).  If the cell is unable to generate 
enough force, it cannot progress forward. 
As with all aspects of wound healing, re-epithelialization is a tightly 
regulated process.  The signals that initiate cell migration are unclear; however, 
data, primarily from cell culture, have implicated several signaling cascades with 
promoting cell migration, including the receptor tyrosine kinase (RTK) and Jun 
N-Terminal kinase (JNK) signaling pathways (Galko and Krasnow, 2004a; 
Matsubayashi et al., 2004b; Sharma et al., 2003).  Activated by growth factors, 
including PDGF and VEGF, RTK signaling activation leads to the activation of 
extracellular-related kinase (ERK)  and promotes migration of epidermal cell 
sheets following scratch assays in cell culture (Lemmon and Schlessinger, 2010; 
Matsubayashi et al., 2004b), as well as in vivo in Drosophila larvae (Wu et al., 
2009b).  In mice, ERK-dependent cell migration is activated by an increase in 
calcium (Ca2+), which is released by damaged keratinocytes and propagates in 
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waves through  the epidermis surrounding the wound site (Leiper et al., 2006).  
On a side note, increases in intracellular calcium are also required for cell 
proliferation following injury (Sung et al., 2003).  ERK has been shown to induce 
transcriptional activation of genes that promote cell motility and invasiveness 
(Doehn et al., 2009b), further implicating ERK signaling as an important 
regulator of cell migration, and presumably re-epithelialization.  In a Drosophila 
in vivo model, JNK signaling has been shown to also be required for re-
epithelialization as wounds in Basket (Bsk), or Drosophila JNK, fail to close (Galko 
and Krasnow, 2004a).  While there is substantial evidence from both cell culture 
and in vivo models specifying signaling cascades that are involved in regulating 
re-epithelialization, further research is required to elucidate effectors of these 
pathways in order to understand precisely how re-epithelialization is regulated.   
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epidermal cells cease migrating, reestablish cell-ECM adhesions and resume the 
quiescent phenotypes of unwounded epidermis (Gipson et al., 1988; Martin, 
1997).  Contraction of the wound bed is largely the function of myofibroblasts, 
fibroblasts with large α-smooth muscle actin (α-SMA) stress fibers (Desmouliere, 
1995), which when stimulated by TGF-β, remodel the ECM by applying strong 
constrictive forces to the matrix, as well as release MMPs to cleave ECM 
components (Gill and Parks, 2008; Grinnell, 1994; Vyalov et al., 1993).  
Myofibroblast differentiation can be prevented in keratinocyte / fibroblast co-
culture by exogenous application of IL-1 (Shephard et al., 2004), which has been 
shown to induce apoptosis in primary  myofibroblasts, cultured from corneal 
epithelial wounds (Kaur et al., 2009), suggesting that cytokines are important 
regulators of myofibroblast differentiation and wound contraction.  Delays in 
wound healing can occur as a result of failed wound contraction, as found in 
MMP-3 null mice (Bullard et al., 1999a), thus indicating that wound contraction 
and MMPs may play a critical role in enabling wound closure.   
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regenerative processes, while the latter utilizes repair mechanisms (Larson et al., 
2010).  Wound healing in the early embryo induces minimal, if any, 
inflammatory response; whereas in tissues from older animals, a robust 
inflammatory response to wounding ensues (Krummel et al., 1987).  Intriguingly, 
in PU.1 mice, mice with ineffective neutrophils and completely devoid of 
macrophages, not only  are wounds able to heal within a similar timeframe as 
controls, but the wounds heal scarlessly (Martin et al., 2003).  Mast cells are 
another immune response effecter cell that function at the wound site to secrete 
molecules that promote a variety of processes from inflammation to angiogenesis 
to collagen production (Hebda et al., 1993).  Recent studies have implicated mast 
cells in inducing scar formation in E15 mice, a stage where wounds typically heal 
scarlessly, whereas ablation of mast cells in E18 mice, a stage where wounds 
typically scar, prevents scar formation (Wulff et al., 2012).  These results suggest 
that by regulating the inflammatory response, it may be possible to induce 
scarless wound repair in adult tissues. 
 
Models to study wound healing. 
 With a process as intricate as wound healing, naturally there are a myriad 
of models used to study it.  Cultured cells represent the simplest model used to 
study wound healing, where scratch assays are used to study the events involved 
in wound healing on the level of a single cell.  However, wound healing depends 
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on the interactions of multiple cell types, leaving cell culture models overly 
simplistic when it comes to trying to elucidate the regulatory mechanisms 
orchestrating the multiple cell types involved in wound healing.  For that reason 
several in vivo models have been established for studying wound healing from 
using simple multicellular organisms, such as sponges, Drosophila melanogaster, 
and Caenorhabditis elegans (C. elegans) to vertebrate models such as amphibians, 
zebrafish and then of course mammals (Gurtner et al., 2008).  Each system has a 
unique set of advantages and disadvantages, so choosing the proper model 
system should be determined by the question being asked, not simply by the 
tools at hand.  Amphibians, particularly salamanders and planarians have the 
ability to completely regenerate amputated appendages through 
dedifferentiation of differentiated cells at the wound site, inducing blastema 
formation and the potential for regeneration of multiple cell types (Brockes and 
Kumar, 2002; Sanchez Alvarado, 2006).  Elucidation of mechanisms that 
stimulate regeneration in models that naturally regenerate may provide insights 
as to how regeneration can be induced in organisms, such as humans, that 
employ repair mechanisms rather than regenerative mechanisms to heal 
wounds.   
Genetically tractable organisms allow for in vivo characterization of 
biochemical pathways through genetic mutant analysis.  Zebrafish larvae, as a 
genetically tractable model system, have the added advantage of being 
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translucent, a characteristic conducive to live-imaging experiments, which is 
particularly powerful for studying the events of wound healing in real time.  For 
similar reasons, Drosophila embryos are also used to study wound healing in real-
time (Stramer et al., 2005).  Unlike vertebrates, Drosophila have an open 
circulatory system, so they cannot be used to study the signals involved in 
leukocyte extravasation or angiogenesis.  However, Drosophila have a simple 
squamous epithelium (Fig. 1.4) (Martinez Arias, 1993a) that is beneficial for 
studying the mechanisms of re-epithelialization in vivo (Galko and Krasnow, 
2004a; Wood et al., 2002b).  As an established system for studying wound 
healing, Drosophila are also useful for studying the biochemical pathways 
involved in innate immune cell recruitment, hemostasis, and wound healing 
activation, as well as the in vivo dynamics of cell migration during wound 
healing on a cellular level (Razzell et al., 2011).  At present there is no evidence 
for scar formation in Drosophila, but our data does indicate that ECM remodeling 
is required for re-epithelialization in Drosophila larvae.   
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et al., 1999; Sela-Passwell et al., 2010; Van Wart and Birkedal-Hansen, 1990).  
Membrane-anchored MMPs, and secreted MMP-11 and MMP-28, all contain a 
furin-cleavage consensus sequence, indicating that these MMPs can be activated 
intracellularly by furin, a proprotein convertase found in the Golgi (Massova et 
al., 1998; Santavicca et al., 1996; Thomas, 2002).  For those MMPs that do not 
contain a furin cleavage site, there are several proposed activation mechanisms 
including homodimerization, or multidimerization, or interactions with other 
proteases (Lehti et al., 2002; Ra and Parks, 2007; Will et al., 1996b).  In vitro assays 
have shown that MMP9 homodimer formation facilitates interactions with 
MMP3, leading to MMP9 activation (Goldberg et al., 1992; Olson et al., 2000).  
After wounding in mice, immunoprecipitation studies indicate that MMP9 and 
MMP8 are secreted from neutrophils as a heterodimer (Gutierrez-Fernandez et 
al., 2007a), suggesting that MMPs may function as complexes in vivo. 
 Once activated, one mechanism for MMP inhibition is through 
interactions with the endogenous inhibitors, Tissue inhibitor of 
metalloproteinases (TIMP).  There are 4 TIMPs in vertebrates.  TIMP, a wedge-
shaped protein with a conserved N-terminal Cys, inhibits MMPs by binding to 
the MMP active site by chelating the Zn2+ ion (Fernandez-Catalan et al., 1998; 
Maskos and Bode, 2003; Olson et al., 2000).  Functioning as an adaptor, TIMPs 
can also have non-inhibitory MMP interactions, by linking a membrane-
anchored MMP to a secreted pro-MMP, through interactions with the hemopexin 
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domain of the secreted pro-MMP (Fernandez-Catalan et al., 1998; Gomis-Ruth et 
al., 1997; Itoh et al., 2001).  While studies in cell culture suggest that an MT-
MMP/TIMP/pro-MMP complex is required for pro-MMP activation and 
invasive cell behaviors (Itoh et al., 2001), in vivo evidence for the formation and 
functions of such a complex is unclear. 
 
Function. 
  By definition, MMPs are able to cleave extracellular matrix (ECM) 
proteins, but that is not their exclusive function; MMPs have also been shown to 
process bioactive molecules, facilitating various cell signaling events (Gill and 
Parks, 2008; McQuibban et al., 2001).  Up-regulated in virtually every type of 
human cancer, MMPs are associated with tumor progression and poor prognosis 
(Egeblad and Werb, 2002a).  Recent studies have suggested that MT1-MMP may 
facilitate invasive tumor cell migration by degrading focal adhesions, thus 
allowing cell migration (Wang and McNiven, 2012).  MMPs are also associated 
with other human diseases, such as arthritis, where MMP-1 and MMP-13, 
produced by synovial cells and chondrocytes, respectively, degrade collagen and 
aggrecan, a proteoglycan, leading to disease progression (Burrage et al., 2006). 
Due to their roles in disease states such as cancers and arthritis, MMPs are 
alluring therapeutic targets; however, more research is required to understand 
the normal physiological function of these versatile proteases before successful 
20 
 
drug candidates can be developed.  Outside of disease states, MMPs have been 
shown to be required for the regulation of many tissue remodeling processes 
including bone formation, mammary formation, branching morphogenesis, and 
wound healing (Page-McCaw et al., 2007; Rebustini et al., 2009). 
MMPs have been implicated to function during all three phases of wound 
healing (Gill and Parks, 2008).  Beginning with hemostasis, studies in cultured 
platelets and in vitro have suggested that MMP-2 plays a role in platelet 
aggregation (Choi et al., 2008; Kazes et al., 2000), while MMP-12, -13, and -14 
may play a role regulating clotting by cleaving the clotting factor, Factor XII 
(Hiller et al., 2000).  Loss of the neutrophil collagenase (MMP-8) leads to an 
increased inflammatory response and delayed wound healing, as well as an 
increase in MMP-13 (Gutierrez-Fernandez et al., 2007a), suggesting that MMP-13 
and MMP-8 may have redundant functions.  MMP-13, under the control of the 
JNK signaling pathway, plays a role in mediating macrophage recruitment to 
wounds, as knockdown of MMP-13, in zebrafish, results in a dramatic reduction 
in the number of macrophages recruited to the wound site (Zhang et al., 2008).   
In vitro studies indicate that MMPs are able to proteolytically process 
chemokines, which are important for establishing the chemotactic gradients 
necessary for immune cell recruitment (McQuibban et al., 2001; McQuibban et 
al., 2000; McQuibban et al., 2002; Overall et al., 2002), suggesting that MMPs may 
play a key role in modulating the inflammatory response.  Wound closure delays 
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are also observed in MMP-9 and MMP-13 null mice, which both cause a 
reduction in wound contraction and the formation of myofibroblasts (Hattori et 
al., 2009a).  Interestingly, MMP-9/MMP-13 double mutants have an exacerbated 
wound closure phenotype (Hattori et al., 2009a), suggesting that MMP-13 and 
MMP-9 may have redundant functions.  Work in cell culture has shown that 
MMP-1 functions to facilitate cell migration by modifying cell-ECM adhesions by 
cleaving integrins (Pilcher et al., 1997).  MMP7 may play a similar role in 
facilitating re-epithelialization by modifying E-cadherin, as the migration rate of 
culture keratinocytes was accelerated when transfected with active MMP-7 
(McGuire et al., 2003).  However, as with the aforementioned MMPs, facilitating 
cell migration by cleaving E-cadherin, is not a function unique to MMP-7, as 
studies have shown that MMP-28 is also capable of cleaving cell-cell junctions in 
cultured keratinocytes (Saarialho-Kere et al., 2002).  With such a high level of 
redundancy, determining the specific roles of MMPs is challenging in 
vertebrates, particularly during a multifaceted process like wound healing.   
 
MMPs in Drosophila melanogaster. 
 To bypass the complexity of redundancy, we utilized the simple, 
genetically-tractable, model organism, Drosophila melanogaster, to study MMP 
function and regulation in vivo. In Drosophila, there are 2 genes encoding MMPs, 
one of each MMP class, secreted Dm1-Mmp (Mmp1), and membrane-anchored 
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In Drosophila, MMPs are involved in many instances of tissue remodeling; 
however, they are not zygotically required for normal embryonic development, 
as both Mmp1 and Mmp2 mutants have been shown to survive at least until the 
late larval stages (Page-McCaw et al., 2003b).  Similar to vertebrate MMPs, 
Drosophila Mmp1 plays a role during tumor metastasis and invasion (Beaucher et 
al., 2007b; Uhlirova and Bohmann, 2006).  Interestingly, Mmp1 expression 
exclusively in the tumor microenvironment is not sufficient for metastasis. Mmp1 
is also required in the host tissue, indicating that the Mmp1-dependent signals 
released from the tissue surrounding the tumor is required to induce migration 
(Beaucher et al., 2007b).  Invasive cell migration is also a critical step during 
eversion of the wing disc during Drosophila metamorphosis, a process that 
requires basement membrane remodeling and Mmp1 (Srivastava et al., 2007).  
Growth of complex organ systems, such as the trachea and the dendritic arbor, is 
a process that not only requires remodeling of the growing tissue, but also of the 
surrounding extracellular matrix.  During tracheal development, Mmp1 is 
required both for degradation of old cuticle during molts, as well as the 
expansion of the ECM to accommodate the growing trachea (Glasheen et al., 
2010a).  Mmp2 is also involved in tracheal development, functioning to restrict 
FGF signaling to the immediate vicinity of the growing air sac during branching 
morphogenesis (Guha et al., 2009; Wang et al., 2010).  Similarly, during neural 
development, both Mmp1 and Mmp2 are involved in motor neuron guidance and 
defasciculation (Miller et al., 2008).  Additionally, Mmp2 plays role in reshaping 
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sensory neuron dendrites via degradation of the ECM locally, around the 
growing dendrite (Yasunaga et al., 2010).  A common theme amongst all the 
various functions of MMPs in both Drosophila and vertebrates seems to be ECM 
remodeling and modification of signaling molecules in order to facilitate tissue 
growth, migration, and remodeling. 
By combining the simplicity of Drosophila as a model system to study both 
wound healing and MMP functions in vivo, we have found that both Mmp1 and 
Mmp2, as well as their endogenous inhibitor, Timp, play a critical role during 
wound healing, where all three molecules are required for re-epithelialization 
under the control of the JNK signaling pathway.  Additionally, Mmp1, Mmp2, 
and Timp may also facilitate hemostasis and scab formation.  In response to 
wounding, Mmp1 is required for type IV collagen (Viking in Drosophila) 
accumulation at the wound margin, suggesting that Mmp1 is required for 
wound-induced ECM modifications.  The role of Mmp1 in ECM deposition 
extends beyond wound healing, as we find that Mmp1 and Timp, but not Mmp2, 
are required for ECM organization and secretion from epithelial cells in 
unwounded epidermis.  From the redundant phenotypes that we have identified 
in Mmp1, Mmp2, and Timp mutants, along with our results that Mmp2 and Timp 
are required for Mmp1 localization, we hypothesize that Mmp2, Mmp1, and 
Timp function as a tri-molecular complex to promote wound healing in vivo. 
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CHAPTER II 
 
A SECRETED MMP IS REQUIRED FOR RE-EPITHELIALIZATION DURING 
WOUND HEALING 
 (Adapted from Stevens and Page-McCaw (2012)) 
 
Introduction 
Healing a human skin wound requires a complex interplay of cells and 
extracellular matrix (ECM) within a tissue architecture that directs and restricts 
molecular interactions. In the hemostasis phase, platelets form a plug, which is 
replaced by a temporary fibrin matrix; in the inflammatory phase, white blood 
cells neutralize pathogens and phagocytose cell and ECM debris; in the re-
epithelialization stage, epidermal epithelial cells migrate onto the restored 
wound bed, as collagen-based scar tissue replaces the fibrin matrix; and in the 
resolution phase white blood cells are cleared, and provisional ECM is replaced 
(Goldberg and Diegelmann, 2010; Gurtner et al., 2008; Shaw and Martin, 2009; 
Singer and Clark, 1999). These stages are controlled by many growth factors and 
extracellular signals including PDGF, EGF, TNFα, TGFβ, and IGF. In healthy 
individuals small wounds heal without intervention, but clinical wound-healing 
challenges remain for surgical patients, diabetic patients, and burn victims.  
Pathologies of wound healing can be roughly grouped into two categories: 
excessive wound-healing leading to fibrotic scarring; and incomplete wound 
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healing leading to ulcers and persistent inflammation (Goldberg and 
Diegelmann, 2010).  
Matrix metalloproteinases are a large family of extracellular proteases, at 
least ten of which are up-regulated during wound healing by epidermal, dermal, 
fibroblast, or blood cells in mammals (reviewed by Gill and Parks, 2008).  MMPs 
can be subdivided into two classes: secreted MMPs (seventeen mammalian 
family members) and membrane-anchored MMPs (seven mammalian family 
members). Their endogenous inhibitors are TIMPs (tissue inhibitors of 
metalloproteinases), which sterically hinder the active site in a one-to-one 
stoichiometry (Gomis-Ruth et al., 1997).  In vitro and in cell culture, MMPs are 
capable of cleaving most ECM components and proteolytically modifying many 
signaling molecules important for wound healing (Bergers et al., 2000; Egeblad 
and Werb, 2002b; Gearing et al., 1995; Gill and Parks, 2008; Koshikawa et al., 
2004; Levi et al., 1996; Li et al., 2002; Mott and Werb, 2004; Parks et al., 2004; 
Rebustini et al., 2009; Suzuki et al., 1997; Tholozan et al., 2007; Yu and 
Stamenkovic, 2000).  MMPs are widely considered to be pro-inflammatory 
during the wound healing process because of the high levels of MMP expression 
in chronic wounds (Goldberg and Diegelmann, 2010; Menke et al., 2007; Schultz 
and Wysocki, 2009).  However, MMPs may have larger roles as they sit at the 
nexus of inflammation, ECM remodeling and cell signaling (reviewed in Parks et 
al., 2004).  Mouse MMP knockouts have limited utility in defining MMP 
functions because of redundancy within the MMP family (Page-McCaw et al., 
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2007).  Knock-out mice for each of four secreted MMPs (MMP-3, MMP-8, MMP-9 
and MMP-13) display a mild delay in closing excisional wounds, indicating that 
MMPs have a functional role in wound healing. MMP-3 (stromelysin-1) mutants 
have defects in wound contraction (Bullard et al., 1999b); MMP-8 mutants have 
prolonged inflammation (Gutierrez-Fernandez et al., 2007b); MMP-9 and MMP-
13 mutants have delays in epithelial migration (Hattori et al., 2009b; Kyriakides 
et al., 2009a).  These mild phenotypes probably belie the role of MMPs in wound 
healing, as the vertebrate MMP family displays significant redundancy. The ~24 
mammalian MMPs have overlapping substrate specificity and expression 
patterns (Egeblad and Werb, 2002b).  Indeed, MMP redundancy in wounding 
has been reported: MMP-9/-13 double mutants have longer wound healing 
delays than the single mutants (Hattori et al., 2009b), yet even these mice still 
have a large number of intact MMP genes that may be masking other MMP 
wound-healing functions.  This genetic redundancy clouds a mechanistic 
understanding of wound healing in vivo.  
Drosophila is an established model system for wound healing (Galko and 
Krasnow, 2004b; Wood et al., 2002a), and in Drosophila there are only two MMPs: 
one secreted (DmMmp1) and one membrane-anchored (DmMmp2) (Llano et al., 
2002; Llano et al., 2000; Page-McCaw et al., 2003a).  Additionally, the Drosophila 
MMPs are inhibited by a single endogenous TIMP (DmTimp) (Godenschwege et 
al., 2000a; Wei et al., 2003), in contrast to the four TIMPs in mammals.  This 
simplicity allows us to identify the roles of the secreted and membrane-anchored 
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MMPs as a class in vivo, including their tissue sources and regulatory 
mechanisms.  Drosophila wound healing involves the same wound healing 
phases as vertebrates (hemostasis, inflammation, re-epithelialization, and 
resolution)(Galko and Krasnow, 2004b), including the migratory re-
epithelialization phase.  We report here that Mmp1 and Mmp2 are each required 
for re-epithelialization during wound healing, as puncture wounds remain open 
in the mutants.  Focusing on the secreted MMP, Mmp1, we report that it 
facilitates re-epithelialization by promoting ECM assembly, cell elongation, actin 
cytoskeletal reorganization, and extracellular signal-regulated kinase (ERK) 
activation.  The wound-induced up-regulation of Mmp1 is controlled by jun N-
terminal kinase (JNK), and when JNK is ectopically activated by TNFα to 
produce high levels of Mmp1, wound closure is accelerated in an Mmp1-
dependent manner. 
 
Methods 
Fly lines.  
The following lines are described in Page-McCaw et al (2003):  Mmp12 and 
Mmp2 Df(2R)Uba1-Mmp2 (imprecise P excision alleles resulting in deletions of most or 
all of the coding region); Mmp1Q112* and Mmp2W307* (EMS-induced nonsense 
alleles resulting in premature truncations); UAS-Timp and tubP-GAL4 (Flybase ID 
FBtp0002651). The dominant-negative Mmp1 line used was UAS-Mmp1.f1E225A 
(Glasheen et al., 2009b; Zhang et al., 2006). Other fly lines used were A58-Gal4 
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(M. Galko), UAS-BskDN (Flybase ID FBti0074418) and He-Gal4 (Flybase ID 
FBti0064641) both from the Bloomington Drosophila Stock Center,  two lines of 
UAS-Mmp1-dsRNA (D. Bohmann and the Vienna Drosophila RNAi Center 
insertion 101505), Vkg-GFPG205 (Yale Flytrap), UAS-egr (M. Muiro, shorter RB 
isoform (Igaki et al., 2002b), and UAS-GFP-actin5C (D. Kiehart,).  w1118 was used 
as wild type. 
 It has not been possible to perform rescue experiments using standard 
Mmp1 constructs because Mmp1 over-expression is lethal when widely expressed 
(even under permissive temperatures with a heat-shock promoter, or under 
GAL4/GAL80ts control).  As an alternative approach, a non-complementation 
screen in an independent genetic background was performed in Page-McCaw et 
al (2003a) to identify new Mmp1 alleles to show genetic specificity for Mmp1. 
Phenotypes in trans-heterozygotes (carrying a P-generated allele and an EMS 
allele) have been used to establish Mmp1 specificity in previous reports 
(Glasheen et al., 2009b; Glasheen et al., 2010a; Page-McCaw et al., 2003a), a 
strategy we employ in this study as well. 
 
Wounding assays.   
3rd instar larvae were impaled with a 0.1mm steel needle (Fine Science 
Tools) on the dorsal side between segments A3-5, on molasses plates on ice.  For 
pinch wounds, #5 dissecting forceps were used to gently pull / pinch the cuticle 
for about 5s, without puncturing, on the dorsal side of 3rd instar larvae.  Both 
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assays were adapted from Galko and Krasnow (2004).  After wounding, animals 
recovered on agar plates with access to wet yeast and water at 25°C.  
 
Dissection, fixation, immunohistochemistry.   
To excise the epidermis, larvae were decapitated at the cerebral tracheal 
branch and filleted along the right lateral side, followed by removal of the 
posterior end at approximately segment A7.  Dissections were done in PBS + 
1%BSA or directly in fixative.  Tissue was pinned flat and fixed in PBS + 4% 
formaldehyde at RT for 30 min. Fixed samples were washed and permeabilized 
in PBS + 0.2% Triton X-100, blocked in PBS + 5% goat serum + 0.02% NaN3, 
incubated in 1o antibody (diluted in PBS + 1% goat serum + 0.02%NaN3) 
overnight at 4°C, washed and incubated in 2o antibodies for 1.5 h at RT in the 
dark, and mounted in Vectashield mounting media with DAPI (Vector Labs).  
Anti-Mmp1 catalytic domain (a 1:1:1 cocktail of mouse monoclonal IgG1 
antibodies 3B8, 5H7, and 23G, generated by Page-McCaw et al (2003) and 
obtained from the Developmental Studies Hybridoma Bank (DSHB)), was used 
at 1:100.  Anti-FasIII (a mouse monoclonal IgG2a from the DSHB) was used at 
1:10.  Rabbit anti-GFP (Molecular Probes) was pre-absorbed against larval 
epidermis and used at 1:100. Mouse anti-Integrin-βPS (a monoclonal IgG2b from 
DSHB) was used at 1:10. Mouse monoclonal IgG1 anti-diphosphorylated-ERK 
1&2 (Sigma) was used at 1:200. Mouse monoclonal anti-collagen IV (gift of Lisa 
and John Fessler) was used at 1:25.  Cy3 or FITC labeled goat anti-mouse IgG1 
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(Jackson ImmunoResearch), DyeLight649 labeled goat anti-mouse IgG2a 
(Jackson ImmunoResearch), Cy3 labeled goat anti-mouse (Jackson 
ImmunoResearch), FITC-labeled donkey anti-rabbit (Jackson ImmunoResearch) 
were all used at 1:300.  
 
Microscopy.  
Optical sectioning was performed with a Zeiss Apotome mounted on an 
Axio imager Z1 or M2, with the following objectives: 20X/0.8 Plan-Apochromat, 
40X/1.3 oil EC Plan-NeoFluar, or 63X/1.4 oil Plan-Apochromat. Fluorescent 
images were acquired with an Axiocam MRm (Zeiss) camera paired with 
Axiovision 4.8 (Zeiss). Z-stacks were compressed into 2-deminsional projections 
using the Orthoview function in Axiovision.  All images were exported from 
their acquisition programs as 16-bit, grayscale, TIFF files for post-processing in 
Adobe Photoshop CS4, or ImageJ v.1.43u.  
 
Wound measurements.   
Closure and wound area were assessed based on the presence of both 
FasIII staining at cell borders and epidermal polyploid nuclei as stained with 
DAPI. To calculate wound area, the outline tool in Axiovision (Zeiss) was used to 
manually outline the wound edge.  This feature automatically calculates the area 
of the outlined region using image acquisition specifications.  In Figure 2.1E-F, 
the wounded animals are as follows. Wild type (n=19): w1118. Mmp1 (n=6): 4 
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Mmp1Q112*/2 and 2 Mmp12. Mmp2 (n=7): 4 Mmp2 W307*/Df(2R)Uba1-Mmp2 and 3 
Mmp2W307*.  A58>Timp (n=5). Student’s t-tests were performed with the analysis 
tools available in GraphPad Prism v. 5.01 to compare mutant and wild-type 
wound area within each time point. 
To measure aspect ratios (Fig. 5 and S3), wounded epidermal samples 
were fixed at varying times post-wounding (0h is immediately after wounding) 
and stained for FasIII and DAPI. XY projections of wounds were generated from 
optical sections taken at 20X.  On each leading edge cell a line was drawn 
manually with ImageJ on the longest axis determined by FasIII staining, and then 
the longest perpendicular axis was drawn. The ImageJ measurement tool 
measured the lines, and aspect ratios were calculated in Microsoft Excel. Since 
this method ignores cell orientation, the long axis was used as the numerator, so 
that the smallest possible ratio was 1.0.  Only cells with FasIII on all edges were 
measured. n≥29 cells from 3 different animals for each column.  Mmp1 was the 
transheterozygous Mmp1Q112*/2. The mean aspect ratio for each genotype at each 
time point was calculated and graphed using GraphPad Prism v. 5.01 (GraphPad 
Software).  Error bars represent the standard error of the mean.  Student’s t-test 
was used to determine the statistical significance between pairs of columns.   
 
Expression analysis.   
To generate heat maps of pixel intensity from fluorescent images, single 
channel 16-bit grayscale 2D projection from Z-stacks were converted to 8-bit 
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images in ImageJ v1.43u.  The “fire” look-up table (LUT) was then applied to the 
image to pseudo-color pixels based on intensity, white = 256 and dark navy blue 
= 0.   
To measure relative dpERK expression between genotypes over time, 2D 
projection images were opened in ImageJ and the ellipse tool was used to mark 
nuclei at the leading edge of the wound based on DAPI staining and anti-FasIII 
expression, while the dpERK channel was hidden.  The multi-measure tool was 
then used to calculate an integrated intensity density for each region of interest 
(ROI, representing each nucleus) for the dpERK channel.  Each integrated 
density value was imported into GraphPad Prism v5.01, where GraphPad Prism 
analysis tools were used to perform Student’s t-test to compare mutant intensity 
to wild-type intensity at each time point and to compare wild-type wounded 
intensity to wild-type unwounded intensity at each time point.    
For Vkg-GFP intensity analysis in unwounded tissue, XY images of Vkg-
GFP taken at 63X during seven blindly-scored, independent trials were opened 
in ImageJ and automatically sized to 9.25in x 6.93in.  A 1 in2 square grid was 
applied to the image and integrated density was calculated within each square 
using the ImageJ measure tool.  Squares that contained only basement membrane 
were measured; squares that contained folds in the tissue or ECM from other 
tissue types were excluded.  All intensity measurements were imported in a 
Microsoft Excel spreadsheet and the average pixel intensity for each sample 
(each animal) was calculated along with the overall average intensity for each 
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genotype within each experimental replicate.  To calculate relative expression 
intensity between Mmp1 mutants and wild type, the ratio of mutant versus wild-
type intensity was calculated for each sample within experimental replicate.  The 
negative inverse was calculated for all ratios less than 1.  Ratios for each mutant 
and wild-type sample were imported in GraphPad Prism and plotted on a box 
and whiskers plot, with wild type ranging from -1 to 1.  Student’s t-test was used 
to assess the differences between genotypes.  A similar method was used to 
quantify anti-collagen IV staining intensity, except that the grid squares were ½ 
in2. 
 
Western blots.   
Third instar larvae (1-3 Vkg-GFP/CyO larvae or 2-5 Vkg-GFP 
Mmp12/Mmp1Q112* larvae) were homogenized in 30µl 2X Laemmli buffer with 
mini-complete protease inhibitors (Roche).   20µl of each lysate was loaded in 
each lane of a 4-15% tris-glycine PAGE gradient gel (BioRad). Blots were washed 
in PBS + 0.1% Tween-20, blocked in Odyssey Blocking Buffer (BioRad) and 
probed with rabbit anti-GFP (Molecular Probes) used at 1:1,000, or mouse anti-
actin (Abcam) used at 1:5,000, overnight at 4°C.  Secondary antibody incubations 
were 1h at RT with goat anti-mouse labeled with IRdye800 (Li-Cor) at 1:7,500, or 
donkey anti-rabbit tagged with IRDye680 (Li-Cor) at 1:5,000, followed by 
developing with the Odyssey Infrared Imaging System (Li-Cor).  Integrated 
fluorescence intensity was calculated for the top bands (shown in Fig. 4K) using 
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ImageJ v. 1.43u, as these had no corresponding background bands in non-GFP 
containing wild-type lanes; the intensities of these bands were summed to find 
total expression.  Expression was normalized against integrated fluorescence 
intensity of the actin loading control.  Fold change of anti-GFP expression in 
Mmp1 mutants was calculated relative to that in wild type.  No statistically 
significant difference was found between Mmp1 mutants and wild type over 3 
independent trials.  
 For the Mmp1-dsRNA knock-down efficiency blots (Fig. S2), third instar 
larvae (2 Tub>Mmp1-dsRNA of both the DB line and the VDRC line, 4 Mmp12, or 
2 Tub-Gal4) were homogenized in 30ul 2X Laemmli buffer.  20µl of each lysate 
was loaded in each lane of a 10% tris-glycine PAGE gel (BioRad).  Blots were 
washed in PBS + 0.1% Tween-20, blocked in Odyssey Blocking Buffer (BioRad) 
and probed overnight at 4°C with 1:1:1 cocktail of monoclonal mouse anti-Mmp1 
antibodies 3B8, 5H7, and 3A6 (DSHB) used at 1:100 and with rat anti-α-Tubulin 
(AbD Serotec) used at 1:5000.  Secondary antibody incubations were at RT for 1h 
in donkey anti-mouse labeled with IRdye800 (Li-Cor) at 1:5,000, or donkey anti-
rat tagged with IRDye680 (Li-Cor) at 1:7,500, followed by developing with the 
Odyssey Infrared Imaging System (Li-Cor).  Three independent trials were 
performed and results were quantified following the methods outlined for the 
Vkg-GFP blots, with Mmp1 expression normalized against α-Tubulin expression 
within each lane.  Normalized intensity values were imported into 
GraphPadPrismv5.01, where the mean and standard error of the mean was 
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plotted for each genotype and the p-value was calculated by a Student’s t-test 
comparing each mutant/knockdown expression level to wild type. 
 
 
Results 
Both Drosophila MMPs are required for re-epithelialization. 
Mmp1, the secreted Drosophila MMP, is required for developmental tissue 
remodeling during tracheal growth and metamorphosis (Glasheen et al., 2009b; 
Glasheen et al., 2010a; Srivastava et al., 2007).  We asked if Mmp1 is required for 
the tissue remodeling required during wound healing of the larval epidermis.  
Larval epidermis is a monolayer squamous epithelium, protected on the apical 
side by a chitinous cuticle, and overlying a basal basement membrane (Martinez 
Arias, 1993b).  Most larval epidermal cells are highly polyploid and incapable of 
proliferation (Smith and Orr-Weaver, 1991). To assess wound healing, we 
punctured larval epidermis in wild-type and Mmp1 null mutants with a fine 
needle, using the procedure of Galko and Krasnow (2004b).  We used third instar 
animals; Mmp12 null mutants die during a prolonged third instar, almost never 
entering metamorphosis (Page-McCaw et al., 2003a).  After puncture, the animals 
were allowed a recovery period for healing, and then we dissected, fixed and 
stained the epidermis with anti-FasIII and DAPI to visualize cell borders and 
nuclei.  In wild-type larvae 5h after wounding, epidermal cells at the wound 
edge had elongated and begun spreading into the wound; by 14h wounds had 
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typically closed, often forming syncitia over the center of the wound, as 
previously reported (Galko and Krasnow, 2004b).  Assessing wound closure by 
location of nuclei and cell borders, we found that 79% of wild-type animals 
closed their wounds by 14h (n=19, Fig. 2.1A, E).  
In contrast, re-epithelialization failed to occur in 100% of wounded Mmp1 
null animals, both homozygous null Mmp12 larvae, and transheterozygous null 
Mmp12/Q112*, demonstrating specificity for Mmp1 (Fig. 2.1B, E).  The Mmp1 
wounds gapped open by 1h (Fig. 2.1G) and remained larger than the size of the 
original puncture (Fig. 2.1F, G).  These were not simply delays in wounding, as 
Mmp1 wounds never closed: even at 50h post-wounding, the rare surviving 
Mmp1 mutants still had open wounds (n=2) whereas all wild type wounds were 
closed (n=4).  
There are only two MMPs in Drosophila, so we asked whether the 
predicted GPI-anchored MMP, Mmp2 was also required for wound healing.  In 
both Mmp2W307* and Mmp2W307*/ Df(2R)Uba1-Mmp2 animals, wounds failed to close (Fig. 
2.1C, E, F). We overexpressed the catalytic inhibitor Timp throughout the larval 
epidermis using the A58-GAL4 driver (Galko and Krasnow, 2004b), and the 
expression of this endogenous inhibitor recapitulated the failure of re-
epithelialization in the MMP mutants with very large wounds (Fig. 2.1D-F).  
Thus each Drosophila MMP is involved in wound closure in a non-redundant 
manner.   
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To further test for redundant roles, we administered puncture wounds to 
double mutant Mmp2 Mmp1 animals.  Both single MMP mutants had an 
incompletely penetrant clotting defect, such that many of the animals died after 
puncturing (discussed further in chapter 3).  In double mutants, the clotting 
defect was pronounced and fully penetrant: all the animals bled out and died 
shortly after wounding, indicating that they have clot formation defects (n=84).  
Thus Drosophila MMPs appear to act redundantly in the hemostasis phase of 
wound healing, but are each required for re-epithelialization.  The remainder of 
this chapter is focused on Mmp1.  Mmp2 and Timp will be discussed further in 
chapter 5. 
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Figure 2.1. Each Drosophila MMP is required for re-epithelialization.   
A-D) Wounded larval epidermis 14h post-wounding from indicated genotypes.  Anti-FasIII 
(yellow) labels cell borders and DAPI (blue) labels the nuclei.  The white arrow (A) indicates the 
center of the closed wound, while the white dashed lines outline open wounds (B-D). Scale bar 
on (A) represents 20µm for A-D.  E) Percent of wounds open versus closed 14 h post-wounding.  
The numbers on each bar (E-F) indicate the number of animals for each sample set.  F) Mean 
wound area 14h post-wounding (including all wounds, open and closed).  The red dashed line 
represents the area of the needle used to induce wounds (~8,000µm2).   Mutants are significantly 
different from wild type, as calculated by t-test: Mmp1 (p=0.0004), Mmp2 (p=0.011), A58>Timp 
(p<0.0001).  G) Graph of wound area over time in wild type (black line) and Mmp1 mutants (blue 
line).  At 1h (Mmp1 n = 4, wild type n=21), 5h (Mmp1 n=14, wild type n=23), and 14h (Mmp1 n=6, 
wild type n=19) post-wounding, mutant wounds are significantly larger than wild type (p=0.003, 
p=0.032, and p=0.0001, respectively).  There is no significant difference in wound area between 
Mmp1 mutants and wild type at 0h (Mmp1 n=4, wild type n=8) and 0.5h (Mmp1 n=5, wild type 
n=15) post-wounding.  Error bars (F-G) represent standard error of the mean. See Materials and 
Methods for alleles used.  (Adapted from Stevens and Page-McCaw 2012). 
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Mmp1 is required in the epidermis for re-epithelialization.   
Epidermal wound healing involves the coordination of at least two 
different tissue types: epidermal epithelial cells and hemocytes (innate immune 
cells of the blood).  To elucidate which tissue(s) require Mmp1 during re-
epithelialization, we knocked down Mmp1 using an inducible RNAi targeting 
construct (Uhlirova and Bohmann, 2006) under the control of tissue-specific 
GAL4 drivers A58-GAL4 (epidermis) and He-GAL4 (hemocytes).  By 18h post-
wounding, wounds closed in 86% of wild-type animals (Fig. 2.2A, E). Similar to 
the whole animal Mmp1 mutants (Fig. 2.1B), when Mmp1 was knocked down 
specifically in the epidermis (A58>Mmp1-dsRNA) wounds remained open in 
100% of animals 18h post-wounding (Fig. 2.2C, E), with an average wound area 
that was significantly larger than wild type (Fig. 2.2F).  In contrast, when Mmp1 
was knocked down in hemocytes (He>Mmp1-dsRNA), healing was similar to 
wild-type (Fig. 2.2B, E, F).  To ensure specificity of the RNAi, we used an Mmp1-
dsRNA line targeting another region of the transcript (from the VDRC), with 
similar results (unpublished data).  An anti-Mmp1 western blot confirmed both 
lines reduced protein levels, with the Bohmann line more effective (Fig. 2.3).  
These results demonstrate that Mmp1 expression in the epidermis is required for 
re-epithelialization.     
To test whether the catalytic activity of Mmp1 was required for wound 
closure, we expressed in the epidermis a catalytically inactive Mmp1, UAS-
Mmp1E225A, which harbors an alanine mutation at a conserved glutamic acid in 
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the active site and acts as a dominant-negative (Glasheen et al., 2009b; Zhang et 
al., 2006).  In animals expressing Mmp1E225A in the epidermis, wounds remained 
open in 100% of the animals tested 18h post-wounding (Fig. 2.2D, E), with an 
average wound area that is similar to the RNAi-mediated knock-down of Mmp1 
(Fig. 2.2F).  Our results indicate that Mmp1 catalytic activity is required for re-
epithelialization. 
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Mmp1 is up-regulated in the epidermis in response to wounding. 
 To test if there is a local response to wounding, we analyzed wound-
induced Mmp1 expression changes in the epidermis. To accommodate the large 
dynamic range of Mmp1 expression, we visualized Mmp1 expression changes by 
pseudo-coloring anti-Mmp1 images based on pixel intensity, generating heat 
maps (see Fig. 2.4 and Methods for this chapter).  Using specific monoclonal 
antibodies that recognize the catalytic domain of Mmp1 (Glasheen et al., 2010a; 
Page-McCaw et al., 2003a), we found that Mmp1 was expressed at low levels 
throughout the unwounded epidermis (Fig. 2.4A, B).  In XY projections, Mmp1 
appeared localized to the cell-cell borders (Fig. 2.4A), but in XZ projections it was 
clear that Mmp1 also lines the basal surface of the epidermal cells, where it could 
come in contact with the basement membrane (Fig. 2.4B, B’).  A half-hour after 
wounding Mmp1 expression had not changed at the wound site (Fig. 2.4C), but 
by three hours after wounding Mmp1 was up-regulated in the epidermal cells 
specifically around the wound site (Fig. 2.4D), with no detectable changes in 
expression in cells more than 4-5 cell diameters away from the wound.  Maximal 
up-regulation was observed at 5h post wounding (Fig. 2.4E and data not shown).  
Elevated Mmp1 levels persisted in the syncytia and surrounding epithelial cells 
even after the wound was closed (Fig. 2.4F).  In pinch wounds, where the cuticle 
remains intact, Mmp1 was also up-regulated (Fig. 2.5), suggesting that Mmp1 
up-regulation is triggered by damage rather than by the introduction of 
pathogens.  We found that Mmp1 is generally up-regulated in a gradient highest 
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in the cells at the wound margin (see Fig. 2.4D, E).  Although Mmp1 is generally 
up-regulated throughout these cells (Fig. 2.4E-G), we observe an accumulation of 
Mmp1 at the distal edge (Fig. 2.4E white box, G, H; white arrows indicate distal 
accumulation), as well as high levels of Mmp1 proximal to the wound margin 
(Fig. 2.4H, H’ yellow arrow). 
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membrane during wound healing in wild-type and Mmp1 mutant larvae.  We 
used a Vkg-GFP (collagen IV α2) protein trap expressed under its endogenous 
promoter to visualize the basement membrane (Morin et al., 2001).  By 1h post-
wounding in wild-type animals there was no detectable Vkg-GFP accumulation 
along the wound edge (data not shown); however, by 5h post-wounding in wild-
type larvae there was dramatic Vkg-GFP accumulation at, or directly in front of, 
the leading edge (n=6, Fig. 2.6A, A’, C).  In the Mmp1 null mutants, there was no 
accumulation of Vkg-GFP at the leading edge (n=8, Fig. 2.6B, B’, D).  Notably, 
Mmp1 is expressed heavily around the leading edge by 5h after wounding (Fig. 
2.6E, G) at the site where Vkg is assembled. Our data suggests that Mmp1 
promotes the assembly of collagen IV at wound sites, rather than promoting 
widespread degradation of collagen IV.  It is likely that without new basement 
membrane, Mmp1 mutant wounds are unable to close because the epidermal 
cells lack a substrate upon which to migrate. 
As Mmp1 is needed for wound-induced basement membrane assembly, 
we asked if it is necessary for basement membrane maintenance in unwounded 
epidermis, especially considering that Mmp1 protein is localized to the basal side 
of these cells (Fig. 2.6B).  We used the Vkg-GFP protein trap to analyze baseline 
collagen IV levels and structure in unwounded tissue (Fig. 2.6E, F).  In wild-type 
basement membrane underlying unwounded epidermis, Vkg-GFP appeared as a 
fibrous mesh, slightly concentrated around the cell nuclei (Fig. 2.6E, E’).  In 
Mmp1 mutants, the overall Vkg-GFP fibrous pattern was similar to wild type, but 
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the intensity was significantly lower than wild-type (Fig. 2.6F, F’, I), as scored in 
seven blind experiments.  As an independent confirmation of collagen IV 
localization in the unwounded basement membrane, we stained epidermal 
samples with a monoclonal antibody raised against cg25C (collagen IV α1); this 
antibody has been used previously for immunostaining (Murray et al., 1995).  We 
again observed reduced levels of collagen IV in the Mmp1 unwounded epidermal 
basement membrane (Fig. 2.6H, H’, J) compared to wild type (Fig. 2.6G, G’, J). 
These data suggest that either Mmp1 is necessary for assembling collagen IV into 
the basement membrane, or that Mmp1 is required for the expression or stability 
of collagen IV proteins.  To test the latter hypothesis, we compared Vkg-GFP 
protein levels in whole larvae on western blots probed for GFP (Fig. 2.6K).  We 
found no significant differences in Vkg-GFP levels between wild-type and Mmp1 
mutants (Fig. 2.6K, K’).  Our data suggest that Mmp1 is required to facilitate 
Vkg-GFP deposition into the basement membrane, both at wound sites and 
during normal growth, but not for overall Vkg-GFP expression or stability. 
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Figure 2.6: Mmp1 is required for ECM remodeling and maintenance. 
A-B) Vkg-GFP at wound margin 5h post-wounding (green), with nuclei (blue, DAPI) and cell 
borders (red, anti-FasIII) in Vkg-GFP/+ (A, n=6 animals) and in Vkg-GFP Mmp1Q112*/Mmp12 (B, n=8 
animals). White asterisk indicates wound bed.  A’-B’) Heat maps of Vkg-GFP from panels A, B. 
C-D) XZ image of Vkg-GFP (green), fasIII (red) and DAPI (blue) at the wound edge 5h post-
wounding in control (C) and Mmp1 mutants (D).  White asterisks designate wound beds.  E-F) 
Vkg-GFP localization in unwounded epidermis in control (E) and Mmp12/Q112* mutants (F). E’-F’) 
XZ image of Vkg-GFP in unwounded control (E’) and Mmp1 mutants (F’).   G-H) Anti-collagen 
IV (Cg25C) staining in unwounded epidermis in wild type (G) and in Mmp1 mutants (H), n=6 
animals for each genotype. G’-H’) XZ images of anti-collagen IV staining in wild type (G’) and 
Mmp1 mutants (H’). All scale bars represent 20µm; scale bar in A for A-D; scale bar in F for E-H; 
scale bar in F’ for E’-H’. I-J) Box-and-whiskers plot of Vkg-GFP intensity (J) or collagen IV 
staining intensity (K) in unwounded basement membrane in control and Mmp1 mutants. 
Numbers in the boxes on graph indicate the number of animals measured. By Student’s t-test, 
Vkg-GFP intensity (p=0.0051) and anti-collagen IV staining intensity (p=0.0054) are significantly 
lower in Mmp1 mutants relative to wild type.  K) Western blot of anti-GFP in unwounded whole 
Vkg-GFP/+ and Vkg-GFP Mmp1Q112*/Mmp12 larvae, anti-actin as a loading control. K’) 
Quantification of 3 western blots (as in K) showing no significant difference between Vkg-GFP 
protein levels in whole Mmp1 mutant larvae versus wild-type by paired t-test (p=0.87). The 
fluorescence intensity of the bands was normalized to the loading control. Error bars represent 
standard error of the mean.  (Adapted from Stevens and Page-McCaw 2012). 
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Mmp1 is required for migration after wounding. 
Cell migration is required to close wounds, so we asked whether cells at 
the leading edge of Mmp1 mutant wounds were able to migrate.  As cells 
migrate, they elongate in the direction of migration (reviewed in Mogilner and 
Keren, 2009a).  We measured the aspect ratio of epidermal cells at the leading 
edge of the wound site (see Materials and Methods), comparing cell shape in 
healing wounds to initial cell shape in wounds that were immediately fixed after 
puncture, reasoning that the cell elongation represents a measure of migration.  
In wild-type wounds, we found that cell aspect ratios appeared to increase 
gradually over time, but that by 5h after wounding cells had clearly elongated 
(Fig. 2.7C).  By 5h post-wounding, wild-type leading edge cells were almost 
twice as elongated as they were immediately post-wounding (Fig. 2.8A, A’, C).   
In contrast, leading edge cells failed to elongate by 5h in Mmp1 mutants 
(Fig. 2.8B, B’, C), and the aspect ratio remained fairly constant after wounding 
(Fig. 2.7D). In these mutants, cells maintained the aspect ratio they took on 
immediately after injury.  We noticed that Mmp1 epidermal cells are smaller than 
wild-type cells (see Figs. 2.8A, B and 2.7A, B), which may be secondary to the 
pronounced tracheal defects in the mutant that causes hypoxia (Beaucher et al., 
2007a; Glasheen et al., 2010a).  Epidermal cells knocked down for Mmp1 
(A58>Mmp1-dsRNA, Fig. 2.8C) did not exhibit marked changes in cell size, and 
these cells also failed to elongate after wounding (Fig. 2.8D), demonstrating that 
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Mmp1 is specifically required for cell elongation and migration. Similarly, when 
we overexpressed Timp in the epidermis, leading-edge cells failed to elongate 
(Fig. 2.8D). These data demonstrate that Mmp1 in the epidermis is required for 
cells to elongate, the first step of migration.   
Another characteristic of migrating cells is the presence of actin-rich 
projections in the direction of migration (reviewed in Mogilner and Keren, 
2009a).  As a second indicator of cell migration, we analyzed wound-induced 
actin changes in leading-edge epidermal cells using an Actin5C-GFP fusion 
protein (Verkhusha et al., 1999) expressed specifically in the epidermis with A58-
GAL4.  In wild-type tissue 1h after wounding we observed actin accumulation 
along the proximal side of leading edge cells, along with small, thin actin-rich 
projections extending into the wound bed (data not shown).  By 5h post-
wounding, wild-type cells had dense actin mesh along the proximal side of the 
leading edge cells with long, thick actin-rich projections extending into the 
wound bed (Fig. 2.8E), suggesting that these cells were actively migrating.  In 
contrast, in Mmp1 mutants 5h post-wounding we observed actin accumulation in 
stress fibers along the leading edge, but no projections extending into the wound 
bed (Fig. 2.8F), suggesting that leading edge cells in Mmp1 mutants do not 
migrate to close the wound.  
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Figure 2.8: Mmp1 is required for leading edge cell migration.   
A-B) Aspect ratios of wild-type (A,A’) and Mmp1 (B,B’) leading edge cells were calculated by 
measuring perpendicular axes (shown in red), at 0h (A,B) and 5h (A’,B’) after wounding. See 
Materials and Methods for details.  C) Aspect ratio analysis for wild type (black bars) and Mmp1 
mutants (blue bars).  Black stars indicate that wild-type cells at 5h are significantly different from 
wild-type cells at 0h post-wounding (p<0.0001) by Student’s t-test.  Blue stars show that Mmp1 
mutant cells are significantly different from wild type at 5h (p=0.0001) post-wounding by 
Student’s t-test.  There is no significant difference in aspect ratio between wild-type and Mmp1 
mutant cells 0h post-wounding, and similarly cells in Mmp1 mutants show no significant change 
in aspect ratio between 0 and 5h after wounding.  D) Aspect ratio 5h post-wounding.  Leading 
edge cells in Mmp1 mutants (p=0.0001), A58>Mmp1-dsRNA (p=0.0015), A58>Timp (p=0.041), and 
A58>BskDN (p=0.0043) are significantly less elongated than wild-type at 5h post-wounding.  
Numbers in the base of each bar (C-D) denote the number of cells measured. Error bars represent 
the standard error of the mean.  E, F) Actin-GFP localization around control A58>Actin-GFP (E) 
and mutant Mmp12 A58>actin-GFP (F) wounds (n=3 for each genotype). White arrows (E) indicate 
actin-rich protrusions into the wound bed.  Asterisk indicates a wound bed (A-B, E-F).  All scale 
bars are 20µm: A-B’ scale bar in A’, E-F scale bar in F.  (Adapted from Stevens and Page-McCaw 
2012). 
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One possible explanation for the lack of cell elongation in Mmp1 mutants 
is that Mmp1 may be required to release the adhesion of cells from the ECM.  In 
cell culture models, integrins on the distal edges of migrating cells are released 
from the basement membrane, allowing cells to progress forward, and there are 
reports of MMPs cleaving integrins (Pal-Ghosh et al., 2011; Vaisar et al., 2009).  
We examined βPS integrin localization at wild-type wounds by antibody 
staining, and we found that Mmp1 protein co-localized with βPS integrin at the 
distal edges of cells at the wound (Fig. 2.9).  Although this co-localization 
suggested that Mmp1 may have a role in releasing β-integrins after wounding, 
we did not observe changes to integrin localization in our fixed wild-type 
samples at any time points during re-epithelialization (data not shown).  
Similarly, no changes in β-integrin staining were evident in Mmp1 mutant 
wounds relative to wild-type wounds (data not shown).  Although these 
negative results do not rule out the hypothesis that Mmp1 releases integrin-
based adhesion, it seems unlikely that a failure to release adhesion at the distal 
edge would result in the observed failure of cell elongation (Fig. 2.8A-D); rather, 
persistent integrin adhesion at the distal edge would be expected to result in 
perpetually elongated cells that are non-motile, a phenotype not observed. 
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staining within the marked areas (see Materials and Methods).  In wild-type 
animals, we found that dpERK activation is nearly undetectable in unwounded 
epidermis and increases modestly at 0.5h and 1h after wounding; but by 3h and 
5h after wounding, dpERK levels are much greater in nuclei at the leading edge 
of wounds (Fig. 2.10 and Fig. 2.11).  In contrast, in Mmp1 mutant animals, ERK 
activation does not change appreciably after wounding (Fig. 2.11B, D).  Similarly, 
in epidermal knock-downs of Mmp1 (A58>Mmp1-dsRNA), dpERK activation is 
significantly decreased after wounding (Fig. 2.11C, D), although not as 
completely as in the Mmp1 null animals, perhaps because of the residual 
leakiness of the knock-down (Fig. 2.3), or because of Mmp1 contributions from 
other unaffected tissues.  Our data demonstrate that Mmp1 is required to 
promote ERK signaling in epidermal cells after wounding.  
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Mmp1 is regulated by JNK signaling during wound healing. 
 Another pathway known to be required for wound healing is the JNK 
pathway (Galko and Krasnow, 2004b; Ramet et al., 2002; Wu et al., 2009a).  
Previous studies have shown that Mmp1 is regulated by JNK signaling during 
tumor invasion and wing disc eversion (Srivastava et al., 2007; Uhlirova and 
Bohmann, 2006).  We asked if JNK signaling regulates Mmp1 activity during re-
epithelialization by using a JNK (Bsk) dominant-negative construct (UAS-BskDN) 
to interfere with JNK signaling specifically in the epidermis (A58>BskDN).  In 
unwounded tissue, there was no apparent difference in Mmp1 expression or 
localization in wild type compared with A58>BskDN (compare Fig. 2.12A to B).  
After wounding, however, Mmp1 was not up-regulated in the epidermis of 
A58>BskDN mutants as it was in wild-type (compare Fig. 2.12B to D).  
Furthermore, the re-epithelialization defects seen in the Mmp1 mutants are also 
observed in the A58>BskDN mutants including cell elongation failures (Fig. 2.12D) 
and wound closure failures (Galko and Krasnow, 2004b; our data not shown).  
Ectopic up-regulation of the JNK pathway resulted in the up-regulation of 
Mmp1.  Previous studies have shown that tumor necrosis factor-alpha (TNFα) 
stimulates JNK activation in mammalian cells and in Drosophila (Brenner et al., 
1989; Igaki et al., 2009).  When we over-stimulated the JNK pathway by 
overexpressing Drosophila TNF, eiger (egr), in the epidermis (A58>egr), Mmp1 
expression in unwounded A58>egr epidermis was similar to wild-type (compare 
Fig. 2.12A to E).  In contrast, 5h after wounding A58>egr epidermis, we observed 
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dramatic Mmp1 up-regulation not only in the epidermal cells at the wound site, 
but extending to epidermal cells about 5 cell-lengths from the wound (compare 
Fig. 2.12B to F).  Importantly, egr overexpression in the epidermis caused 
accelerated wound closure.  Five hours post-wounding, A58>egr wounds are 
significantly smaller than wild-type (Fig. 2.12B, F, G-G”, H-H”, I, J).  To 
determine if the accelerated wound closure is Mmp1-dependent, we generated 
mutants that simultaneously overexpressed egr and knocked down Mmp1 in the 
epidermis (A58>egr, Mmp1-dsRNA).  We found that by 5h post-wounding, the 
average wound area in A58>egr, Mmp1-dsRNA mutants was not only 
significantly larger than both wild-type and A58>egr alone, but the wound areas 
were similar between A58>egr, Mmp1-dsRNA compared to A58>Mmp1-dsRNA 
(Fig. 2.12J).  Taken together with the expression data, these results indicate that 
Mmp1 is downstream of and required for the accelerated healing function of egr.  
Although our data are consistent with the hypothesis that Mmp1 levels 
determine the rate of closure, it is also possible that other targets of egr signaling 
accelerate healing, and Mmp1 is simply a permissive factor.  Unfortunately we 
could not test if increased Mmp1 directly accelerates healing because all animals 
ectopically expressing (GAL4-mediated) epidermal Mmp1 were lethal before 
third instar, even in the presence of GAL80 (not shown).  As a whole, our results 
demonstrate that the Drosophila secreted MMP, Mmp1, is up-regulated in 
wounded epidermis where it promotes epidermal re-epithelialization, basement 
membrane repair, and wound signaling.     
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Figure 2.12: Mmp1 is positively regulated by JNK signaling during wound healing.   
A-F) Heat map showing Mmp1 expression in the epidermis in unwounded (A,C,E) and 5h post-
wounding (B,D,F) in the designated genotypes, pseudo-colored based on pixel intensity 
(intensity scale shown on right).  A white dashed line (B,D) outlines the open wound beds.  The 
white arrow (F) indicates the very small wound bed in A58>egr wounded epidermis. n≥5 for each 
genotype. Scale bar in E represents 20µm for A-F.  G-H) Images of wounds at 0h (G,H), 3h 
(G’,H’), and 5h (G”,H”) post-wounding in wild type (G-G”) and A58>egr (H-H”) labeled with 
FasIII (yellow) and DAPI (blue).  White dashed lines outline the wound bed. Scale bar in G 
represents 20µm for G-H”.  I) Quantification of wound area over time in A58>Mmp1-dsRNA 
(orange line), wild type (black line), and A58>egr (purple line). A58>Mmp1-dsRNA wounds are 
significantly larger than wild type at 0.5h (p=0.032), 1h (p=0.0005) and 5h (p=0.0027) by Student’s 
t-test. A58>egr wounds are significantly smaller than wild type at 5h (p=0.031) by t-test.  There is 
no significant difference in wound area between mutants and wild type in initial wound area 
(0h). Areas of  ≥3 wounds were measured for each time point.  J) Wound area 5h post-wounding 
for the indicated genotypes.  By t-test, wounds in A58>Mmp1-dsRNA (p = 0.021), A58>egr (p = 
0.031) and A58>egr, Mmp1-dsRNA (p = 0.017) are all significantly different from wild type.  
Additionally, by t-test A58>egr wounds are significantly smaller than A58>egr, Mmp1-dsRNA (p= 
0.0024) wounds at 5h post-wounding.  There is no significant difference in wound area 5h post-
wounding between A58>Mmp1-dsRNA and A58>egr, Mmp1-dsRNA mutants (p=0.77) by t-test.  
All error bars represent the standard error of the mean. (Adapted from Stevens and Page-McCaw 
2012). 
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Discussion 
 To bypass the complexities of the large and redundant set of MMPs 
expressed in mammalian wounds, we utilized the simple model organism, 
Drosophila, to analyze MMP function in wound healing.  We find that both Mmp1 
and Mmp2 null mutants display not just delays in wound healing, but a complete 
failure of re-epithelialization.  Interestingly, wounding the double MMP mutants 
identifies the first instance of MMP redundancy in Drosophila:  the two MMPs are 
redundant for clotting, as the double mutants bleed out within a few hours after 
wounding.  Thus both MMPs are required for re-epithelialization and either 
MMP is required for hemostasis.  Focusing on the role of the secreted MMP, we 
find that Mmp1 is required in the epidermis for re-epithelialization, and that 
Mmp1 is required for cell elongation, reorganizing the actin cytoskeleton, 
repairing the basement membrane, and promoting ERK signaling.  
 
Mmp1 promotes assembly and repair of the basement membrane 
Of the many defects observed in the Mmp1 mutant wounds, it is possible 
that the defects in the basement membrane are primary, with the other 
phenotypes as consequences.  Not only do leading edge cells fail to deposit 
collagen IV at the wound, but even unwounded basement membrane appears 
abnormal with respect to collagen IV levels.  These data lead to the surprising 
conclusion that a secreted MMP is required not for matrix degradation, but to 
promote matrix assembly.  Although this may seem paradoxical, we envision 
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MMPs contributing to ECM assembly by cleaving the existing basement 
membrane in order to insert new molecules, a step that may be required for 
matrix expansion as the animal grows.  We note that the MMP-14 (MT1-MMP) 
knock-out mouse has weakened tendons, suggesting a precedent for MMPs in 
promoting extracellular matrix assembly (Holmbeck et al., 1999), although the 
matrices of fibrillar collagen and basement membrane are very different. 
The inability to deposit basement membrane could lead to severe 
consequences for wound healing.  If the wound cannot repair the basement 
membrane, the cells could lack a scaffold to support cell migration, resulting in 
cell elongation failures and open wounds, as observed.  It seems likely that the 
compromised basement membrane in the mutants is weaker than wild-type.  The 
Mmp1 mutant wounds were much larger than wild-type wounds, suggesting 
that they gap open after puncture. The actin stress-fibers observed in Mmp1 
mutant wounds may simply be a compensatory mechanism for the weak 
basement membrane, as the tissue attempts to increase stability with actin cables, 
similar to the actin cable formed in Drosophila embryos closing wounds (Wood et 
al., 2002a).  As cells migrate they pull on their surrounding matrix, and a weak 
basement membrane may lack the resistance necessary for cell migration 
(Discher et al., 2005a; Kirmse et al., 2011b).  Additionally, we note that the Mmp1 
epidermal samples are much more fragile during dissection than the wild-type 
controls, possibly because of weakened basement membranes.  
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Mmp1 levels are regulated by JNK in response to wounding. 
Wound healing is a tightly regulated processes, involving the 
orchestration of several signaling cascades including JNK signaling, which has 
previously been shown to be required for wound healing (Galko and Krasnow, 
2004b; Ramet et al., 2002).  MMPs have been shown to be regulated by JNK 
signaling in Drosophila during imaginal disc morphogenesis (Srivastava et al., 
2007), in Drosophila tumor models (Uhlirova and Bohmann, 2006), and in 
zebrafish during the inflammatory phase of wound healing (Zhang et al., 2008); 
and JNK-regulation of MMPs has been observed in mammalian cell culture 
(Gum et al., 1997).  We find that the dramatic Mmp1 up-regulation in wounded 
epidermis is dependent on JNK signaling.  However, in unwounded epidermis, 
Mmp1 is expressed independently of JNK signaling, suggesting that only 
wound-induced expression of Mmp1, but not homeostatic expression of Mmp1, 
are under JNK control.  Animals misexpressing TNF (eiger) in the epidermis and 
hyper-activating JNK had dramatically increased Mmp1 expression after 
wounding, and they displayed accelerated re-epithelialization.  Importantly, this 
accelerated healing was dependent on Mmp1.  
In mammals, MMP-3, MMP-8, MMP-9, and MMP-13 knock-out mice have 
defects in wound healing.  Although all these are secreted MMPs, the wounding 
phenotypes observed in fly Mmp1 mutants, which lack all secreted MMPs, are 
most similar to MMP-9 -/- mice.  These mice have delayed re-epithelialization 
attributed to reduced mobility of their keratinocytes, which migrate more slowly 
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ex vivo (Kyriakides et al., 2009a).   Interestingly, these mice also have abnormal 
deposition of collagen fibers.  The main phenotypic difference between the 
MMP-9 -/- mice and the Mmp1 mutant flies is that the fly wounds do not heal at 
all.  By taking advantage of the many genetic tools available in Drosophila, our 
data demonstrates that Mmp1, under the control of the JNK pathway, functions 
during re-epithelialization in vivo to promote basement membrane deposition, 
cell elongation and migration, actin cytoskeletal reorganization, and ERK 
signaling. 
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CHAPTER III 
 
MATRIX METALLOPROTEINASES ARE REQUIRED FOR  
HEMOSTASIS IN DROSOPHILA 
 
Introduction 
 The initial step to wound healing, hemostasis, functions to seal the wound 
area, prevent further fluid loss and neutralize invading external pathogens 
(Singer and Clark, 1999).  This initial step is critical to the success of the wound 
healing process, as well as for the survival of the organism, as clotting failures, 
such as those caused by hemophilia, lead to excessive fluid loss and often death 
after injury.  In mammals, the components of the blood coagulation pathways are 
well understood.  The components are quiescent under normal physiological 
conditions and only become activated in response to injury (Furie and Furie, 
1992).  Activation of clotting factors begins with the activation of tissue factor, a 
membrane protein found only on nonvascular, activated, cell surfaces (Osterud 
and Rapaport, 1977; Spicer et al., 1987), which leads to the activation of factor IXa 
and factor VIIIa creating the tenase complex, which converts factor X to factor 
Xa.  Factor Xa will then interact with factor Va to form the prothrombinase 
complex (Mann et al., 1988).  The thrombinase complex converts membrane-
bound pro-thrombin to thrombin, releasing it from the membrane.  To this point, 
all steps of the coagulation pathway occur at the cell membrane of activated 
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platelets (Mann et al., 1988).  The clot is then formed by thrombin cleaving 
fibrinogen to create fibrin, which auto-polymerizes to form a fibrin clot, sealing 
the wound (Furie and Furie, 1992).   
 Injury promptly elicits the recruitment and activation of platelets, small 
cells that circulate in an inactive form in the blood.  Upon activation, platelets 
will aggregate and adhere to the wound site (Furie and Furie, 1992).  Activated 
platelets shed plasma membrane-derived microparticles (Ando et al., 1988; Sims 
et al., 1988) to provide the extensive volume of plasma membrane surface 
required for coagulation.  These microparticles highly express factor VIII binding 
sites which promote prothrombinase complex formation and facilitates fibrin 
plug generation (Gilbert et al., 1991).   
 Like vertebrates, effective hemostasis is a critical initial step to the wound 
healing process in arthropods, particularly in light of the fact that arthropods 
have open circulatory systems.  In insect larvae in particular, efficient clotting is 
especially important because the open circulatory system not only maintains 
body shape by hydrostatic pressure, but it also facilitates  locomotion (Martinez 
Arias, 1993a).  The components of the clotting mechanisms of mammals and 
arthropods share only functional similarity, with very few actual orthologs 
(Theopold, Schmidt et al. 2004).  However, the end result of these pathways is 
similar: blood is coagulated to form a plug at the wound site, preventing fluid 
loss and neutralizing pathogens.  In Drosophila melanogaster, as with other insects, 
there are two basic steps of hemostasis.  First is the formation of a soft clot, which 
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is followed by activation of phenoloxidase (PO) to form a cross-linked, optically 
dense hard clot (Bidla et al., 2005; Galko and Krasnow, 2004a; Goto et al., 2003).  
Soft clot formation is mediated by hemocytes (Drosophila blood cells) that adhere 
to extracellular matrix (ECM) fibers,  and then extend filopodia and membrane 
blebs across the wound area forming a clot matrix (Bidla et al., 2005).  This 
fibrous matrix also ensnares hemocytes, which aid in clearing the wound site of 
pathogens (Scherfer et al., 2004).  Formation of the soft clot is Ca2+-dependent 
(Bidla et al., 2005) and is believed to involve hemolectin (Hml), a Drosophila 
protein with a domain structure similar to mammalian clotting factors, factor V, 
factor VIII, and von Willebrand factor  (Goto et al., 2003; Goto et al., 2001).  This 
initial clot formation is independent of the following melanization steps, clotting 
is observed in mutants that lack the key melanization cascade component, 
prophenoloxidase (PPO) (Scherfer et al., 2004). 
 A hallmark of the second phase of insect clot formation is the activation of 
melanization cascade through activation of the the zymogen, prophenoloxidase 
by the serine protease, prophenoloxidsae activating enzyme (PPAE) to create 
phenoloxidase (PO) (Cerenius and Soderhall, 2004).  Once activated, PO 
functions to catalyze the oxidation of tyrosine-derived phenols to form quinones, 
which non-enzymatically polymerize to form melanin, a cytotoxic polymer that 
is deposited to seal wounds and encapsulate pathogens (Cerenius and Soderhall, 
2004; Nappi et al., 2005).  PPO is primarily produced by a specialized type of 
hemocyte called crystal cells, named for the crystalline inclusions observed 
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within these cells (Lanot et al., 2001; Meister and Lagueux, 2003).  The 
melanization cascade is tightly regulated by the serine protease inhibitor, Serpin 
27A (Spn27A) that functions to inhibit activated-PPAE (De Gregorio et al., 2002).  
In response to injury, or immune challenge, Spn27A mutants display profuse 
melanization, often form ectopic melanotic masses, and a have reduced ability to 
encapsulate pathogens during natural infections (De Gregorio et al., 2002; 
Ligoxygakis et al., 2002; Nappi et al., 2005), demonstrating the importance of 
maintaining precise control over the melanization cascade.  In the absence of 
either PPO, such as in Black cell  (Bc) mutants, or in the absence of hemocytes all 
together, as is the case in Domino  (Dom) mutants, there are marked melanization 
failures, as well as diminished immune response following septic injury (Braun 
et al., 1998; Rizki and Rizki, 1959); indicating that PPO, and the hemocytes, from 
where it is primarily produced, play a vital role during wound healing and in the 
Drosophila innate immune response. 
From our preliminary studies of MMPs during Drosophila wound healing, 
we have observed pronounced clotting and melanization defects in both Mmp1 
and Mmp2 mutants, suggesting that both Mmp1 and Mmp2 may be required for 
hemostasis and scab formation following wounding.  We also show that both the 
hemopexin and the catalytic domains of Mmp1 may be required for 
melanization.  Interestingly, we find that re-epithelialization is not dependent on 
scab formation, as even wounds with light melanization successfully re-
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epithelialize.  Furthermore, in wounds lacking scabs, such as those induced by a 
pinch wound, Mmp1 is required for re-epithelialization. 
 
Methods 
Fly lines. 
The following lines are described in Page-McCaw et al (2003):  Mmp12 and 
Mmp2 Df(2R)Uba1-Mmp2 (imprecise P excision alleles resulting in deletions of most or 
all of the coding region); Mmp1Q112*, Mmp1Q273*, Mmp1W439*, and Mmp2W307* (EMS-
induced nonsense alleles resulting in premature truncations); UAS-Timp. The 
dominant-negative Mmp1∆Cat line, which lacks the catalytic domain, used was 
UAS-Mmp1.f1∆cat (Glasheen et al., 2009b; Zhang et al., 2006).  Other fly lines used 
were A58-Gal4 (M. Galko), and He-Gal4 (Flybase ID FBti0064641) both from the 
Bloomington Drosophila Stock Center,  UAS-Mmp1-dsRNA (D. Bohmann),  Bc1 
(Flybase ID FBgn0261382) from the Bloomington Drosophila stock center, Domino 
(K.V. Anderson), Spn27A1 (B. LeMaitre).  For epistasis experiments, we generated 
Bc1 Mmp12 and Spn27A Mmp12 double mutant flies.   w1118 was used as wild type.   
 
Clotting kinetics.  
 The clotting kinetics assay was adapted from Goto, Kadwaski, et al (2003).  
Third instar larvae were impaled through the dorsal side between abdominal 
segments A3-A5 with a 0.1mm steel needle (Fine Science Tools) and left to heal 
on apple juice plates for the designated amount of time (5-30minutes).  Wounded 
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larvae were then transferred to Whatman filter paper soaked in hemolymph-like 
solution (70mM NaCl + 5mM KCl + 1.5mM CaCl2 + 20mM MgCl2 + 10mM 
NaHCO3 + 5mM Trehalose + 5mM HEPES, pH 7.2) at 5m intervals beginning at 
t=0; with animals transferred from wounding needle directly to filter paper (n=7 
w1118; n=2 Mmp12; n=2 Mmp1Q273* animals tested at each time point).  Animals 
were left on wet filter paper, on ice, for 3h.  Animals were then removed and the 
filter paper was incubated at 25C overnight to induce melanization of the 
collected hemolymph.   Appearance of a melanized spot of hemolymph indicated 
that the wound had not undergone hemostasis prior to transferring the animal to 
the filter paper.   
 
Scab formation analysis and quantification. 
 To assess scab formation phenotypes, 3rd instar larvae were impaled on 
the dorsal side between abdominal segments A3-A5 with a 0.1mm steel needle 
(Fine Science Tools) and allowed to heal at 25C for desired amount of time.  For 
initial scab formation analysis (t = 0-30m post-wounding) bright field images 
were then taken of the dorsal wound on whole larvae (11 w1118 at 5m, 5 w1118 at 
10m; at 30m:  28 w1118, 30 Mmp12 or Mmp12/Q1112*, 3 Dom, 24 Mmp1Q27*3/W439*, 10 
He>Mmp1-dsRNA, 13 A58>Mmp1-dsRNA, 7 He>Mmp1∆Cat, 7 A58>Mmp1∆Cat, 7 Bc1, 
21 Spn27A1, 9 Bc1 Mmp12, 3 Spn27A1 Mmp12).   
 For scab phenotype relative to wound area correlation experiments, 
animals were wounded and dissected according to procedures outlined in 
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Chapter II and Stevens and Page-McCaw (2012), and allowed to heal for 14h at 
25C.  DIC images at 20X were taken of scabs 14h post-wounding.  Scab formation 
was classified as discrete (melanization formed neatly over wound area), profuse 
(melanization extends beyond wound bed and / or there are sites of ectopic 
melanization), or incomplete (discontinuous, lightly colored melanization, or 
very small melanin deposits near the wound site).  The distribution of scab 
phenotypic class within genotype was plotted as percentage of total animals 
examined within genotype with GraphPad Prism v 5.01.   
 For wound area versus scab formation phenotype correlation studies, the 
wound area corresponding to each scab was calculated by Axiovision v.4.8 using 
the outline tool to specify the wound edge, as defined by FasIII and DAPI 
expression (see Methods from chapter II for more details regarding wound area 
measurements).  Average wound area was calculated within each scab formation 
phenotypic class for each genotype and plotted, along with the standard error of 
the mean, using GraphPad Prism v.5.01.   
  
Immunohistochemistry. 
Fixed samples were washed and permeabilized in PBS + 0.2% Triton X-
100, blocked in PBS + 5% goat serum + 0.02% NaN3, incubated in 1o antibody 
(diluted in PBS + 1% goat serum + 0.02%NaN3) overnight at 4°C, washed and 
incubated in 2o antibodies for 1.5 h at RT in the dark, and mounted in 
Vectashield mounting media with DAPI (Vector Labs).  Anti-Mmp1 catalytic 
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domain (a 1:1:1 cocktail of mouse monoclonal IgG1 antibodies 3B8, 5H7, and 
23G, generated by Page-McCaw et al (2003) and obtained from the 
Developmental Studies Hybridoma Bank (DSHB), was used at 1:100.  Anti-FasIII 
(a mouse monoclonal IgG2a from the DSHB) was used at 1:10.  Cy3 labeled goat 
anti-mouse IgG1 (Jackson ImmunoResearch), DyeLight649 labeled goat anti-
mouse IgG2a (Jackson ImmunoResearch) were all used at 1:300.  
 
Microscopy. 
Bright field images of whole larvae were acquired on a Zeiss SteREO 
Lumar. V12 mircoscope equipped with a NeoLumar S 0.8X FWD 8mm objective, 
using an additional ~22.5X digital zoom to acquire color bright field images of 
the dorsal wound site using an AxioCam MR3 color camera and Axiovision v4.8 
acquisition software (Zeiss).  Images were collected using AxioVision v4.8 
software (Ziess).  Fourteen hour scab formation images were obtained with a 
Zeiss Axio imager Z1 microscope using the 20X/0.8 Plan Apochromat objective.  
DIC images were acquired with an Axiocom MRc color camera using Axiovision 
v4.8 acquisition software (Zeiss).  Optical sectioning was performed with a Zeiss 
Apotome mounted on an Axio imager Z1 or M2, with the 20X/0.8 Plan 
Apochromat objective.  Fluorescent images were acquired with an Axiocam 
MRm (Zeiss) camera paired with Axiovision 4.8 (Zeiss). Z-stacks were 
compressed into 2D XY projections using the orthoview function in Axiovision.  
All DIC images were exported from Axiovision v.4.8 as 16-bit, color, TIFF files.  
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All fluorescent images were exported from their acquisition programs as 16-bit, 
grayscale, TIFF files.  All post-processing was done in either in Adobe Photoshop 
CS4, or ImageJ v.1.43u.  
 
Melanization inhibition assay. 
 3rd instar larvae were anaesthetized by exposure to diethyl ether for 
approximately 2 minutes in a closed chamber.  A nanoinject was used to inject 
27.6nl of 1mM Phenylthiourea (PTU) in PBS + 20%DMSO, or 27.6nl of vehicle 
only (PBS + 20%DMSO), in larvae on the dorsal side between abdominal 
segments A3-A5 with a glass needle.  Larvae were transferred to apple juice 
plates and animals were allowed to recover for 14h at 25C.  The injection site 
served as the wound site for all subsequent analysis.  Wounded epidermis was 
dissected and collected according to protocol outlined in Chapter II (Stevens and 
Page-McCaw, 2012).   
  
Wounding assays. 
Both puncture and pinch wounding assays were adapted from Galko and 
Krasnow (2004a) and are described in detail in chapter II, as well as in Stevens 
and Page-McCaw (2012).  For puncture wound suturing, 3rd instar larvae (12 
w1118 and 15 Bc1) were wounded with a 0.1mm steel needle through the dorsal 
side.  Immediately after wounding, a flat toothpick was used to apply a small 
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amount of Krazy® Glue to the wound site.  Animals were left to heal at 25C for a 
desired amount of time. 
 
Results 
Mmp1 is required for hemostasis and scab formation. 
In mammals, the secreted MMP, MMP-2, has been shown to be secreted 
by activated platelets and to play a role in platelet aggregation in vitro (Kazes et 
al., 2000; Sawicki et al., 1997).  In Drosophila, as in mammals, hemostasis is a 
critical first step in the wound healing process, so we asked if MMPs were 
involved in clotting in our in vivo wound healing model.  First we characterized 
wild-type clotting kinetics using a  bleeding assay developed by Goto, et al. 
(2003).  In wild-type larvae, evidence of clotting is observed as early as 10min 
post-wounding (Fig 3.1A).  After 30min post-wounding, wild type animals have 
successfully completed hemostasis, with no detectable hemolymph spots in the 
filter paper (Fig. 3.1A).  Using brightfield microscopy to analyze melanization of 
the wound site on the animal, we found a slight darkening of the wild-type 
wound site at 5min (fig. 3.1B; n=10) and 10min (Fig. 3.1B’; n=5) with a very dark 
melanin deposit observed by 30min post-wounding (fig. 3.1B”; n=28), similar to 
that observed by Galko and Krasnow (2004a). The clotting kinetic assay showed 
only minimal hemolymph in the absence of Mmp1 5min post-wounding 
(fig3.1C).  While there appears to be some variability, the general lack of 
melanized hemolymph spots on the filter paper, suggests that either loss of 
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Mmp1 may induce accelerated clotting relative to wild type, or that these 
mutants have may have defects in the melanization cascade.  By this assay a 
wound that has successfully completed hemostasis and defective melanization 
appear the same.  It is important to note that these are preliminary results and 
need to be repeated.   
To determine if Mmp1 mutants have melanization defects, we analyzed 
melanin deposition at the wound site 30min post-wounding.  In Dom mutants, 
which lack hemocytes, 30min post-wounding wounds are have no detectable 
melanization and in most cases have failed to form the initial soft clot (Fig. 3.1E, 
n=2), as these mutants often bleed out shortly after wounding, indicating that 
both hemostasis and scab formation require hemocytes.  Similarly, in Mmp1 
mutants (fig. 3.1F; n=40) we observe only very light melanization, often forming 
a halo pattern around the wound site.  Additionally, in Mmp1 mutants we often 
find hemolymph and internal organs forming a bleb out of the wound site (an 
example is shown in fig 3.1F).  
During tracheal development, the Mmp1 hemopexin and catalytic 
domains have independent functions (Glasheen et al., 2009a), so to determine 
which domain of Mmp1 is required for hemostasis, we measured clotting kinetics 
in Mmp1Q273* (Mmp1∆Pex) mutants, which lack the hemopexin, or substrate 
recognition, domain (Glasheen et al., 2009a).  In Mmp1∆Pex mutants, hemolymph 
spots were observed as late at 30min post-wounding (fig. 3.1D), which may 
suggest that the Mmp1 hemopexin domain is required for clot formation, but not 
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melanization as hemolymph collected by our bleeding assays does darken 
similar to that from wounded wild-type animals.  Similar to both the Dom and 
Mmp1 mutants, when we analyzed melanization of the wound site on the whole 
animals 30min post-wounding, we observed only very light melanization, again 
often forming a halo pattern, along what we presume are the wound edges (fig 
3.1G; n=23).  Together, these results suggest that Mmp1, and the Mmp1 
hemopexin domain specifically, are required for melanization of the wound site.  
Additionally, our preliminary clotting experiments, suggest that Mmp1 may play 
a role in hemostasis.   
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driven with Hemese-Gal4 (He-Gal4) specifically in the hemocytes (He>Mmp1-
dsRNA).  Unlike wild-type animals (fig. 3.2A; n=28), wounds in He>Mmp1-
dsRNA animals are incompletely melanized (Fig 3.2B; n=10) 30min post-
wounding, often with the halo pattern similar to that seen in Mmp1 mutants (Fig. 
3.1F); thus suggesting that Mmp1 expression specifically in the hemocytes is 
required for melanization post-wounding.  As Mmp1 is a secreted protease, we 
asked if other tissues are involved in wound healing, namely the epidermis.  
Interestingly, when we knocked down Mmp1 expression specifically in the 
epidermis with the epidermal driver A58-Gal4, we saw less melanization at the 
wound site than wild type (compare fig 3.2C to 3.2A; n=6), suggesting that 
epidermal Mmp1 expression may also promote melanization at the wound site.  
By utilizing an Mmp1 construct lacking the catalytic domain (UAS-Mmp1∆Cat), 
which functions as a dominant-negative (Glasheen et al., 2009a), we can 
determine if Mmp1 catalytic activity is required for melanization.  Expression of 
the catalytically-deleted Mmp1 in either the hemocytes (He>Mmp1∆Cat), or in the 
epidermis (A58>Mmp1∆Cat) resulted in incomplete melanization 30m post-
wounding (Fig. 3.2D, E; n=7 for both genotypes), indicating that catalytically-
active Mmp1 is necessary to facilitate melanization of the wound. However, as 
Mmp1 is a secreted protein, overexpression of the dominant-negative, 
catalytically-inactive Mmp1 could interfere with endogenous Mmp1 release from 
other tissue sources as well; as a consequence we are unable to draw any 
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scabs that cover an area much larger than the initial wound size, often 
accompanied by regions of ectopic melanization near, but not at the wound site 
(see example in Fig. 3.3D); and incomplete melanization, characterized by light, 
often discontinuous melanization near the area of the wound (Fig. 3.3B), or very 
small melanin deposits in the wound bed.  In wild type animals, 14h post-
wounding, the melanin plug can be described as a discrete scab with melanin 
deposited exclusively in the immediate vicinity of the wound in 46% of animals 
tested (Fig 3.3A, E).  In Mmp1 mutants, on the other hand, there is generally  very 
little melanization of the wound site (66% of animals) and what is present is 
typically lightly colored and discontinuous (Fig. 3.3B, E), suggesting that Mmp1 
may function to promote melanization of the wound site.  Interestingly, some 
Mmp1 mutants (33% of animals) are able to form what appear to be discrete 
scabs, suggesting that there may be compensatory mechanisms to overcome the 
loss of Mmp1.   
One possible candidate is the other Drosophila membrane-anchored MMP, 
Mmp2.  Scab formation in Mmp2 mutants 14h post-wounding appears similar to 
wild type, but with a higher propensity to form profusely melanized scabs (42% 
in Mmp2 compared to only 15% in wild type; Fig. 3.3C, E), indicating that Mmp2 
may have a role in limiting the melanization cascade.  Unfortunately, this 
analysis could not be performed on Mmp1 Mmp2 double mutants, as these 
animals have severe clotting defects and bleed out within hours of wounding.  
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The exacerbation of the Mmp1 melanization and clotting phenotypes in the 
Mmp1 Mmp2 double mutants not only indicates that MMPs play a pivotal role in 
regulating scab formation, but suggests that Mmp1 and Mmp2 may function 
redundantly, or additively, to facilitate re-epithelialization.    
Drosophila MMP’s are inhibited by an endogenous inhibitor, Timp (Tissue 
Inhibitor of Metalloproteinase).  In the absence of Timp, both Mmp1 and Mmp2 
would presumably be able to act on their substrate unchecked, leading to 
excessive melanization of the wound site.  Indeed, that is exactly what we find.  
Unlike the Mmp1 mutants, scab formation in Timp mutants ranges from discrete 
to profuse melanization (Fig 3.3D, E), with a much higher incidence of profuse 
melanization than seen in wild type (50% in Timp compared to 15% in wild type).  
The Mmp1-dependent melanization phenotypes are recapitulated when Timp is 
over-expressed in the epidermis (A58>Timp), leading to primarily incomplete 
scab formation (Fig. 3.3E); thus indicating that overexpression of the endogenous 
inhibitor blocks Mmp1 function and prevents proper scab formation.  Together, 
these results suggest that both Mmp1 and Mmp2, under the regulation of Timp, 
function to regulate the melanization cascade.  Additionally, these results 
suggest that Mmp1 may function to promote melanization, while Mmp2 may 
functions to inhibit melanization. 
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pre-cursors, quinones.  Polymerization of quinones, analogous to fibrin 
polymerization in mammals, forms a plug at the wound site, sealing the wound 
(diagramed in fig 3.4A and reviewed in Cerenius and Soderhall (2004).   The 
melanization cascade is regulated by serpin27A (spn 27A), which directly 
inhibits PPAE (De Gregorio et al., 2002; Leclerc et al., 2006; Ligoxygakis et al., 
2002).  Black cell (Bc) mutants have a mutation that causes crystal cells to 
spontaneously melanize, presumably by a mutation in PO (Gajewski et al., 2007; 
Rizki and Rizki, 1959).   When wounded, melanization at the wound site fails in 
Bc1 and the animals often bleed out post-wounding (Fig. 3.4C).  Conversely, loss 
of the inhibitor, Spn27A, results in profuse melanization at the wound site (Fig. 
3.4D, black arrow), as well as formation of ectopic melanotic masses that are 
generally found posterior to the wound site (Fig 3.4D, red arrow; and observed 
by De Gregorio, Han et al. (2002)).  To determine if Mmp1 was directly involved 
in the melanization cascade we generated Bc1 Mmp12 double mutants and 
Spn27A Mmp12 double mutants and assayed scab formation 30m post-wounding 
(Fig. 3.4 B-G).  Similar to Bc1 mutants (Fig. 3.4C), Bc1 Mmp12 double mutants we 
find a complete failure in melanin deposition at the wound site (Fig. 3.4F).  As 
this phenotype is more severe than that observed in the Mmp1 mutant alone (Fig. 
3.4E), we predict that Mmp1 functions downstream of Bc in the melanization 
cascade.  However, as both the Bc1 and Mmp1 single mutants have a similar 
melanization phenotype, the results from the Bc1 Mmp1 double mutants are 
difficult to interpret.  In the Spn27A Mmp1 double mutant there is minimal 
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melanization at the wound site 30m post-wounding (Fig3.4G, black arrow); 
suggesting that even in the absence of the inhibitor, melanin is unable to be 
produced without Mmp1.  However, this is a preliminary result, as only 3 
Spn27A Mmp1 double mutants were tested.  As shown in Fig. 3.3, there is some 
variability in melanization even in wild type, so a larger number of Spn27A 
Mmp1 mutants should be analyzed to confirm the presented result.  Interestingly, 
in the Spn27A Mmp1 double mutants we observe an occasional small ectopic 
melanotic mass, similar to that seen in Spn27A mutants (compare fig 3.4D to 3.4F, 
yellow arrows), suggesting that the formation of ectopic melanotic masses and 
melanin deposition at a wound site may be under the regulation of two 
independent mechanisms, one that requires Mmp1, and one that does not.   
 
 
 
  
Fi
A
pr
ph
m
fo
(G
3 
 
 
R
m
ab
ep
h
an
gure 3.4: Mm
) Schematic o
ophenoloxda
enoloxidase
elanin, facili
rmation 30m
).  Black arro
for all genoty
e-epithelia
In ve
esenchym
sence of 
ithelializa
ave reporte
d Page-M
p1 may func
f the melaniz
se activating
 (PO), or Bc,
tating scab f
 post-wound
ws indicate w
pes.    
lization is
rtebrates, 
al cell migr
the clot, 
tion fails. 
d in Mmp
cCaw (201
tion downst
ation cascad
 enzyme (P
 leading to 
ormation.  P
ing in wild t
ound site.  R
 not depen
the fibrin
ation into 
cells lack
 To determ
1, Mmp2, a
2) are secon
91 
ream of Spn2
e. Wounding
PAE), which
the productio
O is inhibite
ype (B), Bc (C
ed arrows (D
dent on sc
 clot fun
the wound
 a scaffo
ine if the
nd Timp m
dary to m
7A during s
 induced seri
 then conver
n of quinon
d by Spn27A
), Spn27A (D
, G) indicate
ab formati
ctions as 
 bed (Singe
ld to sup
 re-epithel
utants (Ch
elanization
cab formatio
ne protease c
ts propheno
es, which p
.  B- G) D
), Mmp1 (E),
 ectopic mel
on. 
a scaffol
r and Clar
port migr
ialization d
apters II, 
 defects, w
n.   
ascades to ac
loxidase (PP
olymerize to 
IC images of
 Bc Mmp1 (F
anotic masse
d to facil
k, 1999).  In
ation and
efects tha
V, and Ste
e first ask
 
tivate 
O) to 
form 
 scab 
), and 
s.  n ≥ 
itate 
 the 
 re-
t we 
vens 
ed if 
 92 
 
scab formation defects were sufficient to cause re-epithelialization defects.  We 
attempted to measure wound area in Dom or Bc1 mutants, which are unable to 
produce melanin due to a lack of hemocytes. While Bc is presently a mutation 
that is not mapped to the genome, it is hypothesized to be a mutation in PPO 
(Gajewski et al., 2007).  Unfortunately, we were unsuccessful analyzing re-
epithelialization in either mutant because these animals bleed out shortly after 
wound induction due to clotting defects. 
Cyanoacrylate adhesives, or superglue, were first used on human patients 
on battle fields during the Vietnam war to stop severe hemorrhaging, seal 
wounds, and save lives (Coover, 1959).  In an attempt to assess re-
epithelialization in Dom or Bc mutants, we applied small amounts of Krazy® Glue 
to wound sites immediately following stabbing.  Unfortunately, this was 
unsuccessful, as animals either died, or the superglue affixed too much other 
tissue to the wound site, obstructing our view of the epidermis after infection 
(data not shown; n=24 wild type and n=15 Bc mutants).   
Finally to determine if scab formation correlated with re-epithelialization, 
we compared wound area to melanization phenotype, within wild type only, 14h 
post-wounding using the melanization classification system defined above.  By 
this analysis, we find no differences in wound area between scab formation 
classes in wild type (Fig 3.5A), indicating that re-epithelialization is not 
dependent on scab formation.  To confirm these results, we tried to inhibit 
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melanization in wild type animals by injecting the melanization inhibitor, 
Phenylthiourea (PTU), at the time of wounding, allowing the animals to heal for 
18h, then measured wound area.  At 1mM PTU viability was unaffected 
compared to vehicle only controls (data not shown), while still inducing mild 
melanization defects; 4 of 5 animals tested showed incomplete melanization 14h 
post-wounding (compare fig 3.5B to 3.5B’).  Despite these scab formation defects, 
these animals have no re-epithelialization defects, both control and 1mM PTU 
animals complete re-epithelialization within 14h post-wounding (Fig. 3.5C), 
indicating that re-epithelialization is not dependent on scab formation. 
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or scab formation, namely pinch wounds.  In a pinch wound, the overlying 
cuticle remains intact while extensive damage is inflicted upon the underlying 
epidermis.  Presumably the basement membrane is also damaged in the pinch 
wounding process, but this should be confirmed by closer examination of 
basement membrane in general by electron microscopy (EM), or at the analysis of 
individual ECM components, such as Collagen IV, perhaps by simple IHC 
techniques, following pinch wounding.  Wild type and Mmp1 mutants were 
pinched on the dorsal side with #5 dissecting forceps then left to heal at 25C 
(assay adapted from Galko and Krasnow (2004a)).  Eighteen hours post-
wounding, pinch wounds in wild-type animals have completely re-epithelialized 
(Fig 3.6A, C).  However, in the absence of Mmp1, pinch wounds remain open 
(Fig. 3.6B, C), with an average wound area 18h post-wounding that is 
significantly larger than wild type (Fig 3.6D); thus, demonstrating that Mmp1 is 
required for re-epithelialization regardless of the need for hemostasis.  
Interestingly, open wounds in Mmp1 mutants typically have a large number of 
hemocytes congregating in the wound bed (small nuclei in the wound bed in Fig. 
3.6B), often expressing low levels of the cell junction protein, Fasciclin III (FasIII).  
In fact, pinch wounds in Mmp1 mutants can be identified by this characteristic 
concentration of hemocytes within a hole in the epidermal sheet.  The edge of the 
wound is also often lined with numerous, of what appear to be, epidermal cells 
unable to migrate into the wound bed (Fig 3.6B).  Together, these observations 
suggest that perhaps in the absence of Mmp1-induced epidermal cell migration 
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(see Chapter II); hemocytes attempt to compensate by infiltrating the wound bed, 
adopting an adhesive morphology, and forming aggregates to hold the 
weakened epidermis together.  The presence of a large population of hemocytes 
in the wound additionally suggests that pinch wounding elicits an inflammatory 
response in addition to re-epithelialization, which may contribute to pinch 
wound healing.   
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Discussion 
Mmp1 and Mmp2 regulate scab formation.  
Hemostasis is a critical first step in the wound healing process.  Clotting 
failure often leads to hemorrhaging and, in mammals, prevents the subsequent 
re-epithelialization process.  While this important initial step in wound healing is 
well characterized in mammals, it is often overlooked in arthropods, leaving 
much to be learned about the regulation of the clotting and the subsequent scab 
formation process, as well as the function of the melanization cascade during 
wound healing in arthropods.  Our preliminary studies indicate that both the 
secreted extracellular protease, Mmp1, as well as the membrane-anchored 
protease, Mmp2, under the control of Timp, functions during both soft clot 
formation and melanization in response to wounding.   
During the initial clotting phases, our data suggest that Mmp1 is play a 
role in promoting clotting, as we observe clotting delays in the Mmp1 mutant 
background.  It is possible that these clotting defects are secondary to the 
basement membrane defects that we find in Mmp1 mutants (Stevens and Page-
McCaw, 2012).  The clot matrix that is established during Drosophila hemostasis is 
composed primarily of ECM strands and filipodia projected into the clot by 
hemocytes (Bidla et al., 2005); therefore it is plausible that without Mmp1 to 
promote proper basement membrane integrity and to modify ECM components, 
the ability of hemocytes to extend those filopodia into the clot would be 
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compromised, as there would not be the cell would be unable to form the 
requisite cell-ECM adhesions that facilitate such cell morphology changes, 
leading to the impaired clotting phenotypes that we observed in the Mmp1 
mutant background.    
Previous studies in our lab have suggested that the different domains of 
Mmp1 may have independent functions during tissue remodeling (Glasheen et 
al., 2009a).  This does not appear to the case during scab formation, where we 
have demonstrated that both the hemopexin and catalytic domains of Mmp1 are 
required.  When we disrupt the catalytic activity of Mmp1 by driving the 
expression of a dominant-negative Mmp1∆Cat construct in either the hemocytes or 
the epidermis, we find decreased melanization at the wound site, suggesting that 
the catalytic domain of Mmp1 is required to facilitate scab formation.  Similarly, 
Mmp1∆pex mutants, which lack the hemopexin domain, show slowed clotting and 
incomplete melanization.  In cultured activated platelets, the hemopexin-like 
domain of MMP-2 facilitates platelet aggregation in wound sites by binding to 
integrin αIIbβ3 (Choi et al., 2008).  In Drosophila, melanization is mediated by 
activated crystal cells, which facilitate clotting by extending filopodia that will 
adhere to extracellular matrix and other crystal cells forming a clot matrix (Bidla 
et al., 2005).  If the function of the hemopexin domain in Drosophila Mmp1 is 
similar to that of mammalian MMP-2, then, as we observe, loss of the hemopexin 
domain would result in hemostasis defects, due to an impaired ability for crystal 
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cells to form adhesions, suggesting that the Mmp1 hemopexin domain may play 
a role in promoting hemolymph coagulation.   
 Melanization of the soft clot that forms within minutes of wounding (our 
results and Galko and Krasnow (2004a)) is the final outcome of the melanization 
cascade.  Our epistasis test in Spn27A1 Mmp12 double mutant, while preliminary, 
may suggest that Mmp1 functions downstream of the PPAE inhibitor, Spn27A, to 
promote formation of the melanin plug.  This would be the first evidence that 
MMPs participate, either directly or indirectly in the scab formation.  In vitro 
studies have shown that the catalytic domain of mammalian MMPs, MMP-8, 
MMP-12, MMP-13, and MT1-MMP cleave both fibrinogen and clotting factor XII, 
which leads to impaired fibrin clot formation (Hiller et al., 2000; Tschesche et al., 
2000).  If Drosophila MMPs have a similar function in vivo, we would expect the 
loss of an MMP to elicit excessive melanization, such as that seen in Mmp2 
mutants. Perhaps Mmp2 plays a role in the proteolysis of an enzyme required to 
inhibit either directly, or indirectly inhibit PO activity, such as Spn27A; as such, 
loss of Mmp2 would prevent inactivation of PO, resulting in unchecked PO 
activity, melanin polymerization and deposition at the wound site.  In Mmp1 
mutants, however, we find the opposite phenotype, incomplete melanization, 
indicating that the membrane-anchored Mmp2 and the secreted Mmp1 may have 
independent functions during scab formation, either to inhibit, or to promote 
melanization, respectively.  However, the exacerbation of the clotting defects 
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observed in the Mmp1 Mmp2 double mutants, suggests that Mmp1 and Mmp2 
may have redundant functions as well.    
 On activated platelets, a membrane-anchored MMP, MT1-MMP, forms a 
complex with a TIMP, TIMP-2, and a secreted MMP, MMP-2, on the cell surface 
to promote platelet aggregation (Kazes et al., 2000).  Our results can also be 
explained if Mmp1, Mmp2, and Timp formed a similar tri-molecular complex on 
the surface of hemocytes, more specifically crystal cells, which would then 
function to hold Mmp1 at the cell surface and promote melanization.  In this 
model, disruption of the complex by loss of either Mmp2, or Timp, could result 
in the excessive, ectopic melanization phenotypes, as we observe in both Mmp2 
and Timp mutant wounds; thus leaving the secreted Mmp1 free to promote 
melanization on targets outside the immediate vicinity of the wound.  
Overexpression of Timp would similarly disrupt the Mmp2/Mmp1/Timp 
complex, but in this case the excess inhibitor would prevent all Mmp1 function, 
resulting in the observed incomplete melanization phenotypes.  More evidence 
suggesting that Mmp2, Mmp1, and Timp may form a tri-molecular complex, as 
well as additional in vivo functions of the complex, is provided in chapter IV.   
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Re-epithelialization is not dependent on scab formation.  
In mammals, the fibrin clot functions to seal the wound, preventing 
further fluid loss (Singer and Clark, 1999) and is a critical initial step in the 
wound healing process.  Analogously, a melanin plug rapidly forms at wound 
sites in arthropods, which, as in mammals, functions to seal the wound.  As 
previous studies have suggested that the hemocytes, the cells primarily 
responsible for hemostasis in Drosophila, are not required for re-epithelialization 
(Babcock et al., 2008; Stramer et al., 2005; Wu et al., 2009b), we asked if 
melanization is necessary for re-epithelialization.   Our results show that 
there is no correlation between melanization plug size and wound area 14h post-
wounding in wild-type larvae.  While scab formation is not necessary for re-
epithelialization, Mmp1 is required.  To expand on our previous studies 
(discussed in chapter II), which showed that Mmp1 is required in the epidermis 
for re-epithelialization following puncture wounding (Stevens and Page-McCaw 
2012), here we demonstrate that Mmp1 is also required for re-epithelialization 
following pinch wounding.  Together, these results demonstrate the re-
epithelialization defects are not secondary to scab formation defects and Mmp1 
plays a pivotal role in both hemostasis and re-epithelialization. 
Mechanisms of hemostasis in mammals are well understood, but the same 
cannot be said for the mechanisms of hemostasis in arthropods, such as 
Drosophila melanogaster.  Further research is needed to understand both the 
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components and the regulatory mechanisms involved in scab formation.  Our 
studies have shown that both Drosophila Mmp1 and Mmp2 play a role in 
hemostasis functioning during both initial soft clot formation, as well as 
formation of the melanin plug.  However, we do not understand specifically 
what role MMPs have in the melanization cascade, whether they directly or 
indirectly effect scab formation.  Additionally, our data suggest that Mmp1 and 
Mmp2 may function redundantly during hemostasis, the first redundant function 
identified for MMPs in Drosophila.  While the components of the hemostasis 
mechanisms between Drosophila and human are different, the end result is the 
same: the formation of plug to seal a wound preventing excess fluid loss and 
invasion of pathogens.  Comprehension of how MMPs are involved in 
hemostasis and scab formation in a simple system, such as Drosophila, may 
provide insight into how MMPs influence during hemostasis and scab formation 
in higher organisms. 
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CHAPTER IV 
 
DROSOPHILA Mmp1 MAY FUNCTION IN HEMOCYTES TO REGULATE 
INFLAMMATION DURING WOUND HEALING 
 
Introduction 
 Inflammation is the initial response of an organism to tissue damage and 
infection (Medzhitov, 2008).  In the normal physiological state, inflammation is 
an acute response, occurring exclusively at the source of a noxious stimulus.  
However, if an acute inflammatory response is not sufficient to mitigate the 
threat, to neutralize the pathogen, and to repair the damaged tissue, chronic 
inflammation develops.  Chronic inflammation occurs in many disease states, 
such as type II diabetes, ulcerated chronic wounds, and autoimmune disorders 
(Medzhitov, 2008).  The mechanisms that lead to the development of chronic 
inflammation are not well understood.   
Acute inflammation is characterized by an influx of leukocytes into the 
damaged area, which function to engulf pathogens and cell debris, as well as 
secrete a number of cytokines, chemokines, proteases, and growth factors to 
stimulate repair (Eming et al., 2007; Singer and Clark, 1999).  The inflammatory 
pathway is initiated following clotting, with degranulating platelets establishing 
chemoattractant gradients that lead to the extravasation of leukocytes from blood 
vessels and recruitment to the wound site (Larsen et al., 1989).  Among the first 
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responders to tissue damage are neutrophils, or polymorphonuclear leukocytes 
(PMN), which migrate from activated, leaky blood vessels to invade the wound 
site, where they phagocytose pathogens, as well as release reactive oxygen 
species (ROS), proteases, such as matrix metalloproteinases, and other pro-
inflammatory molecules, such as chemokines and cytokines, to amplify the 
inflammatory response, recruit macrophages, and stimulate repair (Werner and 
Grose, 2003).  Macrophages, the other leukocytes predominantly found at wound 
sites, are “professional” phagocytes that function during wound healing to 
engulf foreign particles, cell debris, and neutrophils that have undergone 
apoptosis (Luster et al., 2005; Martin and Leibovich, 2005; Zhang et al., 2008).  In 
zebrafish, macrophage migration to wound sites is dependent on MMP-13, under 
the regulation of the Jun N-Terminal Kinase (JNK) signaling pathway (Zhang et 
al., 2008).   
MMPs have been shown to play diverse roles during inflammation, 
functioning both to promote, as well as dampen, the inflammatory response 
(Gutierrez-Fernandez et al., 2007a; McQuibban et al., 2000; McQuibban et al., 
2002; Zhang et al., 2008).  MMP-8 -/- mice have an increased inflammatory 
response post-wounding and yet these mice also have delayed re-
epithelialization (Gutierrez-Fernandez et al., 2007a), indicating that MMP-8 
functions to dampen the inflammatory response.  However, it is unclear if the re-
epithelialization delays are a secondary result of an excessive inflammatory 
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response, or an independent result of the loss of MMP-8.  Similarly, MMP-2 has 
also been shown to dampen the inflammatory response by generating anti-
inflammatory chemokines through proteolytic processing (McQuibban et al., 
2000; McQuibban et al., 2002).  MMPs in vertebrates are highly redundant, with 
one MMP sometimes up-regulated to compensate for the loss of a different MMP 
family member (Rudolph-Owen et al., 1997).  In mice, for example, MMP-13 is 
up-regulated in MMP-8-/- mice, suggesting a compensatory mechanism for the 
loss of MMP-8 (Hartenstein et al., 2006).  Redundancy of this nature adds an 
additional level of complexity to an already complex process, rendering it 
difficult to elucidate MMP functions during inflammation in vertebrates. 
For that reason, we turned to a simpler model, namely Drosophila 
melanogaster, whose genome only encodes two MMPs, one secreted and one 
membrane-anchored, to examine the in vivo functions of MMPs during tissue-
damage-induced inflammation.  Just as in higher organisms, tissue damage 
induces a rapid, localized inflammatory response involving recruitment of the 
Drosophila innate immunity effector cells, hemocytes to the wound site (Galko 
and Krasnow, 2004a; Stramer et al., 2005).  Drosophila is an established model 
used to study wound healing and inflammation; however, one limitation is that 
Drosophila have an open circulatory system, so diapedesis, or hemocyte 
extravasation, is not required for hemocyte recruitment to wound sites.  As a 
genetically-tractable organism, however, Drosophila is still useful for  studying 
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other aspects of the inflammatory response, such as inflammation resolution and 
hemocyte recruitment, in vivo at a cellular and molecular level (Razzell et al., 
2011).  Studies of inflammation in a simple genetically-tractable system, such as 
Drosophila, may provide insight into the mechanisms of inflammation in more 
complex organisms.    
 There are three basic types Drosophila hemocyte: crystal cells, 
plasmatocytes, and lamellocytes (Meister and Lagueux, 2003).  The most 
abundant population of hemocytes is plasmatocytes, comprising roughly 95% of 
the circulating hemocyte population (Meister, 2004).  Functionally equivalent to 
neutrophils and macrophages, these small cells circulate throughout the animals, 
functioning as a surveillance system, engulfing foreign objects, and apoptotic 
cells (Babcock et al., 2008; Franc et al., 1996; Franc et al., 1999).  Crystal cells are 
named for the crystalline inclusions found within the cells, which are important 
for melanization.  Crystal cells are believed to mediate clotting and melanization 
(Rizki and Rizki, 1959).  The third hemocyte class, lamellocytes, are large flat cells 
that function during an innate immune response to encapsulate and neutralize 
pathogens, such as parasitic wasp eggs, that are too large for phagocytosis 
(Crozatier et al., 2004).  Within minutes of wounding, hemocytes are recruited to 
the damaged area in response to chemotactic gradients established by damaged 
cells (Stramer et al., 2005; Wood et al., 2006).  Once at the wound site, hemocytes 
are captured at the wound surface, where they become tightly adherent, 
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aggregate, then disperse throughout the wound bed, becoming phagocytically-
active (Babcock et al., 2008).  In addition to debriding the wound site of 
pathogens and debris, hemocytes have also been shown to secrete Pvf-1 (platelet-
derived growth factor (PDGF) / vascular endothelial growth factor (VEGF)-
related factor-1), which activates receptor tyrosine kinase (RTK) signaling, and 
promotes re-epithelialization.  Further investigation is needed to fully 
comprehend the precise mechanisms that regulate the inflammatory response to 
tissue damage in vivo. 
 In this chapter, we discuss our findings that the Drosophila secreted MMP, 
Mmp1, is highly up-regulated in response to wounding in hemocytes, via JNK 
signaling, and possibly accumulated in secretory vesicles.  Mmp1 may function 
to dampen JNK signaling in the epidermis, limit the extent of the inflammatory 
response to the immediate vicinity of the wound site, and facilitate epidermal 
migration by promoting RTK signaling.  Mmp1 up-regulation is observed in 
hemocytes after both pinch and puncture wounds, indicating that tissue-damage 
alone is sufficient to activate hemocytes and induce inflammation.  We show that 
catalytically-active Mmp1.f2 may be required in the hemocytes to promote re-
epithelialization, while catalytically-active Mmp1.f1 is required for re-
epithelialization in the epidermis.  These preliminary results represent the first 
indications of independent functions for individual MMP isoforms in vivo.  
Together these results indicate that Mmp1 may have a complex role during 
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wound healing, functioning simultaneously to modulate the inflammatory 
response and promote re-epithelialization. 
 
Methods 
Fly lines. 
The following lines are described in Page-McCaw et al (2003):  Mmp12 
(imprecise P excision alleles resulting in deletions of most or all of the coding 
region). The dominant-negative catalytically-inactive Mmp1 lines, UAS-
Mmp1.f1E225A and UAS-Mmp1.f2E225A, which have a glutamate to alanine mutation 
at amino acid 225 in the catalytic domain  (Glasheen et al., 2009b; Zhang et al., 
2006). Other fly lines used were A58-Gal4 (M. Galko), He-Gal4 (Flybase ID 
FBti0064641) and He-Gal4, UAS-GFP both from the Bloomington Drosophila Stock 
Center, Hml-Gal4,UAS-eGFP (J. Royet),  UAS-Mmp1-dsRNA (D. Bohmann), PucLacZ 
(B. Stronach), Domino (K.V. Anderson), and UAS-preproANF-GFP (Rao et al., 
2001).  Two UAS-Erg-dsRNA lines were used (Vienna Drosophila RNAi Center 
(VDRC)).  w1118 was used as wild type. 
 
Ex vivo bleeding assay. 
 To collect hemolymph samples, 3rd instar larvae were wounded according 
to the protocol described in Chapter II and allowed to heal for a specified 
amount of time at 25C.  Wounded animals were washed once in PBS + 0.1% 
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Tween-20 and then twice in 70% ethanol.  On a Sylgard® plate, a small hole was 
made in the posterior of the larvae with #5 dissecting forceps.  Hemolymph was 
gently squeezed out of animal and the carcass was discarded.  Hemolymph was 
immediately transferred with a fine glass needle to glass multi-well microscope 
slides (MP Biomedical, Cat# 096041205) with a small volume of complete 
Schneider’s culture media.  Cells were left to adhere to the slide for 
approximately 1h at room temperature in a humid chamber.  Cells were fixed 
and stained according to protocol described below.  For all ex vivo bleeding 
experiments n≥3 animals for condition / genotype tested. 
 
Wounding assay. 
Both puncture and pinch wounding assays were adapted from Galko and 
Krasnow (2004a) and are described in detail in chapter II, and Stevens and Page-
McCaw (2012).  
 
Immunohistochemistry.   
Wounded epidermal samples were extracted from larvae according to 
procedure described in Chapter II, as well as in Stevens and Page-McCaw (2012).    
Tissue was fixed in PBS + 4% formaldehyde at RT for 30 min. Fixed samples 
were washed and permeabilized in PBS + 0.2% Triton X-100, blocked in PBS + 
5% goat serum + 0.02% NaN3, incubated in 1o antibody (diluted in PBS + 1% goat 
serum + 0.02%NaN3) overnight at 4°C, washed and incubated in 2o antibodies for 
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1.5 h at RT in the dark, and mounted in Vectashield mounting media with DAPI 
(Vector Labs).  Anti-Mmp1 catalytic domain (a 1:1:1 cocktail of mouse 
monoclonal IgG1 antibodies 3B8, 5H7, and 23G, generated by Page-McCaw et al 
(2003) and obtained from the Developmental Studies Hybridoma Bank (DSHB)), 
was used at 1:100. Anti-Mmp1 hemopexin domain (a mouse monoclonal IgG1 
from DSHB) was used at 1:100, Anti-FasIII (a mouse monoclonal IgG2a from the 
DSHB) was used at 1:10.  Mouse monoclonal IgG1 anti-diphosphorylated ERK 
1&2 (Sigma, Cat# M8159) was used at 1:200. Rabbit anti-GFP (Abcam, 
Cat#ab6556) was pre-absorbed against larval epidermis and used at 1:100. Rabbit 
anti-β-Galactosidase (Cappal/ICN, Cat#55976), pre-absorbed against larval 
epidermis, used at 1:100.   Cy3 or FITC labeled goat anti-mouse-IgG1 (Jackson 
ImmunoResearch), DyeLight649, or FITC labeled goat anti-mouse-IgG2a 
(Jackson ImmunoResearch), Cy3 labeled goat anti-mouse (Jackson 
ImmunoResearch), Cy3, or FITC-labeled donkey anti-rabbit (Jackson 
ImmunoResearch) were all used at 1:300.  
 
Microscopy.  
Optical sectioning was performed with a Zeiss Apotome mounted on an 
Axio imager Z1 or M2, with the following objectives: 20X/0.8 Plan-Apochromat, 
40X/1.3 oil EC Plan-NeoFluar, or 63X/1.4 oil Plan-Apochromat. Fluorescent 
images were acquired with an Axiocam MRm (Zeiss) camera paired with 
Axiovision 4.8 (Zeiss). Z-stacks were compressed into 2-diminsional XY 
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projections using the Orthoview function in Axiovision.  All images were 
exported from their acquisition programs as 16-bit, grayscale, TIFF files for post-
processing in Adobe Photoshop CS4, or ImageJ v.1.43u.  
 
Wound measurements.   
Closure and wound area were assessed based on the presence of both 
FasIII staining at cell borders and epidermal polyploid nuclei as stained with 
DAPI. To calculate wound area, the outline tool in Axiovision (Zeiss) was used to 
manually outline the wound edge.  This feature automatically calculates the area 
of the outlined region using image acquisition specifications.  One-way ANOVA, 
followed by Tukey post-hoc tests were performed with the analysis tools 
available in GraphPad Prism v5.01 to compare mutant and wild-type wound 
area within each time point.  Chi-squared analysis was performed to determine 
significant of closure phenotypes between genotypes using the analysis tools 
available in GraphPad Prism v.5.01.  For all statistical analysis, results were 
considered significant if they were within a 95% confidence interval, or had a p-
value less than 0.05.  Error bars represent the standard error of the mean.   
 
Expression analysis.  
To generate heat maps of pixel intensity from fluorescent images, single 
channel 16-bit grayscale 2D projection from Z-stacks were converted to 8-bit 
images in ImageJ v1.43u.  The “fire” look-up table (LUT) was then applied to the 
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image to pseudo-color pixels based on intensity, white = 256 and dark navy blue 
= 0.   
To measure relative PucLacZ or dpErk expression between genotypes over 
time, 2D projection images were opened in ImageJ and the ellipse tool was used 
to mark nuclei at the leading edge of the wound based on DAPI staining and 
anti-FasIII expression, while the PucLacZ or dpErk channel was hidden.  The 
multi-measure tool was then used to calculate the integrated intensity density for 
each region of interest (ROI, representing each nucleus) for the PucLacZ, or dpErk, 
channel.  Each integrated density value was imported into Orign v8.6 software, 
where statistical analysis tools were used to perform repeated-measure two-way 
ANOVA to determine if either time or genetype significantly influenced 
expression intensity.  Two-way ANOVA analysis was followed-up by Bonferroni 
post-hoc tests to compare expression intensity both within genotype over time 
and between genotypes at each time point.  For all statistical analysis, results 
were considered significant if they were within the 95% confidence interval, or 
had a p-value less than 0.05.  Error bars represent the standard error of the mean. 
 
Cell culture. 
Drosophila S2 cells were cultured at 27oC in Schneider’s Drosophila medium 
(Gibco) + 10% heat-inactivated FBS (BioWest, Lot #B51217) + 50U/ml penicillin 
G + 50µg/ml streptomycin sulfate (Gibco).  Gene expression from the pRMHa-3 
metallothionine promoter was induced by adding 2M CuSO4 to a final 
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concentration of 500µM.   Cells were transiently transfected with a total of 19µg 
plasmid DNA in 2M CaCl2 + 50mM HEPES, pH 7.1 + 1.5mM Na2HPO4 + 280mM 
NaCl.  Transfected plasmids included: pRmHa-3.Gal4, pUASt.GFP, 
pUASt.Mmp1.f1, pUASt.Mmp1.f1E225A, pUASt.Mmp1.f2, pUASt.Mmp1.f2E225A.  For 
immunocytochemistry, 100µl of S2 cells were plated on 12-well multi-well slides 
(MP Biomedical, Cat# 096041205) and allowed to settle for about 1h.   Cells were 
fixed in 4% formaldehyde in PBS for 25m at RT and then stained according to 
immunohistochemistry protocol described above.  
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Results 
Mmp1 is up-regulated in hemocytes post-wounding. 
 In response to wounding, Mmp1 is dramatically up-regulated in the 
epidermis (Stevens and Page-McCaw 2012), so we asked if Mmp1 is also up-
regulated in hemocytes post-wounding.  To assess Mmp1 expression changes, 
we bled 3rd instar larvae after wounding onto glass slides and stained with anti-
Mmp1.  In unwounded animals, Mmp1 is expressed at low levels in the 
hemocytes with no distinct pattern (Fig. 4.1A).  As early as 30m post-wounding 
Mmp1 is slightly up-regulated and localized to punctae (white arrows in Fig. 
4.1B).  By 1h post-wounding, Mmp1 is dramatically up-regulated in hemocytes 
primarily in a punctate pattern throughout the cell (Fig. 4.1C).  By pseudo-
coloring Mmp1 expression based on pixel intensity (scale below Fig 4.1E’-F’), we 
can see that Mmp1 expression becomes continuously more intense through 2h 
post-wounding relative to that seen earlier time points (Fig. 4.1D compared to 
Fig. 4.1A-C).  As Mmp1 is a secreted protein, we asked whether the Mmp1-rich 
punctae were localized on the cell surface, or contained within the cell.  
Hemolectin (Hml) is a protein produced exclusively by a sub-class of 
plasmatocytes (Goto et al., 2003).  By using Hml-Gal4 to drive eGFP expression, 
functioning as a transcriptional reporter, we are able to localize GFP within the 
cell in permeabilized samples (Fig. 4.3E); however in non-permeabilized samples 
we observe no GFP expression (Fig. 4.1F), indicating that our permeability assay 
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is working.  When we compared Mmp1 expression in permeabilized versus non-
permeabilized hemocytes in ex vivo bleeds from larvae 2h post-wounding, Mmp1 
is sequestered in a punctate pattern within the cell (Fig. 4.1E’), with only 
minimal, if any Mmp1 expression on the cell surface (white arrows in Fig. 4.1F’).  
The punctate expression pattern of Mmp1, which is only found within the cell, 
strongly suggests that in response to wounding Mmp1 is being sequestered in 
granules, presumably in preparation for Mmp1 secretion at the wound site.  To 
determine if Mmp1 is localized to vesicles within hemocytes, we looked for co-
localization between Mmp1 and a vesicle marker.  Atrial natriuretic factor 
precursor (ANF) is a marker of dense-core vesicles often used in neurons to 
study the transport of neuropeptides (Pack-Chung et al., 2007; Rao et al., 2001).  
To identify vesicles in hemocytes we used He-Gal4 to drive expression of UAS-
preproANF-GFP fusion protein in hemocytes stained with anti-Mmp1.  One hour 
after wounding Mmp1 is up-regulated and co-localizes with the vesicle marker, 
ANF-GFP in hemocytes (Fig. 4.1G-G”), suggesting that up-regulated Mmp1 is 
localized to secretory vesicles within the hemocytes in response to wounding. 
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Hematopoietic Mmp1.f2 may be required for re-epithelialization.  
 Previous studies in our lab have demonstrated that Mmp1 is required in 
the epidermis for re-epithelialization (Stevens and Page-McCaw (2012); and 
Chapter II).  Successful wound healing requires the orchestration of both the 
epidermis and the hemocytes, so we asked if Mmp1 is required in the hemocytes 
to facilitate re-epithelialization.  We attempted to measure re-epithelialization in 
the hemocytes-deficient mutant, Domino (Dom), but as discussed in chapter III, 
these mutants have clotting defects that cause the animals to bleed out prior to a 
time point sufficient for wound closure analysis.  As this would be a recurring 
obstacle, we decided to focus on the requirement of Mmp1 expression 
specifically in the hemocytes during re-epithelialization, as opposed to the 
broader question of the necessity of hemocytes in general for re-epithelialization.   
Drosophila Mmp1 is predicted to have nine isoforms (National for 
Biotechnology Information (NCBI) database); however, after comparative 
sequence analysis we can break those into four groups of isoforms encoding five 
unique polypeptides (for details see Appendix A).  In all groups, the only 
differences between each Mmp1 isoform are at the C-terminus of the hemopexin 
domain (Fig 4.1B, Appendix A), the putative MMP substrate recognition domain 
(Ra and Parks, 2007).  This suggests that the various Mmp1 isoforms recognize a 
unique set of substrates, which possibly serve as a mechanism to finely regulate 
Mmp1 activity.  For a more in-depth discussion of the differences between the 
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various predicted Mmp1 isoforms see Appendix A.  The remainder of this 
chapter will focus exclusively on Mmp1.f1 (40 unique amino acids) and Mmp1.f2 
(11 unique amino acids), as we currently only have reagents available to study 
these two isoforms in vivo.   
Eighteen hours post-wounding, the majority of wild-type wounds have 
completely re-epithelialized (Fig. 4.2A, I-J, and chapter II).  To test if the catalytic 
activity of Mmp1 is required for re-epithelialization in either hemocytes, or the 
epidermis, we expressed a catalytically-inactive Mmp1 construct, UAS-
Mmp1E225A, which harbors an alanine mutation at a conserved glutamic acid in 
the active site and acts as a dominant-negative (Glasheen et al., 2009b; Zhang et 
al., 2006).   As mentioned above, Mmp1.f1 and Mmp1.f2 differ only at the C-
terminal region of the hemopexin domain (Fig. 4.2B), so to determine if one, or 
both, of these isoforms is required for re-epithelialization, we expressed either 
catalytically-inactive Mmp1.f1 (UAS-Mmp1.f1E225A) or catalytically-inactive 
Mmp1.f2 (UAS-Mmp1.f2E225A) in the epidermis, using A58-Gal4, or in the 
plasmatocytes, using Hemese-Gal4 (He-Gal4), and measured wound area 18h post-
wounding.  In animals expressing Mmp1.f1E225A in the hemocytes 
(He>Mmp1.f1E225A) wounds closed in 50% of the animals tested (Fig. 4.2C, I), with 
an average wound area at 18h post-wounding that was not significantly different 
from wild type (Fig. 4.1J).  However, when the same construct was driven 
specifically in the epidermis (A58>Mmp1.f1E225A) wounds failed to close within 
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18h post-wounding in 100% of the animals tested (Fig. 4.2D, I), with an average 
wound area that is significantly larger than wild type, similar to the RNAi-
mediated knock-down of Mmp1 (Fig. 4.2J).  Conversely, expression of 
catalytically-active Mmp1.f2 in the hemocytes (He>Mmp1.f2E225A) resulted in re-
epithelialization failure in 100% of animals tested (Fig. 4.2E, I).  Interestingly, 
while the wounds remained open in He>Mmp1.f2E225A mutants, the average 
wound area 18h post-wounding was not significantly larger than wild-type (Fig. 
4.2J), suggesting that re-epithelialization in He>Mmp1.f2E225A may simply be 
delayed and wounds in these mutants will close, provided enough time.  To test 
this hypothesis, wound area should be measured in He>Mmp1.f2E225A mutants at 
time points greater than 18h post-wounding.  If wounds in this mutant 
background eventually close, then these data suggest that wound healing is 
merely delayed when we over-express an Mmp1.f2 dominant-negative construct 
in the hemocytes.  Disruption of Mmp1.f2 catalytic activity in the epidermis 
(A58>Mmp1.f2E225A), however, resulted in no re-epithelialization impairment, as 
wounds closed in all animals tested (Fig. 4.2F, I-J).  Together, these results 
suggest that Mmp1.f1 and Mmp1.f2 may have unique, tissue-specific functions 
during wound healing.  The simplest explanation of these results is that Mmp1.f1 
is required in the epidermis, while Mmp1.f2 may play a role in the hemocytes to 
facilitate re-epithelialization.  
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Interestingly, when we used a double-stranded RNA construct to 
knockdown all Mmp1 isoforms in either the hemocytes (He>Mmp1-dsRNA), or 
the epidermis (A58>Mmp1-dsRNA), we recapitulated only the Mmp1.f1E225A 
phenotypes. Eighteen hours post-wounding, wounds in He>Mmp1-dsRNA 
mutants closed (Fig. 4.2G,I-J), while A58>Mmp1-dsRNA mutant wounds failed to 
re-epithelialize (Fig. 4.2H, I), leaving an average wound area 18h post-wounding 
that was significantly larger than wild type (Fig. 4.2J and Stevens and Page-
McCaw (2012)).  These results suggest that Mmp1 in general may not be required 
for re-epithelialization; calling into question our finding that catalytically-active 
Mmp1.f2 may be required in the hemocytes to promote re-epithelialization.  It is 
important to note however, that He-Gal4 is only expressed in approximately 70% 
of hemocytes (data not shown).   
To determine if our mild re-epithelialization phenotypes were an artifact 
of the weakness of the He-GAL4 driver, we repeated the re-epithelialization 
experiments with a second plasmatocyte-specific driver, Hemolectin-Gal4 (Hml-
Gal4), and found a similar result (Fig. 4.3).  Fourteen hours post-wounding, there 
was no significant difference in wound area in Hml>Mmp1-dsRNA mutants 
relative to wild type, despite an observation that wounds remained open in 66% 
of animals tested (Fig. 4.3A-B).  When He-GAL4 is used to knock-down Mmp1 
expression (He>Mmp1-dsRNA), wounds are significantly larger than wild type 
14h post-wounding and, like the Hml>Mmp1-dsRNA animals, there is a 66% re-
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epithelialization failure rate in this mutant background (Fig. 4.3A-B).  As with the 
He-GAL4 driver, it is important to note that the Hml-Gal4 again only drives 
expression in a sub-population of hemocytes (our observations and Goto, 
Kadowaki, et al. (2003).  It is also possible that an n-value of 3 (the sample size of 
both He>Mmp1-dsRNA and Hml>Mmp1-dsRNA at 14h post-wounding) it not 
large enough to adequately account for the variability within the population and 
our results could change with a larger sample size.  Together with our 18h re-
epithelialization data, these findings suggest that knocking down Mmp1 in only 
a subpopulation of hemocytes may be sufficient to cause re-epithelialization 
delays, but insufficient to induce complete re-epithelialization failure; perhaps if 
given enough time, wounds in either He>Mmp1-dsRNA or Hml>Mmp1-dsRNA 
mutants will close.  Conceivably, if we were to use the He-GAL4 and Hml-GAL4 
drivers in combination to interfere with Mmp1 expression we would observe 
stronger phenotypes.   
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Figure 4.2: Mmp1.f2 is required for re-epithelialization in hemocytes.   
A-H) XY projections of wound sites 18h post-wounding in the designated genotypes.  Anti-FasIII 
(yellow) labels the cell borders and cell nuclei are labeled in DAPI (blue).  White arrows (A, C, F, 
and G) indicate the closed wounds and dashed lines (D, E, and H) outline open wounds.  Scale 
bar (A) represents 20µm.  I) Graph showing percentage of open versus closed wounds 18h post-
wounding.  By Chi-squared analysis, genotype significantly influences the percentage of wounds 
that are open versus closed 18h post-wounding (p<0.0001).  J) Graph of average wound area 18h 
post-wounding.  By one-way ANOVA genotype significantly influences wound area (F = 17.26, R 
(p<0.0001).  By Tukey post-hoc tests wounds are significantly larger than wild type in 
A58>Mmp1-dsRNA ( p<0.005, 95%CI[-24590,-7449]) and A58>Mmp1.f1E225A (p<0.005, 95%CI[-
27460,-12370]).  Red dashed line (J) indicates approximate initial wound area (8000µm).  Numbers 
on each bar represent number of animals measured in each group. 
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transiently transfected to overexpress either Mmp1.f1 or Mmp1.f2, or the 
catalytically-inactive constructs of each isoform (Fig 4.4). Cells were also 
transfected with a plasmid containing GFP, as a transfection control.  In mock 
transfected cells we detect only very low levels of endogenous Mmp1 expression 
with either the anti-Mmp1 catalytic domain, or the anti-Mmp1 hemopexin 
domain antibodies (Fig. 4.4 A-A’ and F-F’).  In cells expressing both Mmp1.f1 and 
Mmp1.f1E225A, high levels of both anti-Mmp1 catalytic domain (Fig. 4.4B-B’, D-D’) 
and anti-Mmp1 hemopexin domain antibodies (Fig. 4.4G-G’, I-I’) are detected.  
However, in cells overexpressing either Mmp1.f2, or Mmp1.f2E225A, Mmp1 
expression is only detected with the anti-Mmp1 catalytic domain antibodies (Fig. 
4.4 C-C’, E-E’), not the anti-Mmp1 hemopexin domain antibody (Fig. 4.4H-H’, J-
J’); thus demonstrating that the anti-Mmp1 hemopexin domain antibody 
(hereafter referred to as anti-Mmp1.f1) is specific for Mmp1.f1 and does not 
detect Mmp1.f2. 
Before wounding, Mmp1.f1 is expressed at the low levels in unwounded 
epidermis (Fig. 4.5A) and, in response to wounding, Mmp1.f1 is up-regulated in 
cells at the leading edge of the wound site (Fig. 4.5B); further suggesting that 
Mmp1.f1 plays a role in the epidermis during re-epithelialization.  In the 
hemocytes, 2h post-wounding Mmp1.f1 is expressed in a pattern similar to that 
detected with the general anti-Mmp1 antibody (compare Fig. 4.5C to D) with 
Mmp1 concentrated in punctae, presumably in vesicles (Fig. 4.5C’-D’).  
Hemocytes were also labeled for actin (green in Fig. 4.5C-D) and DAPI (blue in 
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Hematopoietic Mmp1 is regulated by JNK signaling. 
In the epidermis, Mmp1 up-regulation in response to wounding is 
regulated by the Jun N-terminal Kinase (JNK) pathway (Stevens and Page-
McCaw 2012), so we asked if a similar mechanism regulated Mmp1 expression in 
the hemocytes.  One hour post-wounding, Mmp1 is dramatically up-regulated in 
vesicles in wild-type hemocytes (Fig. 4.6A).  However, when we interfere with 
JNK signaling by overexpressing a dominant-negative Drosophila JNK, or Basket 
(Bsk), construct (UAS-BskDN) with He-GAL4 (He>BskDN), Mmp1 up-regulation is 
markedly reduced by 1h post-wounding in ex vivo bleeds (Fig. 4.6B), suggesting 
the JNK signaling is required for wound-induced Mmp1 up-regulation in the 
hemocyte, as well as the epidermis.  Tumor necrosis factor (TNF), or Eiger (Egr) 
in Drosophila, is a pro-inflammatory cytokine that, when released stimulates the 
JNK pathway (Barrientos et al., 2008; Igaki et al., 2011; Igaki et al., 2002a; 
Kauppila et al., 2003).  Using two independent double-stranded RNA constructs 
to interfere with Egr expression in the hemocytes (He>Egr-dsRNA) we blocked 
Mmp1 up-regulation in response to wounding, recapitulating the impaired 
wound-induced Mmp1 up-regulation phenotypes of the He>BskDN mutants (Fig. 
4.6C).  Egr knockdown in hemocytes actually appears to cause a greater 
reduction of Mmp1 response to wounding, relative to He>BskDN, suggesting that 
the Erg-dsRNA construct has some off target effects or could function in a 
positive-feedback loop to enhance the inhibition of Mmp1 up-regulation post-
wounding.  Alternatively, perhaps Egr stimulates other signaling pathway that is 
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the protective cuticle remains intact, preventing influx of external pathogens and 
development of infection.  Together, these results demonstrate that immune 
challenge, such as that induced by invading pathogens during puncture 
wounding, is not required for hemocytes activation, defined in this case by an 
up-regulation of Mmp1, or hemocyte recruitment to areas of tissue damage.   
While analyzing Mmp1 expression in the plasmatocytes recruited to the 
wound, we observe at least two types of hemocytes in the wound bed, a class of 
hemocytes expressing high levels of Mmp1 (white arrows in Fig 4.7A’, B’) and a 
class of smaller hemocytes that are not expressing Mmp1 (yellow arrows in Fig. 
4.7A’, B’).  This observation could be an indication that there are multiple 
subpopulations of hemocytes recruited to the wound site.  Alternatively, Mmp1 
may be released from hemocytes at the wound site; thus resulting in the 
appearance of a subpopulation of hemocyte lacking Mmp1 expression and a 
subpopulation with high levels of Mmp1 expression, when in reality we are 
looking at the same population of hemocytes simply pre- or post-Mmp1 release.  
To distinguish between these two models, the Mmp1 localization pattern in 
hemocytes at the wound site should be assayed in a secretion mutant, an animal 
with a defective secretory system.  If hemocytes are releasing Mmp1-positive 
granules into the wound site, then in mutants where vesicles cannot be released, 
we would not expect to find any hemocytes lacking Mmp1-positive punctae.   
 132 
 
When we use He-Gal4 to drive expression of a UAS-GFP, labeling 
plasmatocytes, we again find multiple subpopulations of hemocytes in the 
wound bed: a class expressing Mmp1 and He>GFP (yellow double-headed 
arrows in Fig. 4.7C), a class expressing Mmp1, but not He>GFP (cyan arrows in 
Fig. 4.7C), and a third class expressing He>GFP, but not Mmp1 (white double-
headed arrows in Fig. 4.7C).  This third class of hemocytes (GFP-positive / 
Mmp1-negative), could also simply be mature plasmatocytes that have 
degranulated, releasing their store of Mmp1 into the wound bed.  When we use 
He>GFP, to simultaneously knock down Mmp1 expression (He>GFP, Mmp1-
dsRNA), we find a large number of plasmatocytes in the wound site that are 
He>GFP positive and Mmp1 negative, as expected (white double-headed arrows 
in Fig. 4.7D); however, we also find many hemocytes in the wound bed that are 
He>GFP negative and Mmp1 positive (cyan arrows in Fig. 4.7D).  Together, these 
results could suggest that there may be multiple sub-types of plasmatocytes 
recruited to the wound site.    
While hematopoietic Mmp1 appears to be involved during the damage-
induced  inflammatory response, we find no reduction in hemocyte recruitment 
to the wound site by 2h post-wounding between wild type animals (Fig. 4.7C) 
and He>Mmp1-dsRNA animals (Fig. 4.7D), indicating that Mmp1 is not required 
for hemocyte recruitment to an area of tissue damage.  However, although very 
preliminary, we observe a larger number of hemocytes, particularly at later time 
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points, in Mmp1-deficient samples relative to wild type (Fig. 4.7D and data not 
shown), suggesting that Mmp1 may play a role in hemocyte release from the 
wound site, or that Mmp1 plays a role in limiting the extent of the inflammatory 
response during wound healing.  It is also possible the hemocyte retention in the 
wound site is secondary to the re-epithelialization defects in Mmp1 mutants, as 
previous studies have suggested that hemocyte release from the wound site is 
dependent on epidermal cells invasion into the wound bed, presumably 
displacing hemocytes (Babcock et al., 2008).   
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Figure 4.7: Mmp1 is expressed only in a subpopulation of hemocytes at the wound site. 
A-B) XY projections of wound sites 5h after either puncture (A-A’) or pinch (B-B’) wounding in 
wild-type larvae with anti-Mmp1 pseudo-colored red and DAPI to label cell nuclei in blue.  
White dashed lines indicate the wound edge and white boxes (A-B) demarcate the area shown at 
higher magnification below (A’-B’).  A’-B’) The same wound sites shown in A-B, but at higher 
magnification.  Yellow arrows indicate hemocytes with up-regulated Mmp1 and white arrows 
indicate hemocytes without increased Mmp1.  C-D) XY projections of wounds 2h post-puncture 
wounding in He>GFP (wild type, C) and He>GFP, Mmp1-dsRNA (D) animals.  Hemese (He)-
expressing hemocytes are labeled with GFP (green, C-D), Mmp1 is shown in red (C-D), and DAPI 
is shown in blue (C-D).  Cyan arrows indicate examples of hemocytes expressing Mmp1, but not 
He-GFP (C-D), yellow double-headed arrows indicate hemocytes expression Mmp1 and He-GFP 
(C only) and white double-headed arrows point out examples of cells expressing He-GFP, but not 
Mmp1 (C-D).  Hemocytes are the small nuclei in each frame, relative to the large polyploid 
epidermal nuclei in all panels.  All scale bars (A, A’, and C) represent 20µm.  For all conditions n 
≥ 4 animals examined.    
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Mmp1 plays a role in regulating JNK signaling. 
 The JNK pathway has been implicated in many processes that require 
tissue remodeling in both Drosophila and vertebrates, such as dorsal and thorax 
closure during development (Sluss et al., 1996; Zeitlinger and Bohmann, 1999), 
tumorgenesis (Uhlirova and Bohmann, 2006), and of course wound healing 
(Galko and Krasnow, 2004a; Martin and Nobes, 1992; Ramet et al., 2002).  In 
Drosophila mutants that are devoid of crystal cells, the cell type that facilitates 
scab formation, wounding leads to super-induction of the JNK pathways (Galko 
and Krasnow, 2004a).  In Chapter III we have shown that Mmp1 is required for 
complete scab formation post-wounding, so we asked if JNK signaling was 
affected when Mmp1 is knocked down in either the plasmatocytes, or the 
epidermis.  A common readout of JNK pathway activation is induction of a lacZ 
transcriptional reporter for puckered (Puc), a JNK phosphatase and JNK feedback 
inhibitor, downstream of the transcription factors Jun and Fos (Martin-Blanco et 
al., 1998; Ramet et al., 2002).  Following wounding, in wild type PuclacZ is 
expressed in a gradient pattern originating at the leading edge of the wound and 
can be detected by 3h post-wounding (Fig. 4.8A’, D), with a significant increase 
in expression intensity observed by 5h post-wounding (Fig. 4.8A”, D).  Minimal, 
if any, PuclacZ can be detected in unwounded epidermis (Fig. 4.8 A-C, D).  When 
we knock down Mmp1 expression in the epidermis (A58>Mmp1-dsRNA) PuclacZ 
intensity can be detected by 3h post-wounding in the epidermal cells at the 
leading edge (Fig. 4.8B’, D), with a significant increase in expression intensity by 
 137 
 
5h post-wounding (Fig. 4.8B”, D), similar to that seem in wild type samples.  In 
fact there is no significant difference in PucLacZ expression intensity between wild 
type and A58>Mmp1-dsRNA mutants at any of the time points that we examined 
(Fig. 4.8D); indicating that Mmp1 expression in the epidermis is not required for 
wound-induced Puc expression.   
In contrast to the A58>Mmp1-dsRNA mutants, knockdown of Mmp1 in the 
hemocytes (He>Mmp1-dsRNA) causes no change in PucLacZ expression intensity at 
the leading edge within genotype over time (Fig. 4.8C-C”, D).  Additionally, 
PuclacZ expression at He>Mmp1-dsRNA wound sites is significantly lower than 
wild type 5h post-wounding (Fig. 4.8C” compared to A”, D).  It is important to 
note that while we do find some variability in PuclacZ intensity, with some leading 
edge cells in He>Mmp1-dsRNA mutants able to induce PuclacZ expression at levels 
that appear to be wild type (white arrow in Fig. 4.8C”), however, the overall 
intensity of PuclacZ in these animals is reduced relative to wild type 5h post-
wounding.  We also observe cells up to 4-5 cell lengths away from the wound site 
with activated JNK signaling, by expression of PuclacZ (yellow arrows in Fig. 
4.8C”); thus suggesting that hematopoietic Mmp1 may play a role in restricting 
the area of the JNK signaling, or inflammation, to the immediate vicinity of the 
wound site.    However this is merely an observation (n=3 animals at 5h) and 
more detailed analysis is required to confirm these results.  Together, these 
results suggest that Mmp1 expression in the hemocytes may be required to limit 
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the area in which the JNK pathway is activated, as well as possibly function in a 
feedback loop to potentiate JNK signaling.  One caveat to consider is that Mmp1 
is a secreted protein, making it difficult to unquestionably determine the tissue 
source of Mmp1 at the wound site; knockdown of Mmp1 expression from one 
tissue source could be compensated for by overexpression / secretion of Mmp1 
from a different tissue source.  
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Figure 4.8: Mmp1 plays a role in regulating JNK signaling.   
A-C) XY projections of PucLacZ (purple) expression changes in unwounded (A-C) and at 3h (A’-
C’), 5h (A”-C”) post-wounding in designated genotypes.  FasIII (green) labels the cell borders, 
white dashed lines outline the wound bed.  White arrows (C”) indicate cells that appear to have 
wild type PuclacZ expression.  Yellow arrows (C”) indicate cells with ectopic PuclacZ, or JNK 
signaling.  Scale bar in A represents 20µm.  D) Graph of mean PucLacZ fluorescence intensity.  
Both genotype and time significantly influence PucLacZ intensity by two-way ANOVA (p<0.0001). 
Bonferroni post-hoc comparison was used to determine significance both with genotype over 
time, and between genotypes within each time point.  In unwounded tissue and by 3h post-
wounding, there is no significant change in PucLacZ intensity between wild type and any of the 
mutant genotypes shown (in all cases P>0.05).  By 5h post-wounding, the change in PucLacZ 
intensity at the leading edge is significant within genotype in both wild type (black star, p<0.05) 
and A58>Mmp1-dsRNA (purple star, p<0.05), but there is no significant difference in PucLacZ 
intensity between wild type and A58>Mmp1-dsRNA at 5h post-wounding.  Within genotype, 
there is no change in PucLacZ intensity in He>Mmp1-dsRNA over time.  Additionally, PucLacZ 
intensity at the leading edge in He>Mmp1-dsRNA mutants is significantly lower than wild type at 
5h post-wounding (green star, p<0.05).  Error bars represent the standard error of the mean.  
Numbers on each bar indicate the number of leading edge nuclei measured in each group.   
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Hematopoietic Mmp1 may function to restrict the area of Erk signaling.  
In addition to clearing infectious agents and damaged cell, neutrophils 
and macrophages secrete growth factors and chemokines to stimulate 
keratinocyte proliferation and migration in response to wounding (reviewed by 
Eming et al. (2007).  In fact, re-epithelialization delays are observed in mice 
lacking macrophages (Leibovich and Ross, 1975).  In Drosophila, re-
epithelialization is induced by the Drosophila the PDGF/VEGF-related factor, 
Pvf-1, which is secreted from the hemocytes (Wu et al., 2009b).  PDGF, VEGF 
(vertebrates), and Pvf-1 (Drosophila) are secreted growth factors that activate 
receptor tyrosine kinase (RTK) signaling on epidermal cells, stimulating cell 
migration (Lemmon and Schlessinger, 2010; Wu et al., 2009b).  Extracellular 
signal-regulated kinase (Erk), a common readout for RTK signaling pathway 
(Wu et al., 2009b), activation is necessary to induce epithelial cell motility and 
invasiveness (Doehn et al., 2009b; Matsubayashi et al., 2004b).   Our previous 
studies have shown that Mmp1 is required for di-phosphorylated Erk (dpErk) 
expression at the leading edge post-wounding (Stevens and Page-McCaw, 2012).   
When we interfere with Mmp1 expression in the hemocytes with either an 
Mmp1 double-stranded RNA construct, or Mmp1.f2E225A dominant-negative 
construct, we find delays in re-epithelialization (Fig. 4.2).  We asked if these 
observed re-epithelialization delays are a result of a failure to induce RTK 
signaling in the epidermis.  By 3h post-wounding dpErk is highly expressed in 
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the epidermal cells at the wound margin in wild type (Fig. 4.9A, E) and 
occasionally in hemocytes near the wound site (white arrows in Fig. 4.9A).  As 
we have reported previously, dpErk expression is significantly reduced in both 
Mmp1 null and A58>Mmp1-dsRNA mutants relative to wild type 3h post-
wounding (Fig. 4.9B-C, Fig. 2.11 and Stevens and Page-McCaw (2012).  While 
both time and genotypes do significantly influence dpErk intensity in the 
wounded epidermis by two-ANOVA analysis (Fig. 4.9E),  there is no significant 
difference in dpErk expression intensity in the leading edge epidermal cells at 3h 
post-wounding when we knockdown Mmp1 in the hemocytes (He>Mmp1-
dsRNA), relative to wild type (Fig. 4.9D-E), by Bonferroni post-hoc tests.  The 
same caveat that accompanies all our data involving the He-Gal4 driver applies 
here as well: Mmp1 is only knocked-down in a subpopulation of plasmatocytes 
with He-GAL4, suggesting that if we were able to knock down Mmp1 expression 
in all hemocytes we could potentially induce a more penetrant phenotype.   
Interestingly, when we look at the expression pattern of dpErk in the 
He>Mmp1-dsRNA mutants we find dpErk expressed in epidermal cells 2-3 cell 
lengths from the wound site (yellow arrows in Fig. 4.9D), an area much more 
extensive than that observed in wild type.  There is some variability in the 
number of epidermal cells ectopically expressing dpErk, so more research needs 
to done to quantify and confirm this observation (n=3 He>Mmp1-dsRNA 
wounded animals).  Occasionally, we also find cells in the whole animal Mmp1 
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mutants that are expressing low levels of dpErk approximately 3 cell length from 
the wound site (yellow arrow in Fig. 4.9B, n=5 Mmp12/Q112* mutant animals), but 
the expression pattern of dpErk in Mmp1 mutants is difficult to interpret because 
the intensity of expression is so low.  We do not observe ectopic dpErk 
expression in A58>Mmp1-dsRNA mutants.  We also find no significant 
differences in dpErk expression in unwounded Mmp1, A58>Mmp1-dsRNA, or 
He>Mmp1-dsRNA mutant epidermis relative to wild type (Fig. 4.9E).  Together, 
these results suggest that Mmp1, in the epidermis, is required to promote dpErk 
expression in epidermal cells at the wound margin; while hematopoietic Mmp1 
may be required to limit wound-induced signaling to the immediate wound 
vicinity. 
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Discussion 
Inflammation, induced within minutes of wounding, involves the 
recruitment of innate immune cells, neutrophils and macrophages, in 
vertebrates, or hemocytes in Drosophila, which function to rid the wound site of 
pathogens, clear damaged cells, and stimulate repair.  In this chapter we have 
shown that the Drosophila, secreted MMP, Mmp1, may have a role in the 
hemocytes to promote re-epithelialization.  More specifically, we have shown 
preliminary data that the Mmp1 isoform, Mmp1.f2, may function in the 
hemocytes for re-epithelialization, while Mmp1.f1 does not.  In the epidermis, 
however, the opposite seems to be the case: Mmp1.f1 is required for re-
epithelialization, while Mmp1.f2 is not.  This result is still preliminary, as it is 
possible that the dominant-negative constructs used to interfere with the Mmp1 
isoforms may have off-target effects, or could cross-react with the other Mmp1 
isoforms.  Additionally, we are assuming that over-expression of a catalytically-
inactive Mmp1 dominant-negative is functioning cell autonomously, but as 
Mmp1 is a secreted protein, it is possible that over-expression of the dominant-
negative is acting non-cell autonomously, interfering with endogenous Mmp1 
from other tissue sources.  These results should be confirmed with rescue 
experiments, by over-expressing a wild-type version of each isoform, while 
simultaneously expressing the catalytically-inactive construct.  Further 
confirmation could be obtained by knocking down each isoform individually by 
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isoform-specific RNAi.  While experiments in cell culture have previously found 
that human MMP-11 (or stromelysin-3) has two isoforms, which have different 
localization patterns within the cell (Luo et al., 2002), our finding would be the 
first in vivo demonstration that different MMP isoforms have independent 
functions and suggests that a mechanism to finely tune MMP functions in vivo 
may be through alternative splicing.    
Our data supports the hypothesis that hemocytes are required for re-
epithelialization, as we find re-epithelialization delays when we knockdown 
Mmp1 specifically in the hemocytes, coupled with reduced Erk activation, which 
is involved in promoting cell migration.  However, there are studies that suggest 
that hemocytes are not required for re-epithelialization in Drosophila (Galko and 
Krasnow, 2004a; Razzell et al., 2011; Stramer et al., 2005).  This seemingly 
contradictory data could be a result of the developmental stage of the animals, as 
much of the wound healing research done in Drosophila is during the embryonic 
stages.  In vertebrates during embryonic and fetal wound healing, wounds heal 
perfectly, or scar-less, and do not invoke an inflammatory response (Bullard et 
al., 2003), indicating that the inflammatory response is not necessary for re-
epithelialization during early development. Perhaps, as with vertebrates, the 
wound healing process in Drosophila embryos also does not require an 
inflammatory response to induce re-epithelialization.  As all of our wound 
healing research has been conducted on third instar larvae, it is plausible that at 
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this later developmental stage, as with older vertebrates, an inflammatory 
response is required for re-epithelialization.   
Loss of crystal cells, in lozenger15 (lzr15) mutants, in Drosophila larvae has no 
effect on re-epithelialization, despite scab formation defects (Galko and Krasnow, 
2004a).  Similarly, when the plasmatocytes-specific driver, peroxidasin-GAL4 (Pxn-
GAL4) was used to drive expression of the apoptosis pathway component Head 
involution defective (UAS-Hid), resulting in apoptosis of all plasmatocytes 
expressing Pxn-GAL4, wounds in 3rd instar larvae were still able to close 
(Babcock et al., 2008), indicating that Pxn-positive plasmatocytes are not required 
for re-epithelialization. Interestingly, re-epithelialization is unaffected in 
neutrophil-depleted mice (Dovi et al., 2003).  However, macrophages may be 
necessary for re-epithelialization (Leibovich and Ross, 1975).  Our studies 
suggest that re-epithelialization may be delayed when we interfere with Mmp1.f2 
in a subset of plasmatocyte, using the He-Gal4 driver, a plasmatocyte marker.  
Together these results suggest that while crystal cells are not required for re-
epithelialization, plasmatocytes may play a role in promoting re-epithelialization 
in Drosophila larvae, but more research is required to clearly define the 
requirement and function of hemocytes during re-epithelialization.   
 In response to wounding, Mmp1 is up-regulated, via JNK signaling, in 
hemocytes systemically, as we find hemocytes with up-regulated Mmp1 
throughout the hemolymph, as observed in both wounded larvae in vivo and by 
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ex vivo bleeds, including the hemocytes found at the wound site.  Unlike the 
epidermis, which appears to up-regulate Mmp1 throughout the cells (Chapter II 
and Stevens and Page-McCaw (2012)), our data suggest that hematopoietic 
Mmp1 is localized in vesicles shortly after wounding.  Additionally, wound-
induced hematopoietic Mmp1 up-regulation is a systemic response; hemocytes 
with elevated Mmp1 levels in granules are found throughout the hemolymph of 
the wounded animals, thus suggesting that the Mmp1-positive vesicles are 
accumulating within the hemocytes prior to the arrival of the hemocyte at the 
wound site, perhaps to be released when the hemocyte reaches the wound bed.  
While we do find that Mmp1 co-localizes with preproANF-GFP, a marker of 
dense-core secretory vesicles, providing evidence for the former hypothesis that 
Mmp1 is accumulating in secretory vesicles, it does not dispel the alternative 
hypothesis that hemocytes are collecting Mmp1 from another tissue source, 
through endocytosis.  Analysis of the Mmp1 expression pattern in secretory 
pathway mutants, as well as endocytosis mutants, could determine if Mmp1 was 
being secreted, or collected as hemocytes respond to the wound stimulus.   
Interestingly, at the wound site we observe two classes of hemocyte, one 
with Mmp1-positive granules and a class without Mmp1-positive granules.  This 
latter class could either represent a set of hemocytes that have released 
accumulated Mmp1 into the wound bed, or they could be a unique sub-set of 
hemocytes that either does not express Mmp1, or does not up-regulate Mmp1 in 
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response to wounding. Further investigation need to be conducted to understand 
how Mmp1, a secreted protease, is regulated in hemocytes.  
  In the process of neutralizing pathogens and clearing damaged cells, the 
inflammatory response releases cytotoxic molecules into the wound site, which 
subsequently leads to some collateral damage, inducing apoptosis in otherwise 
healthy cells (Stramer et al., 2007).  As a result, the inflammatory response is 
highly regulated, with dampening inflammation being equally, if not more, 
important than activation.  In Mmp1 whole animal mutants, or any of our tissue-
specific Mmp1 mutants, we do not observe any defects in hemocyte recruitment 
to wound sites, suggesting that Mmp1 is not required for activation of 
inflammation post-wounding, or accumulation of hemocytes at the wound site.  
However, we observe a large number of hemocytes remaining in and around 
wound sites in Mmp1 mutants at late time points (time>5h).  These preliminary, 
purely observational results, may suggest that Mmp1 plays a role in releasing 
hemocytes from the wound site.   
In both vertebrates and Drosophila, JNK signaling is required for wound 
healing (Galko and Krasnow, 2004a; Martin and Nobes, 1992; Zenz et al., 2003).  
In both mouse and zebrafish models, JNK has been shown to regulate the 
inflammatory response via activation of MMPs, specifically MMP-8 and MMP-
13, and their endogenous inhibitors, tissue inhibitor of metalloproteinase (TIMP), 
where loss of MMP-13 leads to a decreased macrophage recruitment to the 
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wound site, while loss of either MMP-8 or TIMP-3 causes increased inflammation 
and delayed wound healing (Guinea-Viniegra et al., 2009; Gutierrez-Fernandez 
et al., 2007a; Mohammed et al., 2004; Zhang et al., 2008).  Together these results 
implicate MMPs in both activation and inactivation of inflammatory signaling.  
Similar to the vertebrate models, our data also suggest that Mmp1, under the 
regulation of JNK signaling, may function in a feedback loop to limit JNK 
signaling in the epidermis to the vicinity of the wound site, as shown by ectopic 
expression of the JNK signaling reporter PuclacZ  in cells not immediately at the 
wound edge.  Interestingly, while Mmp1 expression in the epidermis does not 
appear to play a role in JNK signaling, hematopoietic Mmp1 may be required to 
potentiate JNK signaling in the epidermis as we significantly lower PucLacZ 
expression epidermal cells at the wound margin in He>Mmp1-dsRNA mutants 
compared to wild type at 5h post-wounding.  Together, these results 
demonstrate the complexity of inflammation regulation and suggest that 
secreted MMPs may perform different functions during an inflammatory 
response, to both limit the area of JNK signaling, as well as promote JNK 
signaling at the wound edge.   
In addition to neutralizing pathogens and clearing dead and dying cells, 
Drosophila hemocytes also function to promote tissue repair by secreting growth 
factors, such as Pvf-1 (Wu et al., 2009b).  Pvf-1 promotes cell migration and re-
epithelialization by activating RTK signaling in the epidermal cells at the wound 
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margin, as indicated by common readout out for RTK signaling, dpErk expression 
(Lemmon and Schlessinger, 2010; Wu et al., 2009b).  Previous studies in our lab have 
shown that Mmp1 expression in the epidermis promotes dpErk expression 
(Stevens and Page-McCaw, 2012).  The present study indicates that Mmp1 
expression in the hemocytes may also play a role in limiting RTK signaling to the 
epidermal cells at the wound margin, as is indicated by our preliminary data 
showing cells 2-3 cell lengths from the wound expressing dpErk, an area of 
expression greater than that observed at most wild-type wound sites.   
By utilizing the genetic tools available in Drosophila, we have shown that 
Mmp1 isoforms, Mmp1.f1 and Mmp1.f2 may have independent tissue-specific 
requirements and play unique roles during wound healing.  Additionally, we 
have found that the hematopoietic Mmp1 is up-regulated, via JNK signaling, and 
accumulates in vesicles; awaiting release once the hemocyte reaches the wound 
site.  Once secreted from the hemocyte, Mmp1 may function to finely regulate 
JNK signaling in a time-dependent manner, while simultaneously limiting the 
area of inflammation to the vicinity of the wound.  Additionally, hemocytes may 
release Mmp1 to stimulate epidermal repair by promoting dpErk signaling in 
epidermal cells at the wound margin.  Further research is required to fully 
understand the functions of Mmp1 in hemocytes during wound healing, as some 
of the data discussed in this chapter is only preliminary.  A better understanding 
of how secreted Mmp1 functions during both the inflammatory and re-
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epithelialization phases of wound healing in a simple Drosophila model, may 
provide insight into the functions of secreted MMPs during an inflammatory 
response in higher organisms, as well as the mechanisms involved in finely 
regulating inflammation during wound healing.   
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 CHAPTER V 
 
DROSOPHILA Mmp1, Mmp2, AND Timp MAY FUNCTION TOGETHER 
DURING WOUND HEALING. 
 
Introduction 
Matrix metalloproteinases (MMPs) have been implicated to function in 
almost every context that requires tissue remodeling from basic development, to 
cancer metastasis, to re-generation and wound healing (Page-McCaw et al., 
2007).  During wound healing, MMPs are known to be involved in all three 
phases: inflammation, re-epithelialization, and scar-formation (Gill and Parks, 
2008).  Mice deficient for MMP-8 have an increased inflammatory response and 
delayed re-epithelialization (Gutierrez-Fernandez et al., 2007a).  Wound 
contraction delays in mice in vivo, as well as inefficient cell migration in cultured 
cells result from a loss of either MMP-10, MMP-3, or MMP-13 (Hattori et al., 
2009a; Krampert et al., 2004; Kyriakides et al., 2009b).  Interestingly, MMP-9 has 
been shown to play multiple roles during healing of corneal epithelial wounds, 
including delaying the inflammatory response, promoting cell proliferation and 
migration, and remodeling the provisional fibrin matrix (Mohan et al., 2002).  
Additionally, MMP-9 MMP-13 double mutants show longer re-epithelialization 
delays compared to either single mutant (Hattori et al., 2009a), indicating that 
MMPs function redundantly during wound healing.  
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Understanding protein structure can suggest how a protein interacts with 
other molecules and how that protein might be regulated; as such, extensive 
research has gone into elucidating the structure of MMPs, as a means to shed 
light on MMP function.  MMPs are enodpeptidases of the metzincin family that 
contain a Zn2+ ion and a conserved methionine turn in the active site (Bode et al., 
1993).  Translated as zymogens, MMPs contain a signaling sequence that targets 
MMPs to secretory vesicles were they will subsequently either be secreted or 
inserted into the plasma membrane (Bode et al., 1993).  In vertebrates, there are 
25 MMPs, all of which have conserved pro and catalytic domains, as well as a 
very similar 3-D structure (Massova et al., 1998).  Most MMPs also have a 
hemopexin-like domain, which is thought to be the substrate recognition domain 
(Bode et al., 1993; Massova et al., 1998).  The MMP family is comprised of two 
classes, the secreted type (of which there are seventeen family members in mice) 
and the membrane-anchored type (which includes seven family members in 
mice).  MMPs are inhibited by four endogenous inhibitors, known as Tissue 
Inhibitors of Metalloproteinases (TIMP), which function by coordinating with the 
Zn2+ ion in the MMP active site via a conserved N-terminal cysteine residue 
(Fernandez-Catalan et al., 1998; Gomis-Ruth et al., 1997).  TIMPs also been shown 
to have functions independent of MMP inhibition (Brew and Nagase, 2010).  
During liver regeneration, TIMP-3-/- mice have increased inflammation and 
excessive necrosis, despite no change in overall MMP activity (Mohammed et al., 
2004), suggesting that TIMPs may have functions independent of MMPs during 
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regeneration and wound healing.  While there is substantial evidence indicating 
that MMPs and TIMPs are involved in wound healing, due to the high level of 
redundancy between MMPs in mammalian systems, it is difficult to elucidate 
precise MMP functions and regulatory mechanisms in a complicated process, 
such as wound healing.  
MMPs have been shown to be activated by several different mechanisms, 
including cleavage at a furin cleavage site prior to MMP secretion (Massova et 
al., 1998; Santavicca et al., 1996; Thomas, 2002), or through the formation of a 
homodimeric or multidimeric MMP complexes (Butler et al., 1998; Olson et al., 
2000; Strongin et al., 1995).  Work in primarily cultured cells, as well as in vitro 
studies, suggest that a membrane-anchored MMP (MMP-14), a TIMP (TIMP2), 
and a secreted pro-MMP (MMP2) form a tri-molecular complex, with TIMP2 
binding in the active site of MMP-14 at the cell surface and functioning as an 
adaptor to localize MMP2 through interactions with the MMP2 hemopexin 
domain (Butler et al., 1998; Itoh et al., 2001; Kinoshita et al., 1998; Strongin et al., 
1995).  In cultured cells, an MMP-14/TIMP2/pro-MMP2 complex has been 
shown to be necessary for pro-MMP2 activation and invasive cell migration 
(Fernandez-Catalan et al., 1998; Ingvarsen et al., 2008; Itoh et al., 2001; Strongin et 
al., 1995; Will et al., 1996a).  However, in vivo for the formation of a complex is 
unclear.  While MMP-14, MMP2, and TIMP2 are all required to promote tail fin 
regeneration in zebrafish (Bai et al., 2005), as would be expected if they function 
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together as a complex, the phenotypes of MMP-2, MMP-14, and TIMP-2 knock-
out mice are not similar (Gill et al., 2010; Holmbeck et al., 1999; Kuzuya et al., 
2003; Oblander et al., 2005; Zhou et al., 2000b).   Additionally, pro-MMP2 does 
not require MMP-14 for activation (Miyamori et al., 2001; Overall et al., 2000; 
Wang et al., 2000) and MMP-14 can promote cell invasion in the absence of 
MMP2 (Hotary et al., 2006; Sabeh et al., 2009); thus suggesting that if such a 
complex does form in vivo it may only be required under specific circumstances.  
To bypass the complications of redundancy, we utilized the simple model 
system, Drosophila melanogaster, to investigate the function and regulatory 
mechanisms of MMPs in vivo during wound healing.  Aside from being an 
established model system in which to study wound healing in vivo (Galko and 
Krasnow, 2004a; Wood et al., 2002b), the Drosophila genome only encodes two 
MMPs: one secreted (dmMmp1) and one membrane-anchored (dmMmp2), as well 
as one TIMP (dmTimp)  (Godenschwege et al., 2000b; Page-McCaw et al., 2003b; 
Wei et al., 2003).  By taking advantage of the simplicity of this system we are able 
to identify the functions of each class of MMP in vivo, as well as their regulatory 
mechanisms.  In this chapter we report that both Mmp2 and Timp are required for 
re-epithelialization, where they play a role in promoting cell elongation post-
wounding.  Additionally, we find that Mmp2 and Timp are required for Mmp1 
localization in the epidermis, as well as in the hemocyte.  From the combination 
of the shared re-epithelialization failure phenotypes and the requirement of 
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Mmp2 and Timp for Mmp1 localization, we hypothesize that Mmp1, Mmp2, and 
Timp may form a tri-molecular complex in vivo, which functions to localize 
Mmp1 and promote wound healing.  During tracheal development, Mmp1 is 
required to promote ECM remodeling and tissue growth, but a role for Mmp2 
has not been identified (Glasheen et al., 2010a), indicating that Mmp1 and Mmp2 
also have independent functions in vivo.  In this chapter, we also report that 
while Mmp1 and Timp are required for ECM maintenance, Mmp2 is not; 
indicating that Mmp1 and Mmp2 have both shared, as well as independent 
functions under normal physiological conditions.  Together these results suggest 
that if an Mmp2/Mmp1/Timp complex does form in vivo, it is context-specific. 
 
Methods 
Fly lines. 
The following lines are described in Page-McCaw et al (2003):  Mmp12, 
Mmp2 Df(2R)Uba1-Mmp2 (imprecise P excision alleles resulting in deletions of most or 
all of the coding region); Mmp1Q112* and Mmp2W307* (EMS-induced nonsense 
alleles resulting in premature truncations).   Timp1 syn28 (imprecise P excision that 
removed all of Timp and the neighboring gene synapsin coding region 
(Godenschwege et al., 2000b).  For most mutant analyses, trans-heterozygous 
mutants (combining a P-generated allele and an EMS allele) were used to ensure 
Mmp1 or Mmp2 specificity (Glasheen et al., 2009a; Glasheen et al., 2010b; Page-
McCaw et al., 2003b).  Other fly lines used were UAS-Timp (Godenschwege et al., 
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2000b; Page-McCaw et al., 2003b), A58-Gal4 (M. Galko), and He-Gal4 (Flybase ID 
FBti0064641) from the Bloomington Drosophila Stock Center, Vkg-GFPG205 (Yale 
Flytrap).  w1118 was used as wild type. 
 
Wounding Assays and ex vivo bleeding assays. 
 The wounding assay protocol is described in detail in chapter II and 
Stevens and Page-McCaw (2012).  Ex vivo bleeding assay for Mmp1 localization 
in Mmp2 and Timp mutant hemocytes was performed as described in Chapter IV. 
 
Immunohistochemistry. 
Samples were dissected and fixed according to protocol described in 
Chapter II.  For permeabilized immunohistochemistry experiments, fixed tissue 
was permeabilized by washing three times in PBS + 0.2% Triton-X100.  For non-
permeabilized immunohistochemistry experiments, samples were prepared in 
the absence of any detergents.  Also for non-permeabilized samples, all washes 
were done in PBS.  All samples were blocked in PBS + 5%goat serum + 
0.02%NaN3.  Anti-Mmp1 catalytic domain (a 1:1:1 cocktail of mouse monoclonal 
IgG1 antibodies 3B8, 5H7, and 23G, generated by Page-McCaw et al (2003) and 
obtained from the Developmental Studies Hybridoma Bank (DSHB)), was used 
at 1:100.  Anti-FasIII (a mouse monoclonal IgG2a from the DSHB) was used at 
1:10.  Rabbit anti-GFP (Abcam, Cat#ab6556) was pre-absorbed against larval 
epidermis and used at 1:100.  Mouse monoclonal IgG2a anti-GFP (NeuroMab, 
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clone N86/38) was used at 1:100. Rabbit anti-perlecan (gift of S. Baumgartner) 
was used at 1:1000.  Cy3 or FITC labeled goat anti-mouse IgG1 (Jackson 
ImmunoResearch), DyeLight649 or FITC labeled goat anti-mouse IgG2a (Jackson 
ImmunoResearch), Cy3 labeled goat anti-mouse (Jackson ImmunoResearch), 
DyeLight649 or FITC labeled donkey anti-rabbit (Jackson ImmunoResearch) 
were all used at 1:300.  
 
Microscopy. 
Optical sectioning was performed with a Zeiss Apotome mounted on an 
Axio imager Z1 or M2, with the following objectives: 20X/0.8 Plan-apochromat, 
40X/1.3 oil EC Plan-NeoFluar, or 63X/1.4 oil Plan-apochromat.  Fluorescent 
images were acquired with an Axiocam MRm (Zeiss) camera.  All images were 
obtained in the dark at RT.  Z-stacks were compressed into 2-diminsional 
projections using the orthoview function in Axiovision.  All images were 
exported from their acquisition programs as 16-bit grayscale TIFF files for post-
processing in Adobe Photoshop CS4, or ImageJ v.1.43u.    
 
Expression analysis. 
To generate heat maps of anti-Mmp1 pixel intensity from fluorescent 
images, single channel 16-bit grayscale from 2D XY projections from Z-stacks 
were converted to 8-bit images in ImageJ v1.43u.  The “fire” look-up table (LUT) 
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was then applied to the image to pseudo-color pixels based on intensity, white = 
256 and dark navy blue = 0.   
To measure Pcan and Vkg-GFP expression in permeabilized versus non-
permeabilized tissues between genotypes, 2D XY projections were made from Z-
stacks acquired at 63X in Axiovision 4.8 and then exported as a stack of single 
channel grayscale TIFF images.  Grayscale images for channels of interest were 
opened in ImageJ and automatically sized to 9.25in x 6.93in.   A 0.5in2 grid was 
applied to each image and integrated density was calculated within each square 
using the ImageJ measure tool.  Squares that contained only basement membrane 
were measured; squares that contained folds in the tissue or ECM from other 
tissue types were excluded.  All intensity measurements were imported into a 
Microsoft Excel spreadsheet and the average pixel intensity for each sample 
(each animal) was calculated and imported into GraphPad Prism v5.01, which 
calculated and plotted the mean intensity for each experimental condition.  The 
error bars all show the standard error of the mean.  Two-way ANOVA was used 
to assess the impact of genotype and permeabilization on Pcan intensity, 
followed by Bonferroni post-hoc tests to determine if there are significant 
differences between mutant and wild type Pcan expression.  Within genotype, 
Student’s T-test was used to determine significance between permeabilization 
conditions.  Student’s t-test was used to determine significance between wild 
type and mutant intensity in non-permeabilized Vkg-GFP samples.  For all 
statistical analysis, results were considered significant if p<0.05. 
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Wound measurements. 
Closure and wound area were assessed based on the presence of both 
FasIII staining at cell borders and epidermal polyploid nuclei as stained with 
DAPI.  To calculate wound area, the outline tool in Axiovision (Zeiss) was used 
to manually outline the wound edge.  This feature automatically calculates the 
area of the outlined region using image acquisition specifications.  Student’s t-
tests were performed with the analysis tools available in GraphPad Prism v5.01 
to compare mutant and wild-type wound area within each time point.  Error bars 
represent the standard error of the mean.  Aspect ratios measurements were 
performed as outlined in Chapter II.  Two-way ANOVA, followed by Bonferroni 
post-hoc tests were performed in OriginPro v8.6 to determine aspect ratios were 
significantly different over time in wild type versus Mmp1, Mmp2, and Timp 
mutants. Aspect ratios in  A58>Timp mutants were only measured at 5h post-
wounding, so to determine if genotype significantly influences aspect ratio 5h 
post-wounding, one-way ANOVA, followed by Tukey post-hoc tests were 
performed in GraphPad Prism v5.01.  For all statistical analysis, results were 
considered significant if they were within a 95% confidence interval, or if p<0.05.  
 
Cell culture. 
Drosophila S2 cells (Schneider, 1972) were cultured at 27C in Schneider’s 
Drosophila medium (Gibco) + 10% heat-inactivated FBS (BioWest, Lot #B51217) + 
50U/ml penicillin G + 50µg/ml streptomycin sulfate (Gibco).  Gene expression 
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from the pRMHa-3 metallothionine promoter was induced by adding 2M CuSO4 
to a final concentration of 500µM.   Approximately 3.5x106 cells (total volume = 
3ml) were plated into wells of a 6-well plates (Corning, cat#3516), allowed to 
settle overnight at 27C, then were transiently transfected with a total of 18µg 
(6µg/plasmid) plasmid DNA in 2M CaCl2 + 50mM HEPES, pH 7.1 + 1.5mM 
Na2HPO4 + 280mM NaCl.  Transfected plasmids included: pRmHa-3.Mmp1.f1, 
pRmHa3.Mmp1.f2, pRmHa3.Timp.c-Myc, and two different pRmHa3.Mmp2.GFP 
plasmids (one with the GFP tag inserted immediately after the furin cleavage site 
and the second with the GFP tag inserted immediately before the GPI anchor). 
pRmHa3.GFP was used as a transfection control during parallel transient 
transfection experiments.  For immunocytochemistry, 50µl of S2 cells were plated 
on 12-well multi-well slides and allowed to settle for about 20min.  Cells were 
fixed in 4% formaldehyde in PBS for 25min at RT and then stained according to 
immunohistochemistry protocol described below. 
 
Co-immunoprecipitation. 
 Drosophila S2, either wild-type or stably transfected with Mmp1.f1, cells 
were cultured and transfected as described above.  When cells reached a density 
of approximately 2.0x106 cells/ml (about 2 days  post-induction) 3ml cultured 
cells were collected (~6.0x106 cells), washed twice in 1ml cold PBS, then lysed in 
500ul cold co-IP lysis buffer (20mM Tris-HCl, pH7.5 + 1mM EDTA + 10% 
glycerol + 0.5% tritonX-100 + 1 tablet/10ml mini complete protease inhibitors 
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(Roche)) by incubating at 4C for 30min with agitation.  Cells were centrifuged in 
a microfuge at 16,110xg at 4C and supernatant was collected.  Protein 
concentration was determined at A280 with the nanodrop.  Lysates were then 
diluted to 1mg/ml in co-IP lysis buffer.  Lysates were pre-cleared against 
ProteinG- conjugated Dynabeads® (Invitrogen).   
The following antibodies were individually bound to ProteinG Dynabeads 
® (Invitrogen): mouse monoclonal IgG1 anti-Mmp1 clones 3A6, 5H7, and 3B8 
(DSHB), mouse monoclonal IgG1 anti-cMyc (DSHB), rabbit anti-GFP (Abcam, 
Cat#ab6556.), mouse monoclonal IgG2a anti-GFP (NeuroMab, clone N86/38).  
After binding, antibodies were cross-linked to beads in 0.2M triethanolamine + 
25mM Dimethyl pimelidate dihydrochloride for 45min at RT, blocked in 0.1M 
ethanolamine for 1h at RT, then resuspended in PBS + 0.1% Tween-20 + 0.02% 
NaN3.  All washes during bead-antibody conjugation steps were done in 0.1M 
Na Phosphate buffer, pH8.0.  Prior to mixing with lysate, beads cross-linked to 
Mmp1 monoclonal antibodies were mixed 1:1:1 (A36:5H7:3B8).  For 
immunoprecipitation, 300µg protein from pre-cleared lysates was mixed with 
30µl antibody cross-linked Dynabeads®  and then incubated overnight at 4C 
with agitation, washed three times in co-IP lysis buffer, then resuspended in 30µl 
3X Laemmli buffer.  Protein was boiled off beads by incubating at 70C for 5min.  
Samples were then tested via western blot for presence of target proteins. 
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Western blotting. 
  Lysates were made from dissected 3rd instar larvae epidermis of 
genotypes w1118, Mmp12/Q112*, Mmp2W307/Df, and Timp1 syn28.  Samples were 
homogenized in 2X Laemmli buffer with mini-complete protease inhibitors 
(Roche), and 3-8 epidermal sample equivalents loaded in each lane.  Blots were 
washed in TBS + 0.05% Tween-20, blocked in TBS + 5% nonfat milk + 0.02% 
NaN3, and probed with the following primary antibodies for 2h at RT: a 1:1:1 
cocktail of mouse anti-Mmp1 monoclonal antibodies, 5H7, 3B8, 3AC used at 
1:100, or goat anti-GAPDH (Imgenex, Cat# IMG-3073), used at 1:10,000.  
Secondary antibody incubations were for 2h at RT with HRP goat anti-mouse 
(Jackson ImmunoResearch) at 1:5000, or HRP donkey anti-goat (Jackson 
ImmunoResearch) at 1:10,000, followed by developing with ECL Plus Blotting 
Detection System (GE Healthcare). 
 For co-IP samples, 30µl of each sample was loaded onto either a 10% tris-
glycine gel, or 4-15% tris-glycine gradient gel.  Separated proteins were 
transferred onto nitrocellulose paper and blocked in Odyssey blocking buffer (Li-
Cor).  Blots were probed with a 1:1:1 cocktail of mouse anti-Mmp1 monoclonal 
antibodies A36, 5H7, 3B8 (DSHB) at 1:100, rabbit anti-cMyc (Abcam, Cat#ab9106) 
at 1:2000, rabbit anti-GFP (Abcam, Cat #ab6556), mouse anti-GFP (NeuroMab, 
Clone N86/38).  Secondary antibodies incubations were for 1h at RT in the dark 
with goat anti-mouse labeled with IRdye800 (Li-Cor) at 1:7,500 and donkey anti-
rabbit tagged with IRDye680 (Li-Cor) at 1:5,000, diluted in odyssey blocking 
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buffer (Li-Cor) + 0.02%NaN3,   followed by developing with the Odyssey Infrared 
Imaging System (Li-Cor).   All blot images were exported as grayscale Tiff files 
for post-processing in Adobe Photoshop Cs4. 
 
 
Results 
Mmp2 and Timp are required for Mmp1 localization. 
 Results from cell culture and in vitro crystal structure studies have 
suggested that a membrane-anchored MMP (MT1-MMP), a secreted MMP 
(MMP-2), and a TIMP (TIMP-2) form a tri-molecular complex, which at least in 
cell culture, functions to localize the secreted MMP to the cell surface, which 
leads to the activation of the secreted pro-MMP, and promotes cell migration and 
invasiveness (Fernandez-Catalan et al., 1998; Itoh et al., 2001).  To test this model 
with our in vivo system, we analyzed Mmp1 expression in unwounded 
epidermis in both permeabilized tissue, to assay total Mmp1 expression, as well 
as non-permeabilized tissue, to assess exclusively the extracellular contribution 
to Mmp1 localization.  Expression of anti-αtubulin was used as a 
permeabilization control, as tubulin, being an intracellular protein, will only be 
detected in permeabilized cells (inset images in Fig. 5.1A-J).  Focusing on total 
Mmp1 expression in unwounded wild-type epidermis, that observed in 
permeabilized samples, Mmp1 is localized primarily at the cell-cell borders, with 
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some low levels of Mmp1 detected in punctae throughout the cell and 
occasionally in a long fiber-like pattern across cells (Fig. 5.1A).  From images in 
the XZ plane, we find that Mmp1 is primarily localized to the basal edge of the 
cell, with some staining seen in more apical regions, as well as at cell junctions 
(Fig. 5.1A’).  In the absence of Mmp2, Mmp1 expression is reduced in 
permeabilized samples (Fig 5.1C), suggesting that Mmp2 plays a role in either the 
localization, or the production, of Mmp1 in unwounded epidermis.  A similar 
phenotype is observed in the absence of the MMP inhibitor, Timp, where again 
we find reduced Mmp1 localization in unwounded epidermis (Fig. 5.1E 
compared to A).   
To confirm that the decreased expression of Mmp1 in both Mmp2 and 
Timp mutants is a result of Mmp1 mislocalization, not a defect in Mmp1 
translation, we analyzed Mmp1 expression via western blot in epidermal 
samples from 3rd instar larvae (Fig. 5.1K).  By western blot, Mmp1 expression in 
both Mmp2 and Timp mutants is similar to wild type.  While this western blot 
was repeated three times, all with the same results, they were not done with a 
quantifiable protocol; as such, these western blot experiments should be repeated 
with a quantifiable technique in order to measure relative band intensity 
between genotypes.   
TIMP has been shown to bind to MMPs with a 1:1 stoichiometry (Cao et 
al., 1996; Imai et al., 1996; Strongin et al., 1995).  When we over-express Timp in 
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the epidermis, therefore disrupting the putative Mmp2/Timp/Mmp1 complex, 
Mmp1 localization appears similar to both that seen in Mmp2 and Timp mutants, 
with reduced Mmp1 localization to cell-cell borders (Fig. 5.1G).  This suggests 
that overexpression of Timp may also disrupt Mmp1 localization.  The predicted 
tri-molecular complex is predicted to sequester the secreted MMP at the cell 
surface by TIMP interacting with the MMP hemopexin domain (Butler et al., 
1998; Itoh et al., 2001; Kinoshita et al., 1998); it would then follow that without 
the hemopexin domain, the secreted MMP would not be properly localized.  In 
the absence of the Mmp1 hemopexin domain (Mmp1∆pex), there is a significant 
reduction in Mmp1 expression relative to wild type (Fig. 5.1I).   In all genotypes 
tested, some Mmp1 can be properly localized to the cell-cell borders, as seen in 
the XY projections (Fig. 5.1A, C, E, G, I) and in varying degrees along the basal 
side of the cell, as seen in the XZ images (Fig. 5.1A’, C’, E’, G’, I’).  Together these 
results suggest that Mmp2 and Timp are required to localize Mmp1 in the 
epidermis, perhaps through formation of an Mmp2/Mmp1/Timp tri-molecular 
complex; however in the absence of either Mmp2 or Timp there may be other 
mechanisms to localize at least a portion of Mmp1 in the epidermis. 
 To determine if Mmp1 trafficking also requires Mmp2 and Timp; we 
analyzed Mmp1 expression in non-permeabilized unwounded epidermis, which 
allows us to visualize extracellular Mmp1 localization exclusively.  Visualization 
of extracellular Mmp1 indicates that most of Mmp1 expression observed in 
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permeabilized samples, particularly that at cell-cell borders and along fibers, is 
extracellular and localized to the basal side of epidermal cells in wild type (Fig. 
5.1B, B’).  Similar, to that observed in permeabilized tissue, in the absence of 
Mmp2, Mmp1 expression is reduced in non-permeabilized samples, relative to 
wild type (Fig 5.1D).  Interestingly, Mmp1 expression levels in non-
permeabilized Mmp2 epidermis appear to be lower when compared to 
permeabilized Mmp1 expression in the Mmp2 mutant background by the XY 
projections (Fig. 5.1D compared to C), suggesting that Mmp2 plays a role in 
facilitating Mmp1 secretion.  While the intensity of Mmp1 expression in the XZ 
projections appears similar in non-permeabilized samples relative to both wild 
type and permeabilized Mmp2, the pattern of Mmp1 expression in the Mmp2 
mutant background appears slightly more diffuse than that seem in wild type 
(Fig. 5.1D’ compared to B’), again suggesting that Mmp2 may be required for 
Mmp1 localization to the cell surface.  In both Timp loss-of-function and Timp 
gain-of-function (A58>Timp) mutants, extracellular Mmp1 expression intensity is 
lower than that in non-permeabilized wild type (Fig. 5.1F, H compared to B), as 
well as to total Mmp1 expression seen within genotype (compare Fig. 5.1F to E 
and H to G).  A similar trend is also observed in the Timp and A58>Timp mutants 
when we analyze Mmp1 expression in the XZ plane, where again we find 
reduced Mmp1 intensity along the basal cell surface relative to wild type, as well 
as within genotype when compared to permeabilized expression intensity (Fig. 
5.1F’, H’).  Together these results suggest that Timp may not only be required for 
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Mmp1 localization, but may also play a role in Mmp1 secretion from the 
epidermal cells.  The intensity of Mmp1 expression in Mmp1∆Pex mutants is so low 
in permeabilized tissue, that it is difficult to assess extracellular Mmp1 
localization in this mutant background, as in both permeabilized and non-
permeabilized samples Mmp1 expression is nearly undetectable (Fig. 5.1J, J’).   
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Mmp2 and Timp are required for re-epithelialization. 
 Previous studies in our lab have shown that the Drosophila secreted MMP, 
Mmp1, is required during re-epithelialization to remodel the ECM and promote 
cell migration (Stevens and Page-McCaw, 2012).  To determine if the membrane-
anchored MMP, Mmp2, or the endogenous inhibitor, Timp, also function during 
wound healing, we punctured 3rd instar larvae with a fine needle.  By 14h post-
wounding, 79% of wild-type animals have closed their wounds (Fig 5.2A,F, and 
Stevens and Page-McCaw (2012)).  In either Mmp1 (Fig 5.1B), or Mmp2 (Fig. 5.2C) 
mutants wounds fail to re-epithelialize in 100% of animals tested by 14h post-
wounding (Fig. 5.2F), with an average wound area 14h post-wounding that is 
significantly larger than wild type (p=0.001, p=0.007, respectively).  This re-
epithelialization failure phenotype is recapitulated when we over-express the 
endogenous MMP inhibitor, Timp, in the epidermis, using the epidermal-specific 
Gal4 driver, A58-Gal4 (Fig. 5.2E, F), again leading to a mean wound area that is 
significantly larger than wild type 14h post-wounding (Fig. 5.2G, p<0.0001).  
Interestingly, loss of the MMP inhibitor, in Timp mutants, also induces re-
epithelialization defects in all animals tested, with wounds not only remaining 
open, but also with an average wound area that is significantly larger than wild 
type by 14h post-wounding (Fig. 5.2D, F-G, p=0.0217).  Together, these results 
suggest that Mmp1, Mmp2, and Timp are all required to facilitate re-
epithelialization.  Unfortunately, we were unable to measure wound area in 
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either Mmp1 Mmp2 or Mmp1 Timp double mutants as these animals have clotting 
defects and often bleed out shortly after wounding (n=84 Mmp12/Q112* 
Mmp2W307*/Df, with n=1 at 14h post-wounding; and n=6 Mmp12 Timp1 syn28, with 
n=2 at 14h post-wounding).  In fewMmp1 Mmp2 and Mmp1 Timp double mutants 
that did survive for 14h post-wounding, the wounds were open (data not 
shown).  The enhancement of the single mutants clotting defects in these double 
mutants (see Chapter III for more details) suggests that Mmp1, Mmp2, and Timp 
may have function some redundant functions during wound healing.    
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The Mmp1 hemopexin domain is required for re-epithelialization. 
Based on the crystallography evidence, the vertebrate MT1-
MMP/TIMP2/MMP2 complex is predicted to form by N-terminal cysteine 
residues in TIMP-2 chelating the Zn2+ ion in the MT1-MMP active site.  Serving 
as a bridge, the C-terminal domain of TIMP-2 will then bind to the outer edge of 
the MMP2 hemopexin domain (Overall et al., 1999; Overall et al., 2000; Strongin 
et al., 1995).  If a similar complex forms between Mmp2, Mmp1, and Timp in 
Drosophila to promote wound healing, as suggested by our Mmp1 localization 
data (Fig. 5.1), we would predict that loss of the Mmp1 hemopexin domain 
would impair complex formation and recapitulate the re-epithelialization 
phenotypes that we observe in Mmp1, Mmp2, and Timp mutants.  To test this 
hypothesis we measured wound closure 18h post-wounding in Mmp1 mutants 
that are  trans-heterozygous for  two independent mutations in Mmp1 (Mmp1Q273* 
and Mmp1W439*)  that induces 2 premature stop codons and, when translated, a 
protein that lacks the Mmp1 hemopexin domain (Mmp1∆Pex) (Glasheen et al., 
2009a).  By 18h post-wounding, where 84% wild-type animals have closed their 
wounds (Fig. 5.3A, D), wounds in both Mmp1 (Fig. 5.3B) and Mmp1∆Pex (Fig. 5.3C) 
mutants fail to undergo complete re-epithelialization in 100% of animals tested 
(Fig. 5.3D).  Note, however, that only 3 Mmp1∆Pex mutants were tested 18h post-
wounding, so this experiment should be repeated to increase the n-value.  In 
both Mmp1 and Mmp1∆Pex mutants, the mean wound area 18h post-wounding is 
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significantly larger than wild type (Fig. 5.3E); thus indicating that not only is 
Mmp1 required for re-epithelialization, the Mmp1 hemopexin domain, 
specifically, is also required to facilitate wound closure.  However, as seen in Fig. 
5.1, very little Mmp1 is detected in the Mmp1∆Pex mutant in general, so it is 
possible that the re-epithelialization defects in the Mmp1∆Pex mutant background 
may not be a result of loss of the Mmp1 hemopexin domain, but may instead 
simply be a consequence of insufficient levels of Mmp1 in general. 
 
 
 
 
  
Fi
A
an
ar
sh
w
M
nu
 
 
M
 
m
re
(M
gure 5.3: Mm
-C) XY proje
d Mmp1W439
row (A) indi
owing perce
ound area 1
mp1∆Pex (p=0
mber of anim
mp2 and T
Re-ep
argin into
arrange th
ogilner a
p1 hemopex
ctions of wou
*/Q273* (C).  Fa
cates closed 
ntage of wo
8h post-wou
.0009), relativ
als tested in
imp are re
ithelializat
 the woun
e actin cy
nd Keren,
in domain is
nded epider
sIII (yellow) 
wounds and 
unds open 
nding.  Wo
e to wild typ
 each group.
quired to p
ion is char
d bed (Sin
toskeleton
 2009b).  
176 
 required for
mis 18h post
labels cell bo
white dashed
versus closed
unds are sig
e by Student’
  Error bars re
romote ce
acterized b
ger and C
 and elon
Our previ
 re-epithelia
-wounding in
rders and DA
 lines outlin
 18h post-w
nificantly la
s t-test.  Num
present the s
ll elongatio
y migration
lark, 1999
gate in th
ous studie
lization. 
 wild type (
PI (blue) sta
e wound bed
ounding.  E
rger in Mmp
bers on bars
tandard erro
n. 
 of the cel
).  As cells
e direction
s indicate
A), Mmp12/Q1
ins nuclei.  W
 (B-C).  D) G
) Graph of 
1 (p=0.0003
 (D-E) indica
r of the mean
ls at the wo
 migrate, 
 of migra
 that Mmp
 
12*(B), 
hite 
raph 
mean 
) and 
te the 
.   
und 
they 
tion 
1 is 
 177 
 
required for cell elongation 5h post-wounding (Fig. 5.4E-F, chapter II and 
Stevens and Page-McCaw (2012)), a phenotype that we can replicate by over-
expression of Timp specifically in the epidermis (Fig. 5.4D, E, F, chapter II and 
Stevens and Page-McCaw (2012)).  As both Mmp2 and Timp are required for re-
epithelialization, we asked if they were also involved in promoting cell 
elongation.  Similar to Mmp1 mutants, in Mmp2 mutants there is no significant 
difference in the aspect ratio of cells at the wound margin immediately post 
wounding, relative to wild type (Figure 5.4E).  However, by 5h post-wounding 
leading edge epidermal cells are significantly less elongated in Mmp2 mutants 
compared to wild type (compare Fig, 5.4B to A, quantified in Fig. 5.4F).  
Intriguingly, in Timp mutants leading edge epidermal cells are significantly 
longer than wild type wild type immediately post-wounding, but at 5h post-
wounding leading edge cells in Timp mutants fail to elongate are significantly 
shorter than wild type at the same time point (Fig. 5.4C, F), this could imply that 
epidermal cells are initially longer than in Timp mutants relative to wild type, a 
hypothesis that could be tested by comparing cell aspect ratio in unwounded 
Timp mutants to wild type.  Together these results suggest that Mmp2 and Timp 
function, like Mmp1, to promote cell elongation, and presumably cell migration, 
in response to wounding. 
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where it has been shown to function to sequester signaling molecules within the 
ECM and support cell polarity and tissue architecture (Schneider et al., 2006).  
We have previously reported that Mmp1 is required for maintenance of the 
unwounded basement membrane (Stevens and Page-McCaw, 2012).  Mmp2 and 
Timp are required for Mmp1 localization (Fig. 5.1) and share the Mmp1 re-
epithelialization phenotypes (Fig. 5.2), so we asked if Mmp2 and Timp were also 
required for organization of the basement membrane in unwounded epidermis.    
Using an antibody against domain V of Drosophila Pcan (Friedrich et al., 2000) as 
an indicator of ECM organization, we analyzed Pcan localization in the basement 
membrane of unwounded larval epidermis.  In unwounded, wild-type tissue 
that was permeabilized prior to exposure to antibodies, we find Pcan 
homogenously expressed throughout the basement membrane with a slight 
concentration at the cell-cell borders (Fig. 5.5A).  In the XZ plane, we find Pcan 
localized to the basal side of cells, as expected of an ECM protein (Fig. 5.5A’).  To 
separate the extracellular from intracellular contributions to Pcan expression, we 
stained tissue in the absence of detergents, using loss of anti-αtubulin expression 
as a non-permeabilization control (inset panels Fig. 5.5A-K).  Similar to the 
permeabilized samples, in non-permeabilized, wild-type tissue we find Pcan 
expressed homogenously throughout the sample and localized to the basal side 
of the epidermal cells, again with a slight concentration at the cell-cell borders 
(Fig. 5.5B, B’).  When we compare Pcan expression intensity within wild-type 
samples we find that there is significantly less Pcan expressed in non-
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permeabilized samples relative to permeabilized samples (Fig. 5.5M), indicating 
that the epidermal cells may be a source of Pcan, which is then secreted and 
deposited in the ECM.   
Deposition of Pcan in the basement membrane appears to be dependent 
on Mmp1, as in the absence of Mmp1, we find significantly less extracellular Pcan 
expression when compared to either that in wild type samples, or to Pcan 
expression in permeabilized Mmp1 mutant samples (Fig. 5.5C, D, M).  
Additionally, we observe a decrease in the complexity of the Pcan expression 
pattern, in that we a less distinct cell-cell border pattern, in the permeabilized 
Mmp1 mutant samples relative to wild type; despite there being no significant 
difference in Pcan intensity between Mmp1 mutants and wild type (compare Fig. 
5.5C to A, quantified in M).  Interestingly, from the images of Pcan expression in 
the XZ plane, Pcan appears to be localized to the basal side of the cells in Mmp1 
mutants, similar to wild type (Fig. 5.5C’); however the lack of Pcan expression in 
non-permeabilized Mmp1 samples (Fig. 5.5D, D’) suggests that Mmp1 may be 
required for the secretion of Pcan from the epidermal cells.   
As validation of our assay, we analyzed extracellular type IV collagen 
localization unwounded basement membrane using the collagen IV-GFP protein 
trap (Vkg-GFP) expressed in either a wild-type, or an Mmp1 mutant background.  
Previously, we have shown that Mmp1 is required for proper Vkg organization 
in unwounded basement membrane in permeabilized samples (Chapter II, fig. 
 181 
 
2.6, published in Stevens and Page-McCaw (2012)).  By utilizing an anti-GFP 
antibody to isolate the extracellular Vkg-GFP component from the total amount 
of Vkg-GFP expressed in our permeabilized versus non-permeabilized 
expression assay (see methods) we found that, as expected, Vkg-GFP is 
expressed extracellularly and localized to the basal side of the epidermal cells, 
presumably the basement membrane, in wild type (Fig. 5.6A, A’), confirming 
that without detergents, we are able to visualize ECM components.  
Recapitulating our previous results from permeabilized samples, loss of Mmp1 
leads to significantly less extracellular Vkg-GFP expression, as observed in non-
permeabilized tissue (Fig. 5.6B, B’, quantified in C), similar to that seen with Pcan 
expression.  Together, these results suggest that Mmp1 plays a critical role in 
facilitating ECM organization, and may facilitate extracellular Pcan insertion into 
the basement membrane.   Studies suggest that Pcan insertion into the ECM 
follows polymerization of the type IV collagen matrix (Fessler et al., 1994), 
therefore, disruption of the collagen IV matrix, as seen in Mmp1 mutants, could 
results in an inability to localize Pcan in the basement membrane.  Cells are 
constantly aware of the consistency of their basement membrane (Discher et al., 
2005b), suggesting that in response to mislocalized Pcan in Mmp1 mutants, 
epidermal cells produce an increased amount of Pcan as an attempt to 
compensate for insufficient amounts of Pcan in the ECM.  Alternatively, Mmp1 
could function to promote Pcan secretion, thus loss of Mmp1 leads to Pcan 
retention within the cell.  The outcome of either hypothesis would result in the 
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increased levels of intracellular Pcan relative to extracellular Pcan that we 
observe in Mmp1 mutants.  
Similar to the Mmp1 mutants, loss of Timp impairs Pcan deposition, as we 
find significantly less extracellular Pcan expression relative to wild type (Fig. 
5.4H, H’, M).  However, in permeabilized tissue there is no significant difference 
in Pcan expression intensity between Timp and wild type (Fig. 5.5G, G’, M).  
These results suggest that Timp may also have a role in facilitating extracellular 
Pcan localization.  However by this analysis it is unclear if Timp is directly 
required for Pcan insertion into the basement membrane, or if Timp has an 
indirect role, where it functions to inhibit a protease, such as Mmp2, that would 
otherwise degrade basement membrane and prevent proper Pcan localization.   
Interestingly, when we over-express Timp in the epidermis we find no 
statistically significant difference in Pcan levels, in either permeabilized or non-
permeabilized tissue relative to wild type (Fig. 5.5I, J, M), or  in the amount of 
Pcan found in non-permeabilized tissue versus that found in permeabilized 
A58>Timp samples within genotype (Fig. 5.5M).  Together these data suggest that 
Timp overexpress does not affect Pcan localization in the basement membrane, 
which appears to be properly  deposited into the ECM, as we observe Pcan 
expressed along the basal side of A58>Timp cells in both permeabilized and non-
permeabilized XZ sections (Fig. 5.51’-J’).  If Mmp1, Mmp2, and Timp are 
functioning together, as our re-epithelialization and Mmp1 localization data 
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suggests, then we would expect a loss of the Mmp1 hemopexin domain 
(Mmp1∆Pex) to phenocopy Mmp1, Mmp2, and Timp mutant phenotypes.  However, 
there is no significant difference in Pcan intensity in either permeabilized or non-
permeabilized tissue relative to wild type (Fig. 5.5K, K’, L, L’, M), suggesting that 
the hemopexin domain of Mmp1 is not required for Pcan insertion into the 
basement membrane. 
Next we asked if the Mmp2 was involved in Pcan deposition into the 
basement membrane.  Unlike Mmp1 mutants, there is no significant difference 
between wild type and Mmp2 mutants in Pcan intensity in either permeabilized 
(Fig. 5.5E) or non-permeabilized (Fig. 5.5F) samples (quantification in Fig. 5.4M).  
The localization pattern of Pcan in Mmp2 mutants also appears to be similar to 
wild type, with Pcan localized to the basal surface of the cells with a 
concentration of Pcan at the cell-cell borders (Fig. 5.5E, E’, F, F’), indicating that 
Mmp2 is not required to for Pcan localization and that Mmp1 and Mmp2 do not 
function together to facilitate unwounded ECM organization. 
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Figure 5.5: Mmp1 and Timp are required for ECM maintenance. 
A-L) XY projections of Pcan expression in unwounded epidermis in designated genotypes.  A’-L’) 
XZ images from a single  frame from optically-sectioned, unwounded epidermis stained with 
Pcan (green), αTub (red) and DAPI (blue) from designated genotypes.  Inset images on upper left 
of A-L are XY images of αTub, a permeabilization control (red) and DAPI (blue) corresponding to 
each grayscale Pcan image.  Samples were permeabilized prior to immunohistochemistry in (A, 
A’, C’, C’, E, E’, G, G’, I, I’, K, K’).  Samples were not permeabilized and immunohistochemistry 
was performed in the absence of detergents (see Methods) in (B, B’, D, D’, F, F’, H, H’, J, J’, L, L’).  
For all XZ images basal side is down and apical side is up.  Scale bar for A-L (A) and A’-L’ (A’) 
represent 20µm.  M) Graph of mean integrated Pcan fluorescence intensity associated with 
permeabilized (black bars) or non-permeabilized (gray bars) unwounded epidermis in 
designated genotypes.  Pcan intensity is significantly different between permeabilized versus 
non-permeabilized tissue in wild type (p=0.0175) and Mmp1 (p=0.0312) by Student’s t-test.  By 
two-way ANOVA, both genotype and permeabilization condition affect Pcan intensity.  There 
are no significant differences in Pcan intensity between mutants and wild type in permeabilized 
tisuue by Bonferroni post-hoc tests.  In non-permeabilized tissue, Pcan intensity is significantly 
different from wild type in Mmp1, Timp (p<0.05).  Numbers on each bar indicate the number of 
samples measured within each class.  Error bars represent standard error of the mean. 
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Mmp2 and Timp are required for wound-induced Mmp1 up-regulation. 
Our data suggest that Mmp2 and Timp are required for re-epithelialization 
during wound healing, as well as Mmp1 localization in unwounded epidermis.  
We next asked if Mmp2 and Timp are required for Mmp1 up-regulation in 
response to wounding.  In wild type, Mmp1 is dramatically up-regulated by 5h 
post-wounding in the epidermal cells at the leading edge in a gradient pattern, as 
we see when we pseudo-color anti-Mmp1 staining based on pixel intensity (Fig. 
5.7A, Chapter II; n=23).  However, in the absence of Mmp2 we observe only 
minimal, if any, Mmp1 up-regulation by 5h post-wounding (Fig. 5.7B; n=10).  
However, due the Mmp1 localization defects in unwounded epidermis that we 
observe in the Mmp2 mutant background, this result is difficult to interpret; 
either Mmp1 is up-regulated, but without Mmp2 is mislocalized, or Mmp2 is 
required on a transcriptional level for Mmp1 production post-wounding.   
Similarly, loss of Timp also results is a reduction of Mmp1 expression by 5h post-
wounding (Fig. 5.7C, n=4), suggesting that like Mmp2, Timp is required for either 
Mmp1 up-regulation, or Mmp1 localization post-wounding.  Interestingly, over-
expression of Timp in the epidermis elicits a milder phenotype than either loss-
of-function Mmp2, or Timp mutants, with slight Mmp1 up-regulation post-
wounding (Fig. 5.7D; n=8), but Mmp1 up-regulation is not to the extent of that 
found in wild type 5h post-wounding (compare Fig. 5.7A to D), again suggesting 
that Timp is either required to promote wound-induced Mmp1 transcription or to 
facilitate Mmp1 localization in the epidermis.  To distinguish between the two 
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proposed hypothesis, an Mmp1 transcriptional reporter should be used in Mmp2, 
Timp, and A58>Timp mutant backgrounds to determine if Mmp2 and / or Timp 
are influence Mmp1 transcription in response to wounding.   
In chapter III we showed that Mmp1 in the hemocytes plays a role in 
wound healing, so we analyzed Mmp1 up-regulation in hemocytes in ex vivo 
bleeds from both unwounded and 1h post-wounded 3rd instar larvae to 
determine if Mmp2 and Timp also play a role in Mmp1 localization in the 
hemocytes (Fig. 5.7E-G).  To clearly visualize the dynamic range of Mmp1 
expression intensity, we pseudo-colored anti-Mmp1 staining based on pixel 
intensity.  In hemocytes from unwounded larvae, Mmp1 is expressed at very low 
levels throughout the hemocyte in both wild type and Mmp2 mutants (Fig. 5.7E, 
F).  In hemocytes from Timp mutants, it is unclear if more Mmp1 is present in 
unwounded hemocytes, relative to wild type, or if the Mmp1 that is expressed is 
simply concentrated in foci within the cell (Fig. 5.7G, compared to Fig. 5.7E).  By 
1h post-wounding, Mmp1 is dramatically up-regulated in wild-type hemocytes 
(Fig. 5.7E’).  However, in the absence of  Mmp2 (Fig. 5.7F’), hemocytes do not 
appear to up-regulate Mmp1, either due to a failure to induce Mmp1 up-
regulation at a transcriptional level, or perhaps Mmp1 is up-regulated in 
hemocytes, but without Mmp2, Mmp1 cannot be properly localized.  As Mmp1 is 
a secreted protein, once it is released from the hemocyte Mmp1 is undetectable 
by this assay.  Timp mutant hemocytes have a slightly milder phenotype, with 
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Mmp1 slightly up-regulated by 1h post-wounding, but as in the epidermis, 
Mmp1 is not up-regulated to the extent of that in wild-type cells at the same time 
point, indicating that Timp plays a role in facilitating Mmp1 up-regulation post-
wounding.  As in Mmp2 mutants, if Mmp1 in the Timp mutant background is up-
regulated, but secreted, then we are unable to detect the full magnitude of the 
Mmp1 expression change in the hemocytes post-wounding.  Further analysis, 
perhaps by a combination of qPCR and western blotting of hemolymph collected 
from wounded and unwounded animals, as well as expression of an Mmp1 
transcriptional reporter in the hemocytes, is required to distinguish between a 
role for Mmp2 and Timp in Mmp1 localization, or transcriptional up-regulation 
post-wounding. 
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were unsuccessful (data not shown).  To test if Mmp2, Mmp1, and Timp 
physically interact, we utilized Drosophila S2 cells transiently transfected with 
inducible Mmp2 tagged with GFP (Mmp2-GFP), and Timp tagged with c-Myc 
(Timp-cMyc) to do co-localization and co-immunoprecipitation studies.   S2 cells 
endogenously express Mmp1 at very low levels, so in an attempt to preserve a 
balance between Mmp1, Mmp2, and Timp, which are predicted to bind in a 1:1:1 
ratio (Cao et al., 1996; Strongin et al., 1995), we simultaneously transfected the 
cells with an inducible Mmp1 construct. Both Mmp.f1 and Mmp1.f2 were tested 
with similar results (data not shown), but only data from cells over-expressing 
Mmp1.f1 are shown.  Two Mmp2-GFP constructs were generated, one with the 
GFP tag inserted towards the C-terminus, just before the GPI anchor (Mmp2-
GFPGPI), and the second with the GFP tag near the N-terminus (Mmp2-GFPNterm), 
immediately following the furin-cleavage site.  For the tagged-Timp construct, 
the cMyc tag was added to the 3’ end of the protein.  In cells transiently 
transfected with Mmp1, Mmp2-GFPNterm, and Timp-Myc we find all three 
proteins expressed in a punctae pattern in the cells (Fig. 5.8B-C), which are 
virtually undetectable in the mock transfected cells (Fig. 5.8A-A’”).  As expected, 
Mmp2-GFP and Timp-cMyc co-localize (yellow arrows in Fig. 5.8B-B’”), just as 
Mmp1 and Timp-cMyc co-localize (cyan arrows in Fig. 5.8C-C’”).  However, in 
our transfected S2 cells, we were unable to find cells where all three components, 
Mmp1, Mmp2-GFP, and Timp-cMyc, co-localized to the same punctae (Fig. 5.8B-
C).  In fact, the incidence of a cell that overexpressed Mmp1, while 
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simultaneously expressing Mmp2-GFP was very rare, despite a high transfection 
rate.  Similar results were obtained when cells were transfected with Mmp2-
GFPGPI (data not shown).  Together these results indicate that Mmp1, Mmp2-
GFP, and Timp-cMyc do not co-localize in S2 cultured cells.  Additionally, they 
suggest that, at least in this cell culture system, Mmp1 overexpression and Mmp2 
overexpression may be mutually exclusive, a cell overexpressing Mmp1 will 
possibly down-regulate Mmp2 and vice versa.     
 In conjunction with the above co-localization experiments, we asked if 
Mmp1, Mmp2-GFP, and Timp-cMyc physically interact.  When anti-Mmp1 was 
used as bait, we were able to pull down both Mmp1, as expected, as well as 
Timp-cMyc (Fig. 5.8D), but we were unable to pull-down Mmp2-GFP with anti-
Mmp1 (Fig. 5.8D), thus confirming our co-localization results that Timp and 
Mmp1 physically interact, but Mmp1 and Mmp2-GFP do not.  Further 
confirming that Mmp1 and Timp-cMyc physically interact, we were able to pull-
down Mmp1 with antibodies against cMyc (Fig. 5.8E).  Similarly, when we use 
anti-GFP as bait to ask if either Mmp1 or Timp-cMyc is associated with Mmp2-
GFP, we are able to pull down Mmp2-GFP and Timp-cMyc, but not Mmp1 (Fig. 
5.8F).    While we are able to resolve a GFP-specific band when we IP with anti-
cMyc, but at approximately 40kDa, the size of the Mmp2-GFP band is much 
smaller than predicted (predicted size of Mmp2-GFP is 116kDa), suggesting that 
we only recovered a portion of Mmp2-GFP (all of GFP (at~25kDa) + 
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approximately 135aa, or most of the catalytic domain only) with Timp-cMyc 
either as a results of experimental error, or due to some as yet unaccounted for 
post-translational modification of Mmp2.  Interestingly, the predicted molecular 
weight of Timp-cMyc is approximately 25kDa, however, we consistently resolve 
Timp-cMyc at approximately 40kDa (Fig. 5.8D-F), suggesting that Timp may 
actually function as a dimer or Timp is post-translationally modified.  
Dimerization of TIMP-3 has been shown to occur in mammals and is associated 
with the retinal disorder, Sorsby fundus dystrophy, which leads in an 
accumulation of TIMP-3 in the ECM and results in age-related macular 
degeneration (Weber et al., 1994; Wei et al., 2003).  Similarly, Mmp2-GFP also 
runs much higher than predicted, (at approximately 200kDa, Fig. 5.8F), 
suggesting the Mmp2 may also either form dimers, as has been suggested by cell 
culture studies of mammalian MMPs (Itoh et al., 2001), or has post-translational 
modifications.  Together, the results from these cell culture experiments show 
that Mmp1 and Timp, as well as Mmp2 and Timp physically interact; however, 
we have no evidence that Mmp1, Mmp2, and Timp physically interact, at least in 
S2 cell culture.   
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Discussion 
 Wound healing involves precise regulation of many factors, including 
matrix metalloproteinases.  Through our studies using the simple model 
organism, Drosophila melanogaster, we have found that both classes of MMP, 
secreted (Mmp1) and membrane-anchored (Mmp2) are required for re-
epithelialization, as well as the endogenous MMP inhibitor, Timp.  Our data 
indicates that Mmp1, Mmp2, and Timp are all required to promote cell elongation, 
an indicator of cell migration, in response to wounding.  Additionally, Mmp1 
localization in unwounded epidermis, as well as up-regulation in both the 
epidermis and the hemocytes involves Mmp2 and Timp.  While the functions of 
Mmp1, Mmp2, and Timp appear to be redundant during the re-epithelialization 
phase of wound healing, our data suggests that they have independent functions 
during baseline ECM maintenance; where Mmp1 and Timp are required for Pcan 
deposition into the ECM, but Mmp2 is not.    
 
An Mmp2/Mmp1/Timp tri-molecular complex may be required in vivo for 
wound healing. 
Previous studies, primarily in cell culture have suggested that a 
membrane-anchored MMP, a TIMP, and a secreted MMP form a tri-molecular 
complex to localize the secreted MMP at the cell surface (Itoh et al., 2001).  
Interestingly, in zebrafish, when the putative MT1-MMP/MMP2/TIMP2 
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complex was disrupted by overexpression of the MT1-MMP hemopexin domain 
during tail fin regeneration, cell proliferation and subsequently the regenerative 
process failed (Bai et al., 2005).  The shared re-epithelialization and cell 
elongation failure  phenotypes observe in Mmp1, Mmp2, and Timp mutants, as 
well as the mis-localization of Mmp1 in the epidermis suggests that a similar 
complex forms between the Drosophila secreted MMP (Mmp1), the membrane-
anchored MMP (Mmp2), and the Timp in the epidermis in vivo (modeled in Fig. 
5.9A).  Following this model then, in the absence of Mmp2 to serve as an anchor, 
an Mmp1/Timp complex could still form, but would not be held at the cell surface 
(Fig. 5.9B).  Similarly, without Timp, to function as an adaptor, linking Mmp1 
and Mmp2, Mmp1 would also be released into the extracellular space (Fig. 5.9C); 
just as an excess of Timp in A58>Timp mutants would disrupt the 1:1 MMP:TIMP 
stoichiometry, disrupt complex formation, and cause Mmp1 secretion into the 
extracellular space (Fig. 5.9D).  To add to the complexity of Mmp1 regulation, 
our data also suggests that Mmp2 and Timp may play a role in promoting Mmp1 
release from epidermal cells, as we find higher Mmp1 expression in 
permeabilized Mmp2 and Timp epidermis, than in non-permeabilized Mmp2 and 
Timp epidermis, indicating that Mmp1 is being retained within the cells.    
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to disruption of Mmp1 localization.  In cell culture, pro-MMP2 is activated by 
MT1-MMP, which forms an MT1-MMP homodimer with an adjacent MT1-MMP.  
When MT1-MMP homodimer formation is disrupted, pro-MMP2 cannot be 
activated (Itoh et al., 2001; Lehti et al., 2002).  It is plausible that a similar 
mechanism regulates Drosophila MMP activation during wound healing, where 
Mmp2, while in a complex with Mmp1 and Timp, may form a homodimer with a 
free Mmp2, which could function to activate Mmp1 to promote re-
epithelialization.  However, Mmp1 contains furin consensus sequence, allowing 
or Mmp1 autoactivation (Llano et al., 2000), thus negating the need for the 
formation of an Mmp2/Mmp1 complex to activate Mmp1.   
A simple mechanism in which to prevent protease function is simply to 
prevent protease/substrate interactions.  We have shown that Mmp1 is required 
for wound healing, and as such it is conceivable that mislocalization of Mmp1 
would interfere with access of Mmp1 to its substrates, precluding Mmp1 
functions during wound healing.  A putative Mmp2/Mmp1/Timp complex may 
simply function as a mechanism to localize secreted Mmp1 to the cell surface, 
thus promoting Mmp1/substrate interactions.  While our data might support the 
hypothesis that formation of an Mmp2/Timp/Mmp1 complex in the epidermis 
is required to facilitate wound healing; at this point the actual formation of an 
Mmp2/Timp/Mmp1 tri-molecular complex in vivo is speculative.  Our work in 
S2 cell culture indicates that both Mmp1 and Mmp2 physically interact with 
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Timp, but the three components do not co-localize or co-IP together.  Just as we 
find both shared and independent phenotypes of Mmp1 and Mmp2 that suggest 
that formation of a tri-molecular complex is context-specific in vivo, it is possible 
that in cell culture as well, Mmp2/Mmp1/Timp complex formation is also 
context specific.  While the formation of an MT1-MMP/proMMP2/TIMP2 
complex has been shown to be required for proMMP2 activation in cell culture 
(Itoh et al., 2001), MT1-MMP is not required for MMP2 activation in vivo (Wang 
et al., 2000; Zhou et al., 2000a), leaving the tri-molecular complex without a 
precise function in vivo.  Precisely how and when this tri-molecular complex 
functions in vivo to facilitate re-epithelialization during wound healing remains 
elusive.  However, until evidence of physical interaction between Mmp2, Mmp1, 
and Timp is established in vivo the re-epithelialization failure phenotypes in 
Mmp1 and Mmp2 mutants may simply represent a shared phenotype between 
Mmp1 and Mmp2 in Drosophila.  As an alternative hypothesis to explain the 
shared Mmp1, Mmp2, and Timp phenotypes as well as our Mmp1 localization 
data, we propose that Mmp2 may function to process some unknown molecule 
that is necessary to promote Mmp1 localization at the cell surface. By this model, 
in conjunction with our data, Timp would still function as an adaptor, a 
hypothesis that our data cannot disprove, perhaps functioning to enhance Mmp1 
localization by promoting interactions between Mmp1 and an unknown factor.   
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Mmp1 and Mmp2 function independently during normal ECM maintenance. 
 Previously we reported that Mmp1 is required for baseline ECM 
maintenance, where we found that in the absence of Mmp1 there is significantly 
less type IV collagen present in the basement membrane (Stevens and Page-
McCaw, 2012).  The present study expands on those results to show that Mmp1 is 
required for Vkg (Drosophila type IV collagen α2) deposition into the ECM.  Our 
data also indicates that proper secretion and deposition of the heparin-sulfate 
proteoglycan, Perlecan, from the epidermal cells into the ECM is dependent on 
Mmp1.  This result could implicate Mmp1 in mediating Pcan localization directly, 
or disruption of Pcan localization in Mmp1 mutants could be a secondary to the 
defects in Vkg deposition.  Previous studies have suggested that type IV collagen 
matrix is established, followed by Pcan insertion into that matrix (Fessler et al., 
1994; Pastor-Pareja and Xu, 2011b); therefore, disruption in the initial type IV 
collagen matrix would lead to mislocalization of Pcan.  An alternative hypothesis 
is then that Pcan is produced, released from the epidermis, but without Mmp1 to 
facilitate type IV collagen matrix formation, Pcan cannot be effectively deposited 
into the ECM and simply mixes into hemocol of the animal.  Cells are actively 
aware of the composition of the basement membrane (Discher et al., 2005b) and 
may respond to Pcan mislocalization by continuously producing and secreting 
Pcan as a mechanism to compensate for the disorganized ECM.  While it is not 
too surprising that over-expression of the endogenous MMP inhibitor, Timp, 
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recapitulates this phenotype, as we would expect overexpression of an Mmp1 
inhibitor to interfere with Mmp1 function, it was surprising to discover that loss 
of Timp also prohibited extracellular Pcan localization.   This phenotype could be 
a secondary defect to the Mmp1 mislocalization defects that we observe in Timp 
mutants, or indicate that Timp itself directly plays a role in facilitating ECM 
organization.  During Drosophila development, loss of Timp results in wing 
blisters and gut malformations that cause tissue autolysis (Godenschwege et al., 
2000b), both of which are phenotypes that could develop due to an impairment 
in ECM organization, further implicating Timp with a role in promoting ECM 
maintenance under normal physiological conditions.   
Unlike either Mmp1 or Timp, Mmp2 is not required for extracellular Pcan 
localization in the ECM, suggesting that Mmp1 and Mmp2 function 
independently during baseline ECM maintenance.  Additionally, independent 
phenotype suggests that an Mmp2/Timp/Mmp1 tri-molecular complex is not 
required for ECM maintenance, which is further validated by our results that 
suggest that the Mmp1 hemopexin domain is also not required for Pcan 
localization.  Mmp1 and Mmp2 have been shown to function independently 
during other tissue remodeling processes, such as trachea development, air sac 
development, dendritic arbor modifications, as well as other instances of tissue 
remodeling during Drosophila development and morphogenesis (Glasheen et al., 
2010b; Page-McCaw et al., 2003b; Wang et al., 2010; Yasunaga et al., 2010).   
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The appearance of both independent and shared functions of Mmp1 and 
Mmp2 suggest that if a tri-molecular complex may form between Mmp1, Mmp2, 
and Timp in vivo, but if it does it is context-specific.  In the context of wound 
healing, our data suggests that the Drosophila membrane-anchored MMP, Mmp2, 
the secreted MMP, Mmp1, and their endogenous inhibitor, Timp, function 
together to promote re-epithelialization, presumably by facilitating cell 
migration.  However, in a context that does not require cell migration, such as 
ECM maintenance and organization, Mmp1, Mmp2, and Timp are not required to 
function together, allowing Mmp1 and Mmp2 play independent roles.  Further 
elucidation of the mechanisms that regulate MMPs during normal physiological 
processes may provide insight into how these versatile proteases function during 
disease states.   
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CHAPTER VI 
 
CONCLUSIONS & DISCUSSION 
  
By utilizing a simple in vivo model to study wound healing, we have 
found that both classes of MMP, secreted and membrane-anchored, as well as the 
inhibitor, Timp, are required for wound healing in Drosophila.  During re-
epithelialization, our data indicate that Mmp1, Mmp2, and Timp are required to 
promote cell elongation, an indicator of cell migration.  Mmp1 is also required for 
Vkg accumulation at the wound margin, in addition to promoting dpERK 
expression in leading edge epidermal cells, signaling cell migration.  During the 
initial inflammation phase, Mmp1, Mmp2, and Timp may function to facilitate 
hemostasis and melanization of the wound site.  In response to wounding, 
Mmp1 is dramatically up-regulated in both the epidermis and the hemocytes, 
under the control of the JNK pathway.  Our investigations into the tissue-specific 
requirement of Mmp1 during wound healing demonstrated that Mmp1 
expression specifically in the epidermis is required for re-epithelialization.  In the 
hemocytes, however,  we do not have a clear phenotype;  Mmp1 is up-regulated 
in response to wounding in hemocytes, but at most He>Mmp1-dsRNA mutants 
only have delayed re-epithelialization, similar to the wound healing delays 
observed in mice deficient for MMP-8, a neutrophil MMP (Gutierrez-Fernandez 
et al., 2007a), suggesting that hematopoietic Mmp1 may play a different function 
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during wound healing than Mmp1 expressed in the epidermis.   Additionally, 
Mmp1 localization in the epidermis, as well as up-regulation in the hemocytes 
may require Mmp2 and Timp, as we find disrupted Mmp1 localization in Mmp2 
and Timp mutants.  The localization phenotype, in conjunction with the shared 
re-epithelialization phenotypes found in Mmp1, Mmp2, and Timp mutants 
provides support for the hypothesis that an Mmp2/Timp/Mmp1 tri-molecular 
complex may be required for localization of secreted Mmp1, and suggests that 
this complex may function in vivo to facilitate re-epithelialization.   
 The potential wound healing delays that we observe when we 
knockdown Mmp1 in the hemocytes, as well as our data that suggests that 
Mmp1.f2 catalytic activity in the hemocytes is required for re-epithelialization, is 
somewhat contradictory the current literature, which indicates that hemocytes 
are not required for wound closure (Babcock et al., 2008; Galko and Krasnow, 
2004a; Stramer et al., 2005).  Loss of crystal cells, in lozenger15 (lzr15) mutants, in 
Drosophila larvae has no effect on re-epithelialization, despite scab formation 
defects (Galko and Krasnow, 2004a).  Similar studies ablated most hemocytes by 
driving Hid, a Drosophila gene involved in inducing apoptosis (Goyal et al., 2000), 
with the hemocyte marker peroxidasin (Pxn-Gal4), showed no effect on re-
epithelialization (Babcock et al., 2008).  However, as with the other hemocyte-
specific GAL4 drivers (He-GAL4 and Hml-GAL4), Pxn-GAL4 is only expressed in 
a portion of the hemocyte population (Meister, 2004), leaving the possibility that 
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hemocytes not expressing Pxn are able to compensate for the loss of Pxn-
expressing hemocytes to promote wound healing.   Until re-epithelialization can 
be assessed in animals completely devoid of hemocytes the requirement for 
functional hemocytes during wound healing in Drosophila larvae cannot be 
adequately determined.   
Even if hemocytes are not required for re-epithelialization, our data does 
suggest that Mmp1 from the hemocytes may play a role in regulating the wound-
induced inflammatory response, as both ERK and JNK signaling are affected 
when we knockdown Mmp1 is the hemocytes.  Similar to the epidermis, we find 
that wound-induced Mmp1 up-regulation in the hemocytes is controlled by the 
JNK pathway; however, by PucLacZ, a transcriptional reporter of Puc expression 
and a readout of JNK signaling, Mmp1 appears to function in a feedback loop, 
restricting epidermal Puc expression in both intensity and spatially limiting Puc 
expression to the vicinity of the wound site.  Similarly, Mmp1 expression from 
the hemocytes may also play a role in limiting wound-induced dpERK 
expression, as we find an expansion, in mutants, in number of epidermal cells 
near the wound site expressing dpERK.  A decrease in epidermal expression of 
both RTK and JNK signaling, which we have shown to induce Mmp1 up-
regulation, may contribute to the delayed wound closure phenotype suggested 
by our He>Mmp1-dsRNA data, as both ERK signaling and Mmp1 expression in 
the epidermis are necessary for re-epithelialization (Stevens and Page-McCaw, 
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2012; Wu et al., 2009b); providing evidence that there is some form of hemocyte / 
epidermal cell cross-talk during wound healing that promotes wound healing.  
Previous studies have shown that the Drosophila PDGE/VGEF-like ligand, Pvf1, 
from the hemolymph is required to induce re-epithelialization (Wu et al., 2009b).  
In vitro studies show that MMPs function to cleave chemokines (Overall et al., 
2002) effecting inflammation and wound healing (McQuibban et al., 2001).  If 
MMPs perform a similar function in vivo, perhaps once hemocytes are recruited 
to the wound site they release Mmp1, which prototypically-processes a signaling 
molecule, such as Pvf1, to stimulate epidermal cell migration. 
  Focusing on the re-epithelialization defects, we propose that the cell 
migration defects found in Mmp1 mutants, as seen in the failed cell elongation 
and actin remodeling, may be secondary to the defects in both baseline ECM 
maintenance and ECM remodeling post-wounding that we observe in Mmp1 
mutants.  A somewhat surprising result, this suggests that during wound 
healing, a secreted MMP is required not simply to degrade ECM, but plays a role 
in ECM deposition.  In light of the results that indicate that Mmp1 is also 
required for baseline ECM maintenance, we propose that Mmp1 may function to 
cleave matrix components in order for new ECM components to be inserted into 
the matrix as it grows, or as the leading edge epidermal cells invade the wound 
bed.  Precedence for an MMP to promote matrix assembly has been shown in 
MT1-MMP null mice, which have weak tendons resulting from an inability to 
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maintain these collagen-rich connective tissues (Holmbeck et al., 1999).   
However, it is important to note the structure of the fibrillar matrix composing 
the structure of the tendons is very different from the non-fibrillar ECM that 
makes-up the Drosophila basement membrane.  This is the first evidence that a 
secreted MMP is required for basement membrane deposition.  A necessary part 
of re-epithelialization is the re-establishment of the ECM that was destroyed 
during wounding.  If the ECM is not repaired, cells will lack the necessary 
structure support to accommodate migration, resulting in re-epithelialization 
failures. 
While our data indicate that Mmp2 is required for re-epithelialization, we 
also find that, Mmp2 is not required for basement membrane maintenance, at 
least by Pcan localization, suggesting that the re-epithelialization defects in 
Mmp2 mutants are not secondary to a weakened basement membrane.  One 
hypothesis is that Mmp2 functions in a complex with Mmp1 to tether Mmp1 at 
the cell surface; therefore, in the absence of Mmp2, Mmp1 is mislocalized and 
does not associate with the necessary substrates to facilitate cell migration. 
Whether those substrates are ECM components, or other bioactive molecules it is 
unclear.  However, from our work in cultured S2 cells, Mmp1 and Mmp2 do not 
physically interact, undermining the tri-molecular complex hypothesis.  If a 
complex does form between Mmp2, Timp, and Mmp1, our data indicate that it is 
context-specific, required for some Mmp1 functions during wound healing, but 
not all.  Alternatively, Mmp2 could function to proteolytically-process an 
 208 
 
unknown molecule that then facilitates Mmp1 localization, a hypothesis that we 
could test by expressing a catalytically-inactive form of Mmp2 in the epidermis 
or the hemocytes followed by assessment of Mmp1 localization.    
  While there are only two MMPs in the Drosophila genome, as opposed to 
the 25 MMPs in vertebrates, suggesting that Drosophila should serve as a simple 
system in which to study MMP function; the function of MMPs in Drosophila 
appears to be more complicated than suggested by the simplicity of their 
genome.  In Drosophila, there is only one secreted MMP to potentially perform 
the functions of seventeen MMPs in vertebrates, just as there is only one 
membrane-anchored MMP in Drosophila to potentially function as nine do in 
vertebrates.  We have identified roles for both Mmp1 and Mmp2, as well as their 
endogenous inhibitor, Timp, during both the inflammatory and the re-
epithelialization phases of wound healing including some shared phenotypes, 
such as promoting cell elongation and re-epithelialization, and possibly 
contributing to hemostasis and melanization, as well as independent functions 
during ECM maintenance and ERK signaling  From our studies of MMPs during 
wound healing we hypotheszie that Mmp1 and Mmp2 functions may be finely 
and differentially regulated in a context-specific manner.  For example, we have 
shown that Mmp1 up-regulation in response to wounding is dependent on JNK 
signaling, but JNK signaling is not required for Mmp1 expression in unwounded 
tissues.   Whereas, the unwounded epidermis requires Mmp2 and Timp or Mmp1 
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localization, ECM maintenance only requires Timp and Mmp1.  Mmp2 and Timp 
may also be required for wound-induced Mmp1 up-regulation, but those results 
are difficult to interpret as mislocalization and failure in Mmp1 up-regulation 
would appear the same in our assay; that hypothesis would be better tested with 
an Mmp1 transcriptional reporter.  Additionally, our data suggest that Mmp2, 
Timp, and Mmp1 may form a tri-molecular complex in order to facilitate 
hemostasis, scab formation, and re-epithelialization, but such a complex is not 
required for many processes outside of wound healing, such as trachea 
elongation (Glasheen et al., 2010a), or wing disc eversion during development.  
Together, this work demonstrates the importance of in vivo analysis, not only to 
identify the function, but also the regulatory mechanisms that control that 
function, particularly for highly versatile proteins, such as MMPs.  Many MMPs 
are up-regulated in wound healing in vertebrates, but they are frequently 
separated spatially and temporally (Gill and Parks, 2008), suggesting that each 
MMP has a unique function during wound healing, which may become clear if 
we understand the context-specific mechanisms regulating that MMP.  
Understanding the functions and complex mechanisms that regulate MMPs 
during wound healing could provide insight into MMP functions during 
pathological states, such as chronic wounds, arthritis, and cancer. 
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CHAPTER VII 
 
FUTURE DIRECTIONS 
 
 As with any line of research, there are always more questions.  Studying 
MMPs in Drosophila provides an in vivo system to study the functions and 
regulatory mechanisms of each class of MMP.  We have identified several shared 
phenotypes between Mmp1 and Mmp2 during wound healing, as well as a few 
independent phenotypes, indicating that MMPs in Drosophila play multiple roles 
during wound healing.  Mmp1, Mmp2, and Timp, are each required for re-
epithelialization, but how each promotes wound healing is unclear.  We have 
suggested that the ERK signaling, actin remodeling, and cell elongation defects 
observed in Mmp1 mutants are secondary to the ECM defects found in this 
genetic background, but an alternative possibility is that each represents an 
independent function of Mmp1 elicited after unique Mmp1-dependent 
proteolytic events.  Further research is required to fully comprehend precisely 
how MMPs are involved during wound healing in vivo. 
 Extensive research has clearly elucidated the mechanism of hemostasis in 
mammals, but the same cannot be said of the mechanisms of hemostasis in 
arthropods, such as Drosophila melanogaster.  The specific components of the 
clotting mechanism are different between mammalian and arthropod systems, 
outcome of the two pathways are similar.  By more thoroughly understanding 
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the individual components of the clotting mechanisms and their functions in 
Drosophila, we can potentially identify parallels between the mammalian and 
insect pathways.  Our studies have shown that both Drosophila Mmp1 and Mmp2 
play a role in promoting hemostasis and scab formation.  However, further 
research is required to understand specifically what role MMPs play in the 
melanization cascade, whether they directly or indirectly facilitate clotting and 
scab formation.  We propose two different mechanisms for the relationship 
between Mmp1 and Mmp2 during scab formation.  First, that Mmp1 and Mmp2 
function independently, but have opposing functions: Mmp1 promotes 
melanization, while Mmp2 inhibits melanization. A second model could be that  
Mmp2, Timp, and Mmp1 form a tri-molecular complex on cell surface, of 
presumably crystal cells, where they function together to restrict Mmp1 activity, 
thus promoting melanization at the wound site.  Our wounding assay does not 
address a response to septic wounding, or response to a real immune threat, 
where melanization would be required to neutralize said pathogen.  To 
determine if Mmp1 or Mmp2 is also required for melanization following 
infection, melanin deposition following septic wounding, as well as exposure to 
actual Drosophila pathogens, such as parasitic wasps, should be assayed in Mmp1 
and Mmp2 mutant backgrounds.  If Mmp1 and/or Mmp2 are only required to for 
melanization at the wound site, then we would not expect any defects in 
pathogen encapsulation in response to infection.  Further research is need to 
understand the extent of the melanization phenotype presented here, to 
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determine if MMP functions are limited to hemostasis, or if they extend to the 
innate immune response.  
During wound healing, hemocytes dramatically up-regulate Mmp1 not 
just when found in the wound bed, but in a systemic response to wounding.  Our 
data suggest that Mmp1 may play a role in limiting both JNK and ERK signaling 
to the vicinity of the wound site.  However, this is merely an observation from 
preliminary experiments, which need to be confirmed through replication and 
quantification.  While we show that Mmp1 is promotes RTK signaling, we do not 
know if Mmp1 directly, or indirectly participates in RTK signaling.  To further 
establish a specific function of Mmp1 during wound healing, research should be 
conducted to elucidate Mmp1 substrates in vivo during wound healing, perhaps 
by co-immunoprecipitation assays of lysates from wounded epidermal samples, 
followed by mass spectrometry analysis to identify proteins that co-IP with anti-
Mmp1.    
Intriguingly, we observe several subpopulations of hemocytes in the 
wound bed, including those that express high levels of Mmp1 and those that do 
not, some that express He, a plasmatocyte marker, and some morphological 
plasmatocytes that do not express Hemese.  These observations suggest that there 
may be unique subpopulations of plasmatocytes involved in wound healing.  
Characterizing these various plasmatocytes subpopulation would be an 
interesting new avenue to pursue, as most of the work in Drosophila 
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hematopoiesis has been focused on the three major types of hemocyte, crystal 
cell, lamellocytes, and plasmatocytes (Kurucz et al., 2007; Meister and Lagueux, 
2003), but little is known about the subpopulations within each class, or the 
precise function and regulation of hemocytes during wound healing. 
We also show data that suggest that the Mmp1 isoform, Mmp1.f2, may be 
required in the hemocytes to promote wound healing, which is contradictory to 
the literature that suggests that hemocytes in general are not required for re-
epithelialization.  However, those experiments were either done in embryos, 
which may repair tissue damage by regeneration mechanisms, not canonical 
wound healing mechanisms (Martin, 1997), or they were performed in 3rd instar 
devoid of only a subpopulation of hemocytes (Wu et al., 2009b).  To more 
stringently determine if hemocytes are essential for wound healing in Drosophila, 
the common hemocyte-specific drivers should be combined in the same animal, 
to effect hemocyte gene expression in multiple hemocyte populations 
simultaneously.  If it turns out that hemocytes are not required for re-
epithelialization, then our Mmp1.f2 results could be a consequence of 
overexpressing a secreted protease that, while catalytically-inactive, may induce 
extraneous functions unrelated to endogenous Mmp1.f2 function.  As with all 
our Mmp1 isoform data, isoform-specific RNA interfering (RNAi) constructs 
should be made to confirm our with the dominant-negative, catalytically-inactive 
Mmp1 constructs, the requirement for Mmp1.f1 in the epidermis and Mmp1.f2 in 
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the hemocytes for re-epithelialization, as well as potentially identify additional 
isoform-specific functions. 
In zebrafish, MMP-13 plays a role in macrophage recruitment to wounds 
(Zhang et al., 2008).  In Mmp1 mutants we actually observe an opposite 
phenotype, where there may be an increased number of hemocytes found in 
wound sites, suggesting that either in the absence of Mmp1 the inflammatory 
response is enhanced, allowing recruitment of more hemocytes to the wound, or 
in the absence of Mmp1 hemocytes once captured at the wound site, are unable to 
release adhesions are a subsequently retained within the wound.  MMPs have 
also been shown to function to modify integrins (Pal-Ghosh et al., 2011; Vaisar et 
al., 2009), if such modifications are required to release hemocytes from the 
wound, then if we were to knock down both Mmp1 and an integrin using RNAi 
in the hemocytes simultaneously, then we would expect to find a decrease in the 
number of hemocytes retained in the wound site.  We have not analyzed wound-
induced hemocyte dynamics in an Mmp2 or Timp mutant background, so it is 
possible that Mmp2 or Timp may also play a role in either recruiting or releasing 
hemocytes from the wound site.   
 Based on our wound closure assays, Mmp1, Mmp2, and Timp may function 
together to promote re-epithelialization; however, it is presently unclear if Mmp1, 
Mmp2, and Timp function together, perhaps as a complex, or if they function 
individually to promote wound healing.  Information regarding the in vivo 
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localization of Mmp2 and Timp could be very informative; however, the tools to 
assess Mmp2 and Timp localization are currently unavailable.  Our attempts at 
generating antibodies against either Mmp2 or Timp were unsuccessful.  An 
alternative tactic would be to generate flies with fluorescently-tagged Mmp2 or 
Timp at the endogenous locus by homologous recombination, in order to 
visualize endogenous Mmp2 or Timp.  If Mmp2 and Timp were tagged with 
unique fluorophores, such as CFP and YFP, then physical interactions between 
Mmp2 and Timp could be assessed by fluorescence resonance energy transfer 
(FRET).  Fluorescently-tagged proteins provide the added benefit of the potential 
for live-imaging, to monitor expression changes in real-time in vivo.  We have 
attempted to determine if Mmp1, Mmp2, and Timp physically interact in vivo by 
co-immunoprecipitation using an anti-Mmp1 antibody combined with mass 
spectrometry to identify any binding partners of Mmp1; however, these attempts 
have been unsuccessful, as we have not been able to recover enough product for 
larval lysates following IP with anti-Mmp1 to detect Mmp1, let alone any 
binding partners.  Further protocol optimization, perhaps by scaling up the 
concentration of both crude protein and antibody, may generate improved 
results. 
 Now that we have an in vivo model in which to study MMP functions 
during normal wound healing, it would be informative to adapt the system in 
order to study the functions of MMPs during abnormal wound healing, chronic 
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ulcerated wounds in diabetic patients.  Recent work has established Drosophila as 
a diabetes model by identifying animals that are mutant in the insulin/IGF 
pathway (Baker and Thummel, 2007).  By performing our wounding assays is 
such a mutant background we could potentially understand how MMPs are 
involved in wound healing under abnormal or chronic wound conditions.  
Further research into the functions and regulation of Drosophila MMPs, by either 
the aforementioned experiments, or along other avenues, is necessary to provide 
more detailed insight into the in vivo functions of each class of MMP during 
wound healing.  By understanding how MMPs function during normal wound 
healing, we may be able to design therapeutic treatments to improve the 
outcome of abnormal wound healing, to induce healing in non-healing wounds.   
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APPENDIX A 
 
SEQUENCE COMPARISON BETWEEN MMP1 ISOFORMS 
 
 The Drosophila genome has been shown to encode 1 secreted MMP, Mmp1 
(Llano et al., 2000) and 1 membrane-anchored MMP, Mmp2 (Llano et al., 2002).  
According to the National Center for Biotechnology Information (NCBI), there 
are 9 predicted isoforms of Mmp1 and 2 predicted isoforms of Mmp2.  Sequence 
alignment between the two predicted Mmp2 isoforms shows that both sequences 
encode an identical polypeptide, indicating that while there might be differences 
in the untranslated regions (UTRs) of the two predicted forms of Mmp2, only one 
Mmp2 polypeptide is transcribed.  For Mmp1, on the other hand, sequence 
comparison suggests that out of the 9 predicted isoforms, 5 unique polypeptides 
are generated.  We have grouped the predicted isoforms into 4 groups based on 
sequence similarity (Fig. A.1).  For all the isoforms, the differences are at the C-
terminal end of the hemopexin domain (Fig. A.1), suggesting that each isoform 
may recognize a unique set of substrates.  Mmp1 form C (hereafter referred to as 
Mmp1.f3a) and Mmp1 form H (hereafter called Mmp1.f3b) are grouped together 
because they share 53 amino acids (aa) at the end of the hemopexin domain, but 
differ by 28aa  which Mmp1.f3a shares with Mmp1.f1, but not Mmp1.f3b (green 
group in Fig. A.1).   
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Figure A.1: Sequence comparison between predicted Mmp1 isoforms. 
A) Mmp1 amino acid sequence with the conserved region in black and the regions unique to each 
isoform in color-coded based on designated group shown in (B).  The base of the arrow indicates 
where the sequence of each isoform deviates from the conserved sequence, or in the case of 
Mmp1.f3a, from the unique region of Mmp1.f1.  B) Table showing how the 9 predicted Mmp1 
isoforms are grouped into 4 groups.  Color shading of each group corresponds to the colored 
sequences in (A).  Also included in the table is the number of amino acids for each predicted 
polypeptide, the number of unique amino acids for each class, the domain that contains the 
unique sequence, and the new name that we assigned to each unique polypeptide.  Mmp1.f1 has 
12 unique amino acids + 28 amino acids that are only shared with Mmp1.f3a.  Mmp1.f2 and 
Mmp1.f4 has 11 and 26 unique amino acids, respectively.  Group 3 has two members, Mmp1.f3a 
and Mmp1.f3b, which differ only by the 28 amino acids that Mmp1.f3a shares with Mmp1.f1, 
which Mmp1.f3b does not contain.   
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Once we determined the sequence similarity between the isoforms, we 
need to determine which if any of these predicted Mmp1 isoforms actually exist. 
Mmp1.f1 and Mmp1.f2 cDNA has been previously isolated from screening 
embryo, larval, and pupal libraries (Page-McCaw et al., 2003b), demonstrating 
that both Mmp1.f1 and Mmp1.f2 are at least translated in Drosophila. As for the 
other isoforms, only Mmp1.C (which we call Mmp1.f3a in Fig. A.1) is strongly 
supported, according the Drosophila database, Flybase (Flybase.org), by the 
existence of 3 cDNA clones that contain a full length Mmp1.C transcript.  This 
strongly suggests that Mmp1.f3a exists in vivo.  There is only weak evidence 
suggesting the existence of either Mmp1.hMmp1.K or Mmp1.I, which we classify 
as Mmp1.f3b or Mmp1.f4, respectively.  For these three predicted isoforms there 
are end sequence only cDNA sequences that contain a portion of Mmp1.H, 
Mmp.I, or Mmp1.K, with 5 expressed sequence tags (ESTs) recognizing Mmp1.H 
and Mmp1.K, but not Mmp1.I.  However, there are no cDNAs that contain full 
length transcripts of Mmp1.H, Mmp1.K or Mmp1.I, calling into the question the 
existence of these isoforms.  Together, this analysis suggests that there are at least 
three Mmp1 isoforms that may have recognize a unique set of substrates and 
perform independent functions in vivo.   
 
 
 
 221 
 
Methods 
Sequence analysis. 
 Amino acid sequences were gathered for each predicted isoform from the 
NCBI database and imported into SerialCloner v.2.1.  Sequences were aligned 
using the Local align feature and then scanned by eye to identify the start and 
stop of each open reading frame.   
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APPENDIX B 
 
 ECM DEFECTS MAY NOT BE SUFFICIENT TO INDUCE  
RE-EPITHELIALIZATION DEFECTS 
 
Introduction 
 Often thought of as a static extracellular structure, the ECM plays an 
important role in facilitating cell mobility and regulating signaling events during 
development, inflammation, and repair processes (Dobaczewski et al., 2010; 
Kirmse et al., 2011a; Wang et al., 2008).  Similar to vertebrates, the basement 
membrane in Drosophila is composed of primarily type IV collagen, laminin, an 
entactin, Nidogen, and a heparan-sulfate proteoglycan, Perlecan (Pcan), (Fessler 
and Fessler, 1989).  Type IV collagen forms heterotrimers between a combination 
of two subfamilies, α1-like, encoded by Collagen at 25C (Cg25C) in Drosophila, and 
α2-like, encoded by Viking (Vkg) (Le Parco et al., 1986; Yasothornsrikul et al., 
1997).  Perlecan is encoded by trol in Drosophila, which has previously been 
shown to be expressed in hemocytes (Lin, 2004; Lindner et al., 2007), and our 
previous studies suggest that Pcan may be produced by the epidermis (Chapter 
V).  Trol has been shown to be involved in several growth factor signaling 
pathways, including PDGF/VEGF, and when mutated results in a decreased 
number of circulating plasmatocytes (Lindner et al., 2007), both of which are 
phenotypes that could lead to impaired wound healing.  However, in this 
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appendix, we report that ECM defects may not be sufficient to induce re-
epithelialization defects.   
 
Methods 
Fly lines. 
The following lines from the Vienna Drosophila RNAi center (VDRC) 
were used: UAS-Vkg-dsRNA (VDRC transformant 106812), UAS-Cg25C-dsRNA 
(VDRC transformants 104536 and 28369), UAS-trol-dsRNA (VDRC transformants 
22642 and 24549).  Other fly lines used were A58-Gal4 (M. Galko), and Hml-Gal4, 
UAS-eGFP (J. Royet), and C564-GAL4 (FlybaseID FBst0006982).  w1118 was used as 
wild type. 
 
Wounding assay and immunohistochemistry. 
 The wounding assay follows the protocol described in Stevens and Page-
McCaw (2012).  Wounded animals were collected 18h post-wounding for wound 
closure analysis.  Dissections, fixation, and immunohistochemistry was done 
according to protocol described in Stevens and Page-McCaw (2012).  Primary 
antibodys used were mouse monoclonal IgG2a anti-FasIII (DSHB) used at 1:10 
and a 1:1 cocktail of mouse monoclonal IgG1 ant Mmp1 clones 5H7 and 3B8 
(DSHB) used at 1:100.  Secondary antibodies used were Cy3-labeled goat anti-
mouse IgG1 (Jackson Immuno) and DyeLight 649-labeled goat anti-mouse IgG2a 
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(Jackson Immuno) both used at 1:300.  Tissue was mounted onto slides in 
Vectashield mounting media + DAPI. 
 
Microscopy. 
Optical sectioning was performed with a Zeiss Apotome mounted on an 
Axio imager Z1 or M2, with the 20X/0.8 Plan-Apochromat objective. Fluorescent 
images were acquired with an Axiocam MRm (Zeiss) camera paired with 
Axiovision 4.8 (Zeiss). Z-stacks were compressed into 2-deminsional XY 
projections using the Orthoview function in Axiovision.  All images were 
exported from their acquisition programs as 16-bit, grayscale, TIFF files for post-
processing in Adobe Photoshop CS4, or ImageJ v.1.43u.  
 
Wound area measurements. 
Closure and wound area were assessed based on the presence of both 
FasIII staining at cell borders and epidermal polyploid nuclei as stained with 
DAPI. To calculate wound area, the outline tool in Axiovision (Zeiss) was used to 
manually outline the wound edge.  This feature automatically calculates the area 
of the outlined region using image acquisition specifications.  Statstical anaylses 
were performed with the analysis tools available in GraphPad Prism v. 5.01 to 
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compare mutant and wild-type wound area by One-way ANOVA.  Error bars 
represent the standard error of the mean.   
 
 
Results and Discussion 
We have previously reported that Mmp1 is required for both wound 
healing and deposition of ECM components into the basement membrane 
(Stevens and Page-McCaw, 2012) and we hypothesized that the re-
epithelialization defects are secondary to the ECM defects that we observe in 
Mmp1 mutants.  To test this hypothesis, we knocked-down expression of trol, 
Cg25C, or Vkg using double-stranded RNA constructs.  There is some debate 
over which tissue, epidermis, hemocyte, or fat body, is important for the 
production of ECM components (Bunt et al., 2010; Lin, 2004; Pastor-Pareja and 
Xu, 2011b), so we utilized three different drivers to knockdown expression in the 
hemocytes with Hemolectin-GAL4 (Hml-GAL4), the epidermis with A58-GAL4, or 
the fat body  with C564-GAL4.  To assess re-epithelialization ability, wound area 
was measured 18h post-wounding.  In wild type larvae 18h post-wounding, 
wounds have closed in 84% of animals tested (Fig. B.1A-C).  When Cg25C, or α1-
like collagen IV, is knocked down using a UAS-Cg25C-dsRNA construct 
expressed specifically in the fat body (C564>Cg25C-dsRNA) wounds remained 
open in 2 out of 3 (67%) animals tested, with a wound area that is not 
significantly larger than wild type 18h post-wounding (Fig. B.1A-A’).  These 
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preliminary data suggest that Cg25C expression in the fat body is not required 
for re-epithelialization.  When we knocked down Cg25C in either the hemocytes 
(Hml>Cg25C-dsRNA), or in the epidermis (A58>Cg25C-dsRNAi), however, 
wounds remained open in 2 of 4 (50%), and 2 of 3 (67%), respectively (Fig. B.1A), 
but there was no significant difference in wound area between mutant and wild 
type 18h post-wounding (Fig. B.1A’).  When we knocked down Vkg, or α2-like 
collagen IV, with the three drivers, wounds closed in 2 of 2 (100%) C564>Vkg-
dsRNA mutants, while wounds remained open in 4 of 7 (57%) Hml>Vkg-dsRNA 
and 2 of 4 (50%) A58>Vkg-dsRNA mutants 18h post-wounding (Fig. B.1B).  In 
Vkg-dsRNA mutant backgrounds, there was no significant difference in average 
wound area 18h post-wounding between mutant and wild type (Fig. B.1B’), 
suggesting that tissue-specific knockdown of Vkg is not sufficient to cause re-
epithelialization defects.  Similarly, interfering with trol expression had no effect 
on re-epithelialization in 2 of 2 (100%) C564>trol-dsRNA mutants, but caused 
wounds to remain open in 2 of 6 (33%) Hml>trol-dsRNA and 2 of 5 (40%) 
A58>trol-dsRNA mutants 18h post-wounding (Fig B.1C); in all trol-dsRNA 
mutants backgrounds there was no significant difference in wound area 18h 
post-wounding relative to wild type (Fig. B.1C’).  Together, these results suggest 
that tissue-specific knockdown of trol is not sufficient to cause re-epithelialization 
defects.    
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RNAi lines needs to be confirmed.  Two independent UAS-Cg25C-dsRNA and 
UAS-trol-dsRNA lines used for the re-epithelialization experiments, with 
equivalent results, which suggest that we are not observing off-target effects, but 
we have not measured, by qPCR, the amount of CG25C or trol knockdown that 
we actually obtained.  It is plausible that the dsRNA constructs that we used do 
not cause sufficient expression knockdown to produce a phenotype.  When these 
experiments were performed, there was only one UAS-Vkg-dsRNA line available, 
so we were not able to control for off-target effects, and like the other ECM RNAi 
lines, the efficacy of Vkg expression interference induced by this UAS-Vkg-dsRNA 
line was not measured.  Assuming that these RNAi lines cause significant 
expression knockdown and do not have off-target effects, it is also possible that 
knocking down either Vkg, Cg25C, or trol in just one tissue is not enough to 
induce a basement membrane defects, this experiment assumes that ECM 
components are only produced from one tissue source, but it is possible that 
either multiple tissues contribute to basement membrane production, or other 
tissue are able to compensate for loss of ECM component expression from a 
primary source, by producing and secreting the necessary ECM component.  We 
could test this hypothesis by driving Cg25C-dsRNA, Vkg-dsRNA, or Trol-dsRNA 
with a more ubiquitous driver, such as tubulin-GAL4 (Tub-GAL4), eliminating the 
need to know specifically which tissue is required for basement membrane 
production.    The finding that ECM defects may not lead to re-epithelialization 
defects post-wounding is surprising and more research is required both to 
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confirm this result, as well as to determine the specific role of the basement 
membrane during wound healing. 
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